How prenatal genetic testing protects patients—and you

Article Type
Changed
Display Headline
How prenatal genetic testing protects patients—and you

The author reports no financial relationships relevant to this article.

CASE 1 ObGyn fails to scrutinize test results

A woman consulted board-certified ObGyns during the first trimester of her pregnancy and informed one of them that she had recently been given a diagnosis of measles, but was unsure whether the illness was German (rubella virus) measles. The physician examined her and ordered a rubella titer. The results, he noted, “were indicative of past infection.” Instead of performing further testing, he told the patient she “had nothing to worry about because she had become immune to German measles as a child.”1

Soon after birth, her child was diagnosed as suffering from congenital rubella syndrome, including eye lesions, heart disease, and auditory defects.1

Apparently, the physician had failed to consider whether the positive test result was indicative of current, rather than past, infection—and failed to perform further testing to determine whether the titer was falling, stable, or rising.

Is he legally liable for this omission?

The physician in this case violated a simple tenet: If a test is ordered, the clinician must be able to interpret the results or order further testing to ensure that the patient is given valid advice. This physician’s error was compounded by the fact that the patient had notified him of the potential for fetal injury.

Would he be held accountable in a court of law?

The answer to that question depends on:

  • the state in which the case arose, and the laws in effect at the time of the incident
  • the action initiated by the plaintiff and her attorneys, which may involve “wrongful birth,” “wrongful life,” or other allegation
  • the time that transpires between the genetic test (or diagnostic test, such as a rubella titer) and the legal case—in other words, the statute of limitations. In some cases, this period encompasses the time elapsed between omission of a test (or birth of a child) and the filing of a legal claim.
In this article, I highlight three pertinent legal cases and the lessons to be learned. Because national legal case reporters generally publish opinions from appellate courts, they usually focus on determinations of law, with factual determinations and decisions on liability remanded back to the trial court.

For the purposes of this article, I assume that the facts in the judicial opinion are correct, but focus on legal principle.

Don’t overlook the patient when planning prenatal tests

Patient testing: ethical issues in selection and counseling. ACOG Committee Opinion No. 363. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2007;109:1021–1023.

Knowledge can be a dangerous thing. At the very least, a bid for genetic data requires careful consideration and preparation, particularly when the information may determine whether a woman continues or terminates her pregnancy.

In April, the American College of Obstetricians and Gynecologists published a Committee Opinion on ethical considerations in the selection and counseling of patients in regard to testing. Although the opinion concerns testing in general—rather than prenatal genetic testing specifically—a number of recommendations are applicable to both:

  • Perform testing for the benefit of the patient, not simply because a third party—e.g., her partner, extended family, employer, insurer, or health-care provider—deems it to be necessary. Ensure that she gives consent before proceeding.
  • Do not base testing decisions on assumptions about how the patient will respond. “Prejudgments about a patient’s wishes regarding fetal abnormalities, for example, should not preclude her being offered prenatal testing,” the opinion states.
  • Tell the patient how the results will be communicated, and to whom.
  • Provide or refer the patient for specific counseling whenever planned testing may have multiple medical or psychological implications.
  • Respect the patient’s autonomy and involve her in decision-making. If she elects to forego a recommended test, document her refusal in the medical record—and include the reason.

Detectable genetic disorders have increased exponentially

Almost any health-care provider encounters patients who have inheritable disease. Cases have arisen against an oncologist for failure to convey to the patient the potential for genetic transmission of colonic polyposis and against a surgeon for failing to warn a young breast cancer patient that she may carry genes that predispose her offspring to ovarian cancer. But the highest-risk category is reserved for the obstetrician, who must, on a daily basis, consider the need for appropriate screening and proper counseling about the availability of genetic testing that may enable the patient to avoid passing catastrophic disease to her children.

 

 

This responsibility is complicated by a dramatic increase in the number of genetic tests. Few areas of medical practice have expanded as rapidly as prenatal genetic testing and counseling. Forty years ago, an obstetrician—or even a nurse—might have discussed the risks of pregnancy at an advanced age, as well as a few possible genetic abnormalities. Today, certified genetic counselors are employed by many clinics and even private practices, and more than 1,000 disorders—as many as 1,300, by some reports—can be detected by the proper test.

Although most of these disorders are uncommon, several dozen or so are more prevalent and, therefore, regularly tested for. They include cystic fibrosis, Down syndrome, and neural tube defects, as well as diseases associated with certain religious, racial, or ethnic groups, such as thalassemia (Mediterranean, Asian, or African heritage), Tay-Sachs (Eastern European or Ashkenazi Jewish descent), and sickle cell disease (African-American ancestry).

Ethical complexity makes resolution difficult

Legal actions are bound to increase as technology evolves, particularly when a child is born with a genetically transmissible disorder that could have been identified with proper counseling and testing. These legal actions are particularly difficult to resolve because they involve complex ethical issues. For example, in “wrongful birth” actions, the parents often allege that they would not have conceived a child if they had known that it might be afflicted with a certain trait or illness, or that they would have terminated the pregnancy if they had learned of the disorder in a timely fashion.

In most of these cases, the plaintiffs are the parents. In a few states, however, successful actions have been brought by the child (“wrongful life”), who, some contend, essentially claims that nonexistence would be better than life with a serious congenital condition. They usually seek the extraordinary expense associated with the condition, as well as other damages.

Similar actions have been brought by children, and parents of children, with acquired conditions such as congenital rubella syndrome, as in the opening case. In that scenario, the parents’ case was declined by attorneys because their state of residence did not allow actions for wrongful birth or wrongful life. The state courts subsequently changed the law to allow wrongful birth actions, but by the time the parents learned of the change in the law, the statute of limitations had expired. They therefore added the attorneys as defendants, alleging that they failed to recall the parents when the law changed, in time to file their lawsuit. By the time the case finally reached the state’s supreme court, the law had changed again, and the child was allowed to proceed with a wrongful life action.

CASE 2 Physician mistakes patient’s tissue for fetus’s

Before becoming pregnant, a woman experienced several medical problems that prompted her and her husband to seek genetic testing and counseling. Testing revealed that she had a balanced translocation of chromosomes 11 and 22.2

After conceiving, the woman underwent chorionic villus sampling, which indicated that the fetus was probably a female with the same chromosomal condition as the mother—therefore, she would develop normally. The mother also underwent several ultrasonographic tests to rule out fetal abnormalities and was told that imaging showed a normally developing fetus.

The woman went on to deliver a boy, and genetic testing revealed that he had trisomy 22, with severe, permanent disabilities.2 The parents sued.

Were the woman’s health-care providers liable?

This case prompts a number of questions:

  • Did the physicians seek confirmation that the tissue studied was fetal?
  • Did they counsel the parents about the possibility that maternal genetic material might be recovered during sampling? If so, did they consider that possibility when the specimen was identical to the mother’s?
  • How is it possible that, on subsequent ultrasonographic evaluations, the male sex of the fetus was not noted? If it was noted, did it register with the providers that the result was inconsistent with the genetic studies?
These questions were not addressed in the court opinion, but they could have had a significant impact on the final outcome of the case. Although the court allowed some aspects of this case to go forward, damages were limited to the costs of the pregnancy and—for reasons not disclosed—that claim was dismissed. If the delivery had been complicated, however, those costs could have been substantial.

Despite the dismissal, which was a favorable turn of events for the physicians, they almost certainly lost substantial work time and experienced the emotional roller-coaster ride that accompanies being sued—not to mention the revelation that they may have harmed a patient.

 

 

CASE 3 Physician fails to complete testing

The mother of a developmentally delayed daughter delivered another child. Before she conceived, however, she and her husband consulted a physician (a pediatrician) to find out whether there was a genetic reason for the daughter’s developmental delay and the mental retardation of another child, the girl’s half-brother.3 The physician wrote in her notes: “? Chromosomes + fragile X” to indicate testing planned for the daughter.

The testing was performed at a medical center and reported to be normal. The physician relayed this finding to the parents, but failed to mention that fragile X testing had not been conducted. Because they had discussed fragile X testing during the initial consultation, the mother assumed it had been performed and was included in the normal results.3

The latest child was also developmentally delayed, and subsequent testing revealed that all three children were positive for fragile X syndrome. The parents sued, alleging that the physician was negligent for failing to perform the genetic test, and claiming that they would not have conceived another child if they had known of the daughter’s fragile X status.

Are their claims reasonable?

Despite a state statute that prohibited wrongful birth and wrongful life actions that allege that the pregnancy would have been terminated if the parents had known of the genetic impairment, the state supreme court allowed this case to proceed because the issue was whether the mother would have avoided conception. The plaintiffs also argued that the claim did not exceed the statute of limitations. Their reasoning: Although the medical care had been provided more than 4 years earlier (the limitation period), the injury did not occur (i.e., action did not “accrue”) until conception of the child.

Perhaps most telling was the court’s statement that, “[O]ur decision today is informed by the practical reality of the field of genetic testing and counseling; genetic testing and diagnosis [do] not affect only the patient. Both the patient and her family can benefit from accurate testing and diagnosis. And, conversely, both the patient and her family can be harmed by negligent testing and diagnosis.”3

Establishing degree of harm is especially difficult

As you might imagine, allegations involving potential pregnancy termination arouse intense emotions on both sides of the abortion debate. The determination of damages is equally contentious. Among the issues that may arise at the time of trial:

  • How much is a parent harmed by the birth of a child with hereditary disease?
  • Should damages be offset by the benefit of having any child, even if the child is not “normal”?
  • How do you measure the value of a life with Down syndrome, for example, compared with no life at all?
  • Should damages include the cost of raising the child, including additional medical expenses, which can be substantial?
These and many other serious questions have faced judges and legislators for more than 30 years, and are expected to remain controversial for the foreseeable future.

Assigning blame for genetic disease is difficult

The arguments in cases involving genetic testing often differ from those made when a fetus sustains injury. In the latter, the injury may be caused by the provider—e.g., after administration of a cytotoxic drug during pregnancy or because of induction of labor at a seriously miscalculated gestational age. Legal actions associated with such injury are widely accepted.

In cases involving genetic counseling, however, the disease is not caused by the practitioner. Rather, the plaintiff alleges that the affected child was born because the provider failed to:

  • properly counsel the patient not to conceive
  • offer the parents the option of terminating the pregnancy or
  • successfully prevent or terminate a pregnancy.
At present, quite a few states allow parents to proceed when the action is for what most courts and commentators call “wrongful conception”—i.e., when negligent preconception advice, or a lack of advice, leads to conception and birth of a normal, but unplanned child (this also applies to negligent contraception and sterilization procedures). Actions for wrongful birth are not as widely accepted. Some courts have allowed recovery of some damages for these actions, whereas others have prohibited them, based on state common law principles or existing statutes. And actions by the child—so-called wrongful life actions—are allowed in only a very few states (California, Washington, and New Jersey), and damages are limited even more strictly.4

It would be unwise to base one’s conduct on existing law, which is unpredictable. The law can change if a judge determines that a prior opinion was incorrect, a statute was unconstitutional, or a particular injury justifies compensation. Legislative bodies also can change with an election, and the statutes can be amended. The best strategy for you to deal with this uncertainty? Provide comprehensive prenatal care of the highest quality.

 

 

Lessons learned

Among the lessons to be gleaned from these cases are:

  • Be sure that you understand the limits of any test that you order, and convey those limits to the patient.
  • When you inform a patient about a planned test, that test should be completed. If it is not, explain the failure to perform the test (or the lost result, etc.) to the patient so that she can act accordingly. In that regard, a laboratory or other facility can be held liable for a negligently performed test or, as was the case in one lawsuit, a sperm bank may be liable for failing to inform the recipient of donor sperm that the donor had a positive family history of renal disease (i.e., autosomal-dominant polycystic kidney disease).5
  • Be aware that, as the amount of information available in the popular literature and on the Web expands, patients will come to question their care more often. An example: A patient recently brought an action against her health-care provider because vitamins containing folate were discontinued shortly before she became pregnant, and the child was born with a neural tube defect.6
  • Most court cases, including those cited in this article, are based on the credibility of witnesses recollecting events. Well-documented, legible records written contemporaneously with an event are of enormous benefit in cases involving sometimes widely divergent recollections. When health care meets appropriate standards and is well documented in the records, most plaintiffs’ attorneys will not undertake what can be protracted and expensive litigation. When they do, the health-care provider usually prevails.
The bottom line? You are more obligated than ever to continue your medical education—not so much to avoid lawsuits, although that is certainly a possible benefit—but to ensure that the care you provide remains current, injury is avoided, and the patient’s concerns are properly addressed.

What’s the standard of care in genetics? And where are the pitfalls?

Aubrey Milunsky, MD, DSc, DCH

The standard of expected care in clinical genetics is generally the same across most medical specialties. That standard is compounded in obstetrics, however, by critical considerations in three areas in the spectrum of care: future conception, ongoing pregnancy, and postnatal implications. Although guidelines and committee opinions on genetics-related care that are issued by professional societies, such as ACOG, are important in practice, they do not, in fact, set the actual standard of expected care—as those issuing bodies have emphasized in their statements.

Mostly, it is expert opinion that informs a jury about the standard of expected care in genetics. And, ultimately, any action (or inaction) taken by a jury is judged according to what the average, prudent physician would do under the circumstances in question.

Errors tend to be basic

Medical negligence claims relative to genetics in obstetrical practice are usually not a complex matter of failure—for example, failing to diagnose an isodicentric chromosome, misinterpreting a copy number genome variation, mistaking a gene polymorphism as a disease-causing mutation, and failing to order a micro-deletion analysis when a gene sequence is reportedly normal. Rather, errors are usually basic and, invariably, not single; often they result in serious consequences. Space allows only a few, brief (and arbitrary) examples here of where pitfalls can be found:

  • genetic counseling
  • laboratory interactions
  • group practice
  • knowledge of practical genetics.

Genetic counseling Simple but critical matters in this area of office practice include taking a family history and not ignoring potential implications in that history of mental retardation, congenital malformations, genetic disorders, specific cancers, and ethnicity. These clues should alert you to offer diagnostic or carrier tests or to refer the patient for a genetics consultation.

Some OBs have the benefit of genetic counselors in their practice, but fail to realize that these members of the staff, albeit very valuable, are not the full and final repository of knowledge about genetic disease. Failure to offer a test, failure to refer for a genetics consultation, and failure to provide accurate information on risk and recurrence all invite litigation.

Laboratory interactions Errors by the office clinician abound in this area. They include failure to obtain the result of a lab test, to provide timely communication, to order the correct test, and to advise the lab about the specific indication for the test (such as a subtle translocation) and misinterpretation of a test result.

Group practice brings with it much benefit but significant risk, too. Assuming that one of your colleagues checked a lab result or communicated important information, without you—personally—having checked the record or obtained the result, can lead to catastrophe. Exercise great care, therefore, in overseeing how lab reports return to the office; who sees them; how, and by whom, they are filed; who is informed, and how, about an abnormal report; and what type of documentation the practice insists upon. Suffice it to say: This territory is replete with litigation.

Knowledge of practical genetics requires your continual learning. Failure to realize (or determine) that a disorder or defect is genetic inevitably raises problems. A lack of awareness of basic advances in medicine—such as preconception folic acid supplementation that provides 70% protection against a neural tube defect—may come to light only after a child is born with spina bifida.

Seek support in your work

Obstetrical practice is exciting and gratifying, but it is ever more challenging in light of the dramatic and continuing advances in human genetics. It is impossible for a busy clinician to keep up with the massive torrent of new information on genetic disease. When possible, establishing linkage—even by telephone—with a clinical genetics group could provide you with the opportunity to practice within the standard of expected care, and without unnecessary anxiety.

Dr. Milunsky is Professor of Human Genetics, Pediatrics, Pathology and Obstetrics and Gynecology, and Director, Center for Human Genetics, Boston University School of Medicine, Boston, Mass. He reports no financial relationships relevant to this article.

References

1. Procanik by Procanik v Cillo, 97 NJ 339 (1984) 478 A2d 755.

2. Schirmer v Mt. Auburn Obstetrics & Gynecology, 108 Ohio St3d 494 (2006) 2006-Ohio-942, 844 NE2d 1160.

3. Malloy v Meier, 679 NW2d 711 (Minn 2004).

4. A recent summary by a state supreme court reveals the position of various states on wrongful life actions: 27 states have refused to recognize actions by the child by court ruling or statute, or both, while three states do allow them. Willis v Wu, 362 SC 146 (2004), 607 SE2d 63.

5. Johnson v Superior Court, Los Angeles County, 101 Cal App 4th 869 (2002).

6. Brown v US, 462 F3d 609 (6th Cir 2006).

Article PDF
Author and Disclosure Information

Jeffrey A. Shane, MD, JD
Dr. Shane is a member of the ELM Exchange Faculty. ELM provides online risk management and patient safety education for physicians and other health-care providers.

Issue
OBG Management - 19(12)
Publications
Topics
Page Number
25-36
Legacy Keywords
Jeffrey A. Shane MD JD; Aubrey Milunsky MD DSc DCH; prenatal genetic testing; genetic testing; genetics; professional liability; liability; lawsuit; genetic disorders; wrongful birth; wrongful life; standard of care; expert opinion; genetic counseling; obstetrics; pregnancy
Sections
Author and Disclosure Information

Jeffrey A. Shane, MD, JD
Dr. Shane is a member of the ELM Exchange Faculty. ELM provides online risk management and patient safety education for physicians and other health-care providers.

Author and Disclosure Information

Jeffrey A. Shane, MD, JD
Dr. Shane is a member of the ELM Exchange Faculty. ELM provides online risk management and patient safety education for physicians and other health-care providers.

Article PDF
Article PDF

The author reports no financial relationships relevant to this article.

CASE 1 ObGyn fails to scrutinize test results

A woman consulted board-certified ObGyns during the first trimester of her pregnancy and informed one of them that she had recently been given a diagnosis of measles, but was unsure whether the illness was German (rubella virus) measles. The physician examined her and ordered a rubella titer. The results, he noted, “were indicative of past infection.” Instead of performing further testing, he told the patient she “had nothing to worry about because she had become immune to German measles as a child.”1

Soon after birth, her child was diagnosed as suffering from congenital rubella syndrome, including eye lesions, heart disease, and auditory defects.1

Apparently, the physician had failed to consider whether the positive test result was indicative of current, rather than past, infection—and failed to perform further testing to determine whether the titer was falling, stable, or rising.

Is he legally liable for this omission?

The physician in this case violated a simple tenet: If a test is ordered, the clinician must be able to interpret the results or order further testing to ensure that the patient is given valid advice. This physician’s error was compounded by the fact that the patient had notified him of the potential for fetal injury.

Would he be held accountable in a court of law?

The answer to that question depends on:

  • the state in which the case arose, and the laws in effect at the time of the incident
  • the action initiated by the plaintiff and her attorneys, which may involve “wrongful birth,” “wrongful life,” or other allegation
  • the time that transpires between the genetic test (or diagnostic test, such as a rubella titer) and the legal case—in other words, the statute of limitations. In some cases, this period encompasses the time elapsed between omission of a test (or birth of a child) and the filing of a legal claim.
In this article, I highlight three pertinent legal cases and the lessons to be learned. Because national legal case reporters generally publish opinions from appellate courts, they usually focus on determinations of law, with factual determinations and decisions on liability remanded back to the trial court.

For the purposes of this article, I assume that the facts in the judicial opinion are correct, but focus on legal principle.

Don’t overlook the patient when planning prenatal tests

Patient testing: ethical issues in selection and counseling. ACOG Committee Opinion No. 363. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2007;109:1021–1023.

Knowledge can be a dangerous thing. At the very least, a bid for genetic data requires careful consideration and preparation, particularly when the information may determine whether a woman continues or terminates her pregnancy.

In April, the American College of Obstetricians and Gynecologists published a Committee Opinion on ethical considerations in the selection and counseling of patients in regard to testing. Although the opinion concerns testing in general—rather than prenatal genetic testing specifically—a number of recommendations are applicable to both:

  • Perform testing for the benefit of the patient, not simply because a third party—e.g., her partner, extended family, employer, insurer, or health-care provider—deems it to be necessary. Ensure that she gives consent before proceeding.
  • Do not base testing decisions on assumptions about how the patient will respond. “Prejudgments about a patient’s wishes regarding fetal abnormalities, for example, should not preclude her being offered prenatal testing,” the opinion states.
  • Tell the patient how the results will be communicated, and to whom.
  • Provide or refer the patient for specific counseling whenever planned testing may have multiple medical or psychological implications.
  • Respect the patient’s autonomy and involve her in decision-making. If she elects to forego a recommended test, document her refusal in the medical record—and include the reason.

Detectable genetic disorders have increased exponentially

Almost any health-care provider encounters patients who have inheritable disease. Cases have arisen against an oncologist for failure to convey to the patient the potential for genetic transmission of colonic polyposis and against a surgeon for failing to warn a young breast cancer patient that she may carry genes that predispose her offspring to ovarian cancer. But the highest-risk category is reserved for the obstetrician, who must, on a daily basis, consider the need for appropriate screening and proper counseling about the availability of genetic testing that may enable the patient to avoid passing catastrophic disease to her children.

 

 

This responsibility is complicated by a dramatic increase in the number of genetic tests. Few areas of medical practice have expanded as rapidly as prenatal genetic testing and counseling. Forty years ago, an obstetrician—or even a nurse—might have discussed the risks of pregnancy at an advanced age, as well as a few possible genetic abnormalities. Today, certified genetic counselors are employed by many clinics and even private practices, and more than 1,000 disorders—as many as 1,300, by some reports—can be detected by the proper test.

Although most of these disorders are uncommon, several dozen or so are more prevalent and, therefore, regularly tested for. They include cystic fibrosis, Down syndrome, and neural tube defects, as well as diseases associated with certain religious, racial, or ethnic groups, such as thalassemia (Mediterranean, Asian, or African heritage), Tay-Sachs (Eastern European or Ashkenazi Jewish descent), and sickle cell disease (African-American ancestry).

Ethical complexity makes resolution difficult

Legal actions are bound to increase as technology evolves, particularly when a child is born with a genetically transmissible disorder that could have been identified with proper counseling and testing. These legal actions are particularly difficult to resolve because they involve complex ethical issues. For example, in “wrongful birth” actions, the parents often allege that they would not have conceived a child if they had known that it might be afflicted with a certain trait or illness, or that they would have terminated the pregnancy if they had learned of the disorder in a timely fashion.

In most of these cases, the plaintiffs are the parents. In a few states, however, successful actions have been brought by the child (“wrongful life”), who, some contend, essentially claims that nonexistence would be better than life with a serious congenital condition. They usually seek the extraordinary expense associated with the condition, as well as other damages.

Similar actions have been brought by children, and parents of children, with acquired conditions such as congenital rubella syndrome, as in the opening case. In that scenario, the parents’ case was declined by attorneys because their state of residence did not allow actions for wrongful birth or wrongful life. The state courts subsequently changed the law to allow wrongful birth actions, but by the time the parents learned of the change in the law, the statute of limitations had expired. They therefore added the attorneys as defendants, alleging that they failed to recall the parents when the law changed, in time to file their lawsuit. By the time the case finally reached the state’s supreme court, the law had changed again, and the child was allowed to proceed with a wrongful life action.

CASE 2 Physician mistakes patient’s tissue for fetus’s

Before becoming pregnant, a woman experienced several medical problems that prompted her and her husband to seek genetic testing and counseling. Testing revealed that she had a balanced translocation of chromosomes 11 and 22.2

After conceiving, the woman underwent chorionic villus sampling, which indicated that the fetus was probably a female with the same chromosomal condition as the mother—therefore, she would develop normally. The mother also underwent several ultrasonographic tests to rule out fetal abnormalities and was told that imaging showed a normally developing fetus.

The woman went on to deliver a boy, and genetic testing revealed that he had trisomy 22, with severe, permanent disabilities.2 The parents sued.

Were the woman’s health-care providers liable?

This case prompts a number of questions:

  • Did the physicians seek confirmation that the tissue studied was fetal?
  • Did they counsel the parents about the possibility that maternal genetic material might be recovered during sampling? If so, did they consider that possibility when the specimen was identical to the mother’s?
  • How is it possible that, on subsequent ultrasonographic evaluations, the male sex of the fetus was not noted? If it was noted, did it register with the providers that the result was inconsistent with the genetic studies?
These questions were not addressed in the court opinion, but they could have had a significant impact on the final outcome of the case. Although the court allowed some aspects of this case to go forward, damages were limited to the costs of the pregnancy and—for reasons not disclosed—that claim was dismissed. If the delivery had been complicated, however, those costs could have been substantial.

Despite the dismissal, which was a favorable turn of events for the physicians, they almost certainly lost substantial work time and experienced the emotional roller-coaster ride that accompanies being sued—not to mention the revelation that they may have harmed a patient.

 

 

CASE 3 Physician fails to complete testing

The mother of a developmentally delayed daughter delivered another child. Before she conceived, however, she and her husband consulted a physician (a pediatrician) to find out whether there was a genetic reason for the daughter’s developmental delay and the mental retardation of another child, the girl’s half-brother.3 The physician wrote in her notes: “? Chromosomes + fragile X” to indicate testing planned for the daughter.

The testing was performed at a medical center and reported to be normal. The physician relayed this finding to the parents, but failed to mention that fragile X testing had not been conducted. Because they had discussed fragile X testing during the initial consultation, the mother assumed it had been performed and was included in the normal results.3

The latest child was also developmentally delayed, and subsequent testing revealed that all three children were positive for fragile X syndrome. The parents sued, alleging that the physician was negligent for failing to perform the genetic test, and claiming that they would not have conceived another child if they had known of the daughter’s fragile X status.

Are their claims reasonable?

Despite a state statute that prohibited wrongful birth and wrongful life actions that allege that the pregnancy would have been terminated if the parents had known of the genetic impairment, the state supreme court allowed this case to proceed because the issue was whether the mother would have avoided conception. The plaintiffs also argued that the claim did not exceed the statute of limitations. Their reasoning: Although the medical care had been provided more than 4 years earlier (the limitation period), the injury did not occur (i.e., action did not “accrue”) until conception of the child.

Perhaps most telling was the court’s statement that, “[O]ur decision today is informed by the practical reality of the field of genetic testing and counseling; genetic testing and diagnosis [do] not affect only the patient. Both the patient and her family can benefit from accurate testing and diagnosis. And, conversely, both the patient and her family can be harmed by negligent testing and diagnosis.”3

Establishing degree of harm is especially difficult

As you might imagine, allegations involving potential pregnancy termination arouse intense emotions on both sides of the abortion debate. The determination of damages is equally contentious. Among the issues that may arise at the time of trial:

  • How much is a parent harmed by the birth of a child with hereditary disease?
  • Should damages be offset by the benefit of having any child, even if the child is not “normal”?
  • How do you measure the value of a life with Down syndrome, for example, compared with no life at all?
  • Should damages include the cost of raising the child, including additional medical expenses, which can be substantial?
These and many other serious questions have faced judges and legislators for more than 30 years, and are expected to remain controversial for the foreseeable future.

Assigning blame for genetic disease is difficult

The arguments in cases involving genetic testing often differ from those made when a fetus sustains injury. In the latter, the injury may be caused by the provider—e.g., after administration of a cytotoxic drug during pregnancy or because of induction of labor at a seriously miscalculated gestational age. Legal actions associated with such injury are widely accepted.

In cases involving genetic counseling, however, the disease is not caused by the practitioner. Rather, the plaintiff alleges that the affected child was born because the provider failed to:

  • properly counsel the patient not to conceive
  • offer the parents the option of terminating the pregnancy or
  • successfully prevent or terminate a pregnancy.
At present, quite a few states allow parents to proceed when the action is for what most courts and commentators call “wrongful conception”—i.e., when negligent preconception advice, or a lack of advice, leads to conception and birth of a normal, but unplanned child (this also applies to negligent contraception and sterilization procedures). Actions for wrongful birth are not as widely accepted. Some courts have allowed recovery of some damages for these actions, whereas others have prohibited them, based on state common law principles or existing statutes. And actions by the child—so-called wrongful life actions—are allowed in only a very few states (California, Washington, and New Jersey), and damages are limited even more strictly.4

It would be unwise to base one’s conduct on existing law, which is unpredictable. The law can change if a judge determines that a prior opinion was incorrect, a statute was unconstitutional, or a particular injury justifies compensation. Legislative bodies also can change with an election, and the statutes can be amended. The best strategy for you to deal with this uncertainty? Provide comprehensive prenatal care of the highest quality.

 

 

Lessons learned

Among the lessons to be gleaned from these cases are:

  • Be sure that you understand the limits of any test that you order, and convey those limits to the patient.
  • When you inform a patient about a planned test, that test should be completed. If it is not, explain the failure to perform the test (or the lost result, etc.) to the patient so that she can act accordingly. In that regard, a laboratory or other facility can be held liable for a negligently performed test or, as was the case in one lawsuit, a sperm bank may be liable for failing to inform the recipient of donor sperm that the donor had a positive family history of renal disease (i.e., autosomal-dominant polycystic kidney disease).5
  • Be aware that, as the amount of information available in the popular literature and on the Web expands, patients will come to question their care more often. An example: A patient recently brought an action against her health-care provider because vitamins containing folate were discontinued shortly before she became pregnant, and the child was born with a neural tube defect.6
  • Most court cases, including those cited in this article, are based on the credibility of witnesses recollecting events. Well-documented, legible records written contemporaneously with an event are of enormous benefit in cases involving sometimes widely divergent recollections. When health care meets appropriate standards and is well documented in the records, most plaintiffs’ attorneys will not undertake what can be protracted and expensive litigation. When they do, the health-care provider usually prevails.
The bottom line? You are more obligated than ever to continue your medical education—not so much to avoid lawsuits, although that is certainly a possible benefit—but to ensure that the care you provide remains current, injury is avoided, and the patient’s concerns are properly addressed.

What’s the standard of care in genetics? And where are the pitfalls?

Aubrey Milunsky, MD, DSc, DCH

The standard of expected care in clinical genetics is generally the same across most medical specialties. That standard is compounded in obstetrics, however, by critical considerations in three areas in the spectrum of care: future conception, ongoing pregnancy, and postnatal implications. Although guidelines and committee opinions on genetics-related care that are issued by professional societies, such as ACOG, are important in practice, they do not, in fact, set the actual standard of expected care—as those issuing bodies have emphasized in their statements.

Mostly, it is expert opinion that informs a jury about the standard of expected care in genetics. And, ultimately, any action (or inaction) taken by a jury is judged according to what the average, prudent physician would do under the circumstances in question.

Errors tend to be basic

Medical negligence claims relative to genetics in obstetrical practice are usually not a complex matter of failure—for example, failing to diagnose an isodicentric chromosome, misinterpreting a copy number genome variation, mistaking a gene polymorphism as a disease-causing mutation, and failing to order a micro-deletion analysis when a gene sequence is reportedly normal. Rather, errors are usually basic and, invariably, not single; often they result in serious consequences. Space allows only a few, brief (and arbitrary) examples here of where pitfalls can be found:

  • genetic counseling
  • laboratory interactions
  • group practice
  • knowledge of practical genetics.

Genetic counseling Simple but critical matters in this area of office practice include taking a family history and not ignoring potential implications in that history of mental retardation, congenital malformations, genetic disorders, specific cancers, and ethnicity. These clues should alert you to offer diagnostic or carrier tests or to refer the patient for a genetics consultation.

Some OBs have the benefit of genetic counselors in their practice, but fail to realize that these members of the staff, albeit very valuable, are not the full and final repository of knowledge about genetic disease. Failure to offer a test, failure to refer for a genetics consultation, and failure to provide accurate information on risk and recurrence all invite litigation.

Laboratory interactions Errors by the office clinician abound in this area. They include failure to obtain the result of a lab test, to provide timely communication, to order the correct test, and to advise the lab about the specific indication for the test (such as a subtle translocation) and misinterpretation of a test result.

Group practice brings with it much benefit but significant risk, too. Assuming that one of your colleagues checked a lab result or communicated important information, without you—personally—having checked the record or obtained the result, can lead to catastrophe. Exercise great care, therefore, in overseeing how lab reports return to the office; who sees them; how, and by whom, they are filed; who is informed, and how, about an abnormal report; and what type of documentation the practice insists upon. Suffice it to say: This territory is replete with litigation.

Knowledge of practical genetics requires your continual learning. Failure to realize (or determine) that a disorder or defect is genetic inevitably raises problems. A lack of awareness of basic advances in medicine—such as preconception folic acid supplementation that provides 70% protection against a neural tube defect—may come to light only after a child is born with spina bifida.

Seek support in your work

Obstetrical practice is exciting and gratifying, but it is ever more challenging in light of the dramatic and continuing advances in human genetics. It is impossible for a busy clinician to keep up with the massive torrent of new information on genetic disease. When possible, establishing linkage—even by telephone—with a clinical genetics group could provide you with the opportunity to practice within the standard of expected care, and without unnecessary anxiety.

Dr. Milunsky is Professor of Human Genetics, Pediatrics, Pathology and Obstetrics and Gynecology, and Director, Center for Human Genetics, Boston University School of Medicine, Boston, Mass. He reports no financial relationships relevant to this article.

The author reports no financial relationships relevant to this article.

CASE 1 ObGyn fails to scrutinize test results

A woman consulted board-certified ObGyns during the first trimester of her pregnancy and informed one of them that she had recently been given a diagnosis of measles, but was unsure whether the illness was German (rubella virus) measles. The physician examined her and ordered a rubella titer. The results, he noted, “were indicative of past infection.” Instead of performing further testing, he told the patient she “had nothing to worry about because she had become immune to German measles as a child.”1

Soon after birth, her child was diagnosed as suffering from congenital rubella syndrome, including eye lesions, heart disease, and auditory defects.1

Apparently, the physician had failed to consider whether the positive test result was indicative of current, rather than past, infection—and failed to perform further testing to determine whether the titer was falling, stable, or rising.

Is he legally liable for this omission?

The physician in this case violated a simple tenet: If a test is ordered, the clinician must be able to interpret the results or order further testing to ensure that the patient is given valid advice. This physician’s error was compounded by the fact that the patient had notified him of the potential for fetal injury.

Would he be held accountable in a court of law?

The answer to that question depends on:

  • the state in which the case arose, and the laws in effect at the time of the incident
  • the action initiated by the plaintiff and her attorneys, which may involve “wrongful birth,” “wrongful life,” or other allegation
  • the time that transpires between the genetic test (or diagnostic test, such as a rubella titer) and the legal case—in other words, the statute of limitations. In some cases, this period encompasses the time elapsed between omission of a test (or birth of a child) and the filing of a legal claim.
In this article, I highlight three pertinent legal cases and the lessons to be learned. Because national legal case reporters generally publish opinions from appellate courts, they usually focus on determinations of law, with factual determinations and decisions on liability remanded back to the trial court.

For the purposes of this article, I assume that the facts in the judicial opinion are correct, but focus on legal principle.

Don’t overlook the patient when planning prenatal tests

Patient testing: ethical issues in selection and counseling. ACOG Committee Opinion No. 363. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2007;109:1021–1023.

Knowledge can be a dangerous thing. At the very least, a bid for genetic data requires careful consideration and preparation, particularly when the information may determine whether a woman continues or terminates her pregnancy.

In April, the American College of Obstetricians and Gynecologists published a Committee Opinion on ethical considerations in the selection and counseling of patients in regard to testing. Although the opinion concerns testing in general—rather than prenatal genetic testing specifically—a number of recommendations are applicable to both:

  • Perform testing for the benefit of the patient, not simply because a third party—e.g., her partner, extended family, employer, insurer, or health-care provider—deems it to be necessary. Ensure that she gives consent before proceeding.
  • Do not base testing decisions on assumptions about how the patient will respond. “Prejudgments about a patient’s wishes regarding fetal abnormalities, for example, should not preclude her being offered prenatal testing,” the opinion states.
  • Tell the patient how the results will be communicated, and to whom.
  • Provide or refer the patient for specific counseling whenever planned testing may have multiple medical or psychological implications.
  • Respect the patient’s autonomy and involve her in decision-making. If she elects to forego a recommended test, document her refusal in the medical record—and include the reason.

Detectable genetic disorders have increased exponentially

Almost any health-care provider encounters patients who have inheritable disease. Cases have arisen against an oncologist for failure to convey to the patient the potential for genetic transmission of colonic polyposis and against a surgeon for failing to warn a young breast cancer patient that she may carry genes that predispose her offspring to ovarian cancer. But the highest-risk category is reserved for the obstetrician, who must, on a daily basis, consider the need for appropriate screening and proper counseling about the availability of genetic testing that may enable the patient to avoid passing catastrophic disease to her children.

 

 

This responsibility is complicated by a dramatic increase in the number of genetic tests. Few areas of medical practice have expanded as rapidly as prenatal genetic testing and counseling. Forty years ago, an obstetrician—or even a nurse—might have discussed the risks of pregnancy at an advanced age, as well as a few possible genetic abnormalities. Today, certified genetic counselors are employed by many clinics and even private practices, and more than 1,000 disorders—as many as 1,300, by some reports—can be detected by the proper test.

Although most of these disorders are uncommon, several dozen or so are more prevalent and, therefore, regularly tested for. They include cystic fibrosis, Down syndrome, and neural tube defects, as well as diseases associated with certain religious, racial, or ethnic groups, such as thalassemia (Mediterranean, Asian, or African heritage), Tay-Sachs (Eastern European or Ashkenazi Jewish descent), and sickle cell disease (African-American ancestry).

Ethical complexity makes resolution difficult

Legal actions are bound to increase as technology evolves, particularly when a child is born with a genetically transmissible disorder that could have been identified with proper counseling and testing. These legal actions are particularly difficult to resolve because they involve complex ethical issues. For example, in “wrongful birth” actions, the parents often allege that they would not have conceived a child if they had known that it might be afflicted with a certain trait or illness, or that they would have terminated the pregnancy if they had learned of the disorder in a timely fashion.

In most of these cases, the plaintiffs are the parents. In a few states, however, successful actions have been brought by the child (“wrongful life”), who, some contend, essentially claims that nonexistence would be better than life with a serious congenital condition. They usually seek the extraordinary expense associated with the condition, as well as other damages.

Similar actions have been brought by children, and parents of children, with acquired conditions such as congenital rubella syndrome, as in the opening case. In that scenario, the parents’ case was declined by attorneys because their state of residence did not allow actions for wrongful birth or wrongful life. The state courts subsequently changed the law to allow wrongful birth actions, but by the time the parents learned of the change in the law, the statute of limitations had expired. They therefore added the attorneys as defendants, alleging that they failed to recall the parents when the law changed, in time to file their lawsuit. By the time the case finally reached the state’s supreme court, the law had changed again, and the child was allowed to proceed with a wrongful life action.

CASE 2 Physician mistakes patient’s tissue for fetus’s

Before becoming pregnant, a woman experienced several medical problems that prompted her and her husband to seek genetic testing and counseling. Testing revealed that she had a balanced translocation of chromosomes 11 and 22.2

After conceiving, the woman underwent chorionic villus sampling, which indicated that the fetus was probably a female with the same chromosomal condition as the mother—therefore, she would develop normally. The mother also underwent several ultrasonographic tests to rule out fetal abnormalities and was told that imaging showed a normally developing fetus.

The woman went on to deliver a boy, and genetic testing revealed that he had trisomy 22, with severe, permanent disabilities.2 The parents sued.

Were the woman’s health-care providers liable?

This case prompts a number of questions:

  • Did the physicians seek confirmation that the tissue studied was fetal?
  • Did they counsel the parents about the possibility that maternal genetic material might be recovered during sampling? If so, did they consider that possibility when the specimen was identical to the mother’s?
  • How is it possible that, on subsequent ultrasonographic evaluations, the male sex of the fetus was not noted? If it was noted, did it register with the providers that the result was inconsistent with the genetic studies?
These questions were not addressed in the court opinion, but they could have had a significant impact on the final outcome of the case. Although the court allowed some aspects of this case to go forward, damages were limited to the costs of the pregnancy and—for reasons not disclosed—that claim was dismissed. If the delivery had been complicated, however, those costs could have been substantial.

Despite the dismissal, which was a favorable turn of events for the physicians, they almost certainly lost substantial work time and experienced the emotional roller-coaster ride that accompanies being sued—not to mention the revelation that they may have harmed a patient.

 

 

CASE 3 Physician fails to complete testing

The mother of a developmentally delayed daughter delivered another child. Before she conceived, however, she and her husband consulted a physician (a pediatrician) to find out whether there was a genetic reason for the daughter’s developmental delay and the mental retardation of another child, the girl’s half-brother.3 The physician wrote in her notes: “? Chromosomes + fragile X” to indicate testing planned for the daughter.

The testing was performed at a medical center and reported to be normal. The physician relayed this finding to the parents, but failed to mention that fragile X testing had not been conducted. Because they had discussed fragile X testing during the initial consultation, the mother assumed it had been performed and was included in the normal results.3

The latest child was also developmentally delayed, and subsequent testing revealed that all three children were positive for fragile X syndrome. The parents sued, alleging that the physician was negligent for failing to perform the genetic test, and claiming that they would not have conceived another child if they had known of the daughter’s fragile X status.

Are their claims reasonable?

Despite a state statute that prohibited wrongful birth and wrongful life actions that allege that the pregnancy would have been terminated if the parents had known of the genetic impairment, the state supreme court allowed this case to proceed because the issue was whether the mother would have avoided conception. The plaintiffs also argued that the claim did not exceed the statute of limitations. Their reasoning: Although the medical care had been provided more than 4 years earlier (the limitation period), the injury did not occur (i.e., action did not “accrue”) until conception of the child.

Perhaps most telling was the court’s statement that, “[O]ur decision today is informed by the practical reality of the field of genetic testing and counseling; genetic testing and diagnosis [do] not affect only the patient. Both the patient and her family can benefit from accurate testing and diagnosis. And, conversely, both the patient and her family can be harmed by negligent testing and diagnosis.”3

Establishing degree of harm is especially difficult

As you might imagine, allegations involving potential pregnancy termination arouse intense emotions on both sides of the abortion debate. The determination of damages is equally contentious. Among the issues that may arise at the time of trial:

  • How much is a parent harmed by the birth of a child with hereditary disease?
  • Should damages be offset by the benefit of having any child, even if the child is not “normal”?
  • How do you measure the value of a life with Down syndrome, for example, compared with no life at all?
  • Should damages include the cost of raising the child, including additional medical expenses, which can be substantial?
These and many other serious questions have faced judges and legislators for more than 30 years, and are expected to remain controversial for the foreseeable future.

Assigning blame for genetic disease is difficult

The arguments in cases involving genetic testing often differ from those made when a fetus sustains injury. In the latter, the injury may be caused by the provider—e.g., after administration of a cytotoxic drug during pregnancy or because of induction of labor at a seriously miscalculated gestational age. Legal actions associated with such injury are widely accepted.

In cases involving genetic counseling, however, the disease is not caused by the practitioner. Rather, the plaintiff alleges that the affected child was born because the provider failed to:

  • properly counsel the patient not to conceive
  • offer the parents the option of terminating the pregnancy or
  • successfully prevent or terminate a pregnancy.
At present, quite a few states allow parents to proceed when the action is for what most courts and commentators call “wrongful conception”—i.e., when negligent preconception advice, or a lack of advice, leads to conception and birth of a normal, but unplanned child (this also applies to negligent contraception and sterilization procedures). Actions for wrongful birth are not as widely accepted. Some courts have allowed recovery of some damages for these actions, whereas others have prohibited them, based on state common law principles or existing statutes. And actions by the child—so-called wrongful life actions—are allowed in only a very few states (California, Washington, and New Jersey), and damages are limited even more strictly.4

It would be unwise to base one’s conduct on existing law, which is unpredictable. The law can change if a judge determines that a prior opinion was incorrect, a statute was unconstitutional, or a particular injury justifies compensation. Legislative bodies also can change with an election, and the statutes can be amended. The best strategy for you to deal with this uncertainty? Provide comprehensive prenatal care of the highest quality.

 

 

Lessons learned

Among the lessons to be gleaned from these cases are:

  • Be sure that you understand the limits of any test that you order, and convey those limits to the patient.
  • When you inform a patient about a planned test, that test should be completed. If it is not, explain the failure to perform the test (or the lost result, etc.) to the patient so that she can act accordingly. In that regard, a laboratory or other facility can be held liable for a negligently performed test or, as was the case in one lawsuit, a sperm bank may be liable for failing to inform the recipient of donor sperm that the donor had a positive family history of renal disease (i.e., autosomal-dominant polycystic kidney disease).5
  • Be aware that, as the amount of information available in the popular literature and on the Web expands, patients will come to question their care more often. An example: A patient recently brought an action against her health-care provider because vitamins containing folate were discontinued shortly before she became pregnant, and the child was born with a neural tube defect.6
  • Most court cases, including those cited in this article, are based on the credibility of witnesses recollecting events. Well-documented, legible records written contemporaneously with an event are of enormous benefit in cases involving sometimes widely divergent recollections. When health care meets appropriate standards and is well documented in the records, most plaintiffs’ attorneys will not undertake what can be protracted and expensive litigation. When they do, the health-care provider usually prevails.
The bottom line? You are more obligated than ever to continue your medical education—not so much to avoid lawsuits, although that is certainly a possible benefit—but to ensure that the care you provide remains current, injury is avoided, and the patient’s concerns are properly addressed.

What’s the standard of care in genetics? And where are the pitfalls?

Aubrey Milunsky, MD, DSc, DCH

The standard of expected care in clinical genetics is generally the same across most medical specialties. That standard is compounded in obstetrics, however, by critical considerations in three areas in the spectrum of care: future conception, ongoing pregnancy, and postnatal implications. Although guidelines and committee opinions on genetics-related care that are issued by professional societies, such as ACOG, are important in practice, they do not, in fact, set the actual standard of expected care—as those issuing bodies have emphasized in their statements.

Mostly, it is expert opinion that informs a jury about the standard of expected care in genetics. And, ultimately, any action (or inaction) taken by a jury is judged according to what the average, prudent physician would do under the circumstances in question.

Errors tend to be basic

Medical negligence claims relative to genetics in obstetrical practice are usually not a complex matter of failure—for example, failing to diagnose an isodicentric chromosome, misinterpreting a copy number genome variation, mistaking a gene polymorphism as a disease-causing mutation, and failing to order a micro-deletion analysis when a gene sequence is reportedly normal. Rather, errors are usually basic and, invariably, not single; often they result in serious consequences. Space allows only a few, brief (and arbitrary) examples here of where pitfalls can be found:

  • genetic counseling
  • laboratory interactions
  • group practice
  • knowledge of practical genetics.

Genetic counseling Simple but critical matters in this area of office practice include taking a family history and not ignoring potential implications in that history of mental retardation, congenital malformations, genetic disorders, specific cancers, and ethnicity. These clues should alert you to offer diagnostic or carrier tests or to refer the patient for a genetics consultation.

Some OBs have the benefit of genetic counselors in their practice, but fail to realize that these members of the staff, albeit very valuable, are not the full and final repository of knowledge about genetic disease. Failure to offer a test, failure to refer for a genetics consultation, and failure to provide accurate information on risk and recurrence all invite litigation.

Laboratory interactions Errors by the office clinician abound in this area. They include failure to obtain the result of a lab test, to provide timely communication, to order the correct test, and to advise the lab about the specific indication for the test (such as a subtle translocation) and misinterpretation of a test result.

Group practice brings with it much benefit but significant risk, too. Assuming that one of your colleagues checked a lab result or communicated important information, without you—personally—having checked the record or obtained the result, can lead to catastrophe. Exercise great care, therefore, in overseeing how lab reports return to the office; who sees them; how, and by whom, they are filed; who is informed, and how, about an abnormal report; and what type of documentation the practice insists upon. Suffice it to say: This territory is replete with litigation.

Knowledge of practical genetics requires your continual learning. Failure to realize (or determine) that a disorder or defect is genetic inevitably raises problems. A lack of awareness of basic advances in medicine—such as preconception folic acid supplementation that provides 70% protection against a neural tube defect—may come to light only after a child is born with spina bifida.

Seek support in your work

Obstetrical practice is exciting and gratifying, but it is ever more challenging in light of the dramatic and continuing advances in human genetics. It is impossible for a busy clinician to keep up with the massive torrent of new information on genetic disease. When possible, establishing linkage—even by telephone—with a clinical genetics group could provide you with the opportunity to practice within the standard of expected care, and without unnecessary anxiety.

Dr. Milunsky is Professor of Human Genetics, Pediatrics, Pathology and Obstetrics and Gynecology, and Director, Center for Human Genetics, Boston University School of Medicine, Boston, Mass. He reports no financial relationships relevant to this article.

References

1. Procanik by Procanik v Cillo, 97 NJ 339 (1984) 478 A2d 755.

2. Schirmer v Mt. Auburn Obstetrics & Gynecology, 108 Ohio St3d 494 (2006) 2006-Ohio-942, 844 NE2d 1160.

3. Malloy v Meier, 679 NW2d 711 (Minn 2004).

4. A recent summary by a state supreme court reveals the position of various states on wrongful life actions: 27 states have refused to recognize actions by the child by court ruling or statute, or both, while three states do allow them. Willis v Wu, 362 SC 146 (2004), 607 SE2d 63.

5. Johnson v Superior Court, Los Angeles County, 101 Cal App 4th 869 (2002).

6. Brown v US, 462 F3d 609 (6th Cir 2006).

References

1. Procanik by Procanik v Cillo, 97 NJ 339 (1984) 478 A2d 755.

2. Schirmer v Mt. Auburn Obstetrics & Gynecology, 108 Ohio St3d 494 (2006) 2006-Ohio-942, 844 NE2d 1160.

3. Malloy v Meier, 679 NW2d 711 (Minn 2004).

4. A recent summary by a state supreme court reveals the position of various states on wrongful life actions: 27 states have refused to recognize actions by the child by court ruling or statute, or both, while three states do allow them. Willis v Wu, 362 SC 146 (2004), 607 SE2d 63.

5. Johnson v Superior Court, Los Angeles County, 101 Cal App 4th 869 (2002).

6. Brown v US, 462 F3d 609 (6th Cir 2006).

Issue
OBG Management - 19(12)
Issue
OBG Management - 19(12)
Page Number
25-36
Page Number
25-36
Publications
Publications
Topics
Article Type
Display Headline
How prenatal genetic testing protects patients—and you
Display Headline
How prenatal genetic testing protects patients—and you
Legacy Keywords
Jeffrey A. Shane MD JD; Aubrey Milunsky MD DSc DCH; prenatal genetic testing; genetic testing; genetics; professional liability; liability; lawsuit; genetic disorders; wrongful birth; wrongful life; standard of care; expert opinion; genetic counseling; obstetrics; pregnancy
Legacy Keywords
Jeffrey A. Shane MD JD; Aubrey Milunsky MD DSc DCH; prenatal genetic testing; genetic testing; genetics; professional liability; liability; lawsuit; genetic disorders; wrongful birth; wrongful life; standard of care; expert opinion; genetic counseling; obstetrics; pregnancy
Sections
Article Source

PURLs Copyright

Inside the Article
Article PDF Media

CPT codes diversify for hysterectomy and repair of paravaginal defects

Article Type
Changed
Display Headline
CPT codes diversify for hysterectomy and repair of paravaginal defects

In 2008, long-awaited surgical codes are being added to Current Procedural Terminology (CPT) for total laparoscopic hysterectomy and repair of a paravaginal defect. Pay attention to code renumbering and revisions in the New Year, too: Bladder aspiration codes have new numbers, and removal of an intra-abdominal tumor will require more careful documentation, to cite two changes.

There’s more: If you’ve been spending time on telephone or on-line counseling, codes that may get you paid for that service are about to make their debut.

Key additions and revisions to CPT for the new year are detailed in this article and in next issue’s Reimbursement Adviser.

Specify repair of paravaginal defect

57284  Paravaginal defect repair (including repair of cystocele, if performed); open abdominal approach

57285   Paravaginal defect repair (including repair of cystocele, if performed); vaginal approach

57423  Paravaginal defect repair (including repair of cystocele, if performed); laparoscopic approach

You’ll now have to carefully document your surgical approach to repairing a paravaginal defect, thanks to creation of two new codes and revision of the existing 57284.

Several bundles are still attached to the new codes, however. CPT did remove references to “stress urinary incontinence, and/or incomplete vaginal prolapse” from the revised and new codes, but repair of a cystocele, by any method, is still included.

CPT 2008 is, therefore, listing codes that cannot be reported additionally. In general, urethropexy codes 51840, 51841, 51990, 58152, and 58267 and cystocele repair codes 57240, 57260, and 57265 should not be reported when a paravaginal defect repair is performed.

Also, be alert for any National Correct Coding Initiatives (NCCI) bundles assigned by Medicare to these new codes if they are different from the ones that will be listed by CPT. In particular, 57288 [sling operation for stress incontinence (e.g., fascia or synthetic)] was permanently bundled into 57284. (If that bundle isn’t removed in 2008, I encourage you to contact ACOG and urge the College to discuss this inappropriate bundle with Medicare administrators.)

Total lap hysterectomy

58570  Laparoscopy, surgical, with total hysterectomy, for uterus 250 g or less

58571  Laparoscopy, surgical, with total hysterectomy, for uterus 250 g or less; with removal of tube(s) and/or ovary(ies)

58572  Laparoscopy, surgical, with total hysterectomy, for uterus greater than 250 g

58573  Laparoscopy, surgical, with total hysterectomy, for uterus greater than 250 g; with removal of tube(s) and/or ovary(ies)

For some time, surgeons have been able to perform a hysterectomy by completely detaching both the uterine cervix and the body of the uterus from their surrounding support structures laparoscopically, then closing the vaginal cuff via this approach as well. Before 2008, the only coding choices were laparoscopic-assisted hysterectomy codes (58550–58554) or the unlisted laparoscopic code 58578. The new codes—as with codes for any vaginal or laparoscopic approach—are selected based on 1) the documented weight of the uterus and 2) whether the fallopian tubes or ovaries have been removed.

Intraperitoneal tumors, coded by size

49203 Excision or destruction, open, intra-abdominal tumors, cysts or endometriomas, 1 or more peritoneal, mesenteric, or retroperitoneal primary or secondary tumors; largest tumor 5 cm diameter or less

49204 …largest tumor 5.1–10.0 cm diameter

49205 …largest tumor greater than 10.0 cm diameter

In 2007, documenting the removal of intraperitoneal or retroperitoneal tumors, cysts, and endometriomas via abdominal incision was fairly simple: There were two codes and you had only to decide if removal was extensive or not.

In 2008, codes 49200 and 49201 are deleted and replaced by three new codes—each of which requires you to document the size of the largest tumor or lesion removed.

The new codes will come in handy during surgery in which the originating organ has been removed but the patient is found to have additional tumors. For example: A patient had ovarian cancer and now there are additional tumors in the abdominal cavity, but an omentectomy is not being performed. Of course, the new codes can still be used for excision or destruction of cysts or endometriomas, as well. But CPT has also listed codes that cannot be billed with the new codes: Among them are 38770 [pelvic lymphadenectomy] and 58900–58960 [surgeries performed on the ovaries]. If the new codes don’t fit the surgery, the other option for tumor debulking after the organ has been removed is to report 58957 or 58958; note, however, that these codes include omentectomy and optional pelvic lymph node sampling.

Bladder aspiration is renumbered

51100 Aspiration of bladder; by needle

 

 

51101 …by trocar or intracatheter

51102 …with insertion of suprapubic catheter

If you have the old codes for bladder aspiration memorized, relearn them. Once again, CPT tinkered with placement of codes and decided that bladder aspiration codes are placed more appropriately under “Bladder, Removal” than “Bladder, Incision.” The uses of those codes are unchanged.

Giving flu, HPV vaccines

90661 Influenza virus vaccine, derived from cell cultures, subunit, preservative and antibiotic free, for intramuscular use

90662 Influenza virus vaccine, split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use

90663 Influenza virus vaccine, pandemic formulation

90650 Human papillomavirus (HPV) vaccine, types 16 and 18, bivalent, 3-dose schedule, for intramuscular use

Four new codes for vaccines can be reported beginning January 1, but only those for the influenza vaccine appear in the CPT 2008 book. The code for the new bivalent HPV vaccine is a valid code for 2008 but will not appear in print until CPT 2009.

Changes made to “modifier -51” exemptions

CPT 2008 also reassessed codes that have been designated as “modifier - 51 exempt.” Typically, these are codes that do not involve significant preoperative or postoperative work. 36660 [catheterization, umbilical artery, newborn, for diagnosis or therapy] now requires a modifier when performed with other procedures, whereas 51797 [voiding pressure studies (VP); intra-abdominal voiding pressure (AP) (rectal, gastric, intraperitoneal)] becomes an add-on code that does not take a modifier -51. Beginning January 1, 51797 can be billed only if 51795 [voiding pressure studies (VP); bladder voiding pressure, any technique] has also been reported.

A few “clarifications” may simplify coding in 2008

Fecal blood testing

If you bill 82272 [blood, occult, by peroxidase activity (e.g., guaiac), qualitative, feces, single specimen (e.g., from digital rectal exam)] for the annual fecal occult blood screening test, CPT has revised the code to make it clear that this code is not to be reported for a screening test.

The only two CPT codes that can be reported for the screening fecal occult blood test are 82270 [blood, occult, by peroxidase activity (e.g., guaiac), qualitative, feces, consecutive collected specimens with single determination, for colorectal neoplasm screening] (that is, the patient was provided three cards or a single triple card for consecutive collection) or 82274 [blood, occult, by fecal hemoglobin determination by immunoassay, qualitative, feces, 1–3 simultaneous determinations].

Note: The physician may collect the specimen for an immunoassay (except on a Medicare patient), but a guaiac test specimen must be collected by the patient.

Cervical biopsy

The descriptor for 57500 will now specifically refer to the cervix as the location for biopsy or excision of a lesion. Before this change, only the subheading title gave any indication of anatomic location.

Hysterectomy

If you perform a laparoscopic-assisted (58550–58554), total (58570–58573), or supracervical (58541–58544) hysterectomy, CPT has added a list of codes that you may not report as well. These include:

  • 49320 [diagnostic laparoscopy]
  • 57000 [colpotomy]
  • 57180 [hemostatic vaginal packing]
  • 57410 [EUA]
  • 58140–58146, 58545–58546, 58561 [myomectomy]
  • 58661 [removal of tubes and/or ovaries]
  • 58670, 58671 [tubal ligations]

Vascular ultrasound

Last, CPT has clarified that, to bill 93975 or 93976 [duplex scan of arterial inflow and venous outflow of abdominal, pelvic, scrotal contents and/or retroperitoneal organs], the purpose of the exam must be to evaluate vascular structures. If color Doppler ultrasound is used to identify anatomic structures at the time of US scan, neither of those two codes may be billed additionally.

Article PDF
Author and Disclosure Information

Melanie Witt, RN, CPC-OGS, MA
Independent coding and documentation consultant; former program manager, Department of Coding and Nomenclature, American College of Obstetricians and Gynecologists

Issue
OBG Management - 19(12)
Publications
Topics
Page Number
59-64
Legacy Keywords
Melanie Witt RN CPC-OGS MA; reimbursement; coding; CPT codes; Current Procedural Terminology; total laparoscopic hysterectomy; paravaginal defect; bladder aspiration; intra-abdominal tumor; online counseling; fascial sling; synthetic sling; stress incontinence; National Correct Coding Initiatives; NCCI; hysterectomy; laparoscopy; intraperitoneal tumors; influenza virus vaccine; HPV vaccine; fecal blood testing; cervical biopsy; modifier -51
Sections
Author and Disclosure Information

Melanie Witt, RN, CPC-OGS, MA
Independent coding and documentation consultant; former program manager, Department of Coding and Nomenclature, American College of Obstetricians and Gynecologists

Author and Disclosure Information

Melanie Witt, RN, CPC-OGS, MA
Independent coding and documentation consultant; former program manager, Department of Coding and Nomenclature, American College of Obstetricians and Gynecologists

Article PDF
Article PDF

In 2008, long-awaited surgical codes are being added to Current Procedural Terminology (CPT) for total laparoscopic hysterectomy and repair of a paravaginal defect. Pay attention to code renumbering and revisions in the New Year, too: Bladder aspiration codes have new numbers, and removal of an intra-abdominal tumor will require more careful documentation, to cite two changes.

There’s more: If you’ve been spending time on telephone or on-line counseling, codes that may get you paid for that service are about to make their debut.

Key additions and revisions to CPT for the new year are detailed in this article and in next issue’s Reimbursement Adviser.

Specify repair of paravaginal defect

57284  Paravaginal defect repair (including repair of cystocele, if performed); open abdominal approach

57285   Paravaginal defect repair (including repair of cystocele, if performed); vaginal approach

57423  Paravaginal defect repair (including repair of cystocele, if performed); laparoscopic approach

You’ll now have to carefully document your surgical approach to repairing a paravaginal defect, thanks to creation of two new codes and revision of the existing 57284.

Several bundles are still attached to the new codes, however. CPT did remove references to “stress urinary incontinence, and/or incomplete vaginal prolapse” from the revised and new codes, but repair of a cystocele, by any method, is still included.

CPT 2008 is, therefore, listing codes that cannot be reported additionally. In general, urethropexy codes 51840, 51841, 51990, 58152, and 58267 and cystocele repair codes 57240, 57260, and 57265 should not be reported when a paravaginal defect repair is performed.

Also, be alert for any National Correct Coding Initiatives (NCCI) bundles assigned by Medicare to these new codes if they are different from the ones that will be listed by CPT. In particular, 57288 [sling operation for stress incontinence (e.g., fascia or synthetic)] was permanently bundled into 57284. (If that bundle isn’t removed in 2008, I encourage you to contact ACOG and urge the College to discuss this inappropriate bundle with Medicare administrators.)

Total lap hysterectomy

58570  Laparoscopy, surgical, with total hysterectomy, for uterus 250 g or less

58571  Laparoscopy, surgical, with total hysterectomy, for uterus 250 g or less; with removal of tube(s) and/or ovary(ies)

58572  Laparoscopy, surgical, with total hysterectomy, for uterus greater than 250 g

58573  Laparoscopy, surgical, with total hysterectomy, for uterus greater than 250 g; with removal of tube(s) and/or ovary(ies)

For some time, surgeons have been able to perform a hysterectomy by completely detaching both the uterine cervix and the body of the uterus from their surrounding support structures laparoscopically, then closing the vaginal cuff via this approach as well. Before 2008, the only coding choices were laparoscopic-assisted hysterectomy codes (58550–58554) or the unlisted laparoscopic code 58578. The new codes—as with codes for any vaginal or laparoscopic approach—are selected based on 1) the documented weight of the uterus and 2) whether the fallopian tubes or ovaries have been removed.

Intraperitoneal tumors, coded by size

49203 Excision or destruction, open, intra-abdominal tumors, cysts or endometriomas, 1 or more peritoneal, mesenteric, or retroperitoneal primary or secondary tumors; largest tumor 5 cm diameter or less

49204 …largest tumor 5.1–10.0 cm diameter

49205 …largest tumor greater than 10.0 cm diameter

In 2007, documenting the removal of intraperitoneal or retroperitoneal tumors, cysts, and endometriomas via abdominal incision was fairly simple: There were two codes and you had only to decide if removal was extensive or not.

In 2008, codes 49200 and 49201 are deleted and replaced by three new codes—each of which requires you to document the size of the largest tumor or lesion removed.

The new codes will come in handy during surgery in which the originating organ has been removed but the patient is found to have additional tumors. For example: A patient had ovarian cancer and now there are additional tumors in the abdominal cavity, but an omentectomy is not being performed. Of course, the new codes can still be used for excision or destruction of cysts or endometriomas, as well. But CPT has also listed codes that cannot be billed with the new codes: Among them are 38770 [pelvic lymphadenectomy] and 58900–58960 [surgeries performed on the ovaries]. If the new codes don’t fit the surgery, the other option for tumor debulking after the organ has been removed is to report 58957 or 58958; note, however, that these codes include omentectomy and optional pelvic lymph node sampling.

Bladder aspiration is renumbered

51100 Aspiration of bladder; by needle

 

 

51101 …by trocar or intracatheter

51102 …with insertion of suprapubic catheter

If you have the old codes for bladder aspiration memorized, relearn them. Once again, CPT tinkered with placement of codes and decided that bladder aspiration codes are placed more appropriately under “Bladder, Removal” than “Bladder, Incision.” The uses of those codes are unchanged.

Giving flu, HPV vaccines

90661 Influenza virus vaccine, derived from cell cultures, subunit, preservative and antibiotic free, for intramuscular use

90662 Influenza virus vaccine, split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use

90663 Influenza virus vaccine, pandemic formulation

90650 Human papillomavirus (HPV) vaccine, types 16 and 18, bivalent, 3-dose schedule, for intramuscular use

Four new codes for vaccines can be reported beginning January 1, but only those for the influenza vaccine appear in the CPT 2008 book. The code for the new bivalent HPV vaccine is a valid code for 2008 but will not appear in print until CPT 2009.

Changes made to “modifier -51” exemptions

CPT 2008 also reassessed codes that have been designated as “modifier - 51 exempt.” Typically, these are codes that do not involve significant preoperative or postoperative work. 36660 [catheterization, umbilical artery, newborn, for diagnosis or therapy] now requires a modifier when performed with other procedures, whereas 51797 [voiding pressure studies (VP); intra-abdominal voiding pressure (AP) (rectal, gastric, intraperitoneal)] becomes an add-on code that does not take a modifier -51. Beginning January 1, 51797 can be billed only if 51795 [voiding pressure studies (VP); bladder voiding pressure, any technique] has also been reported.

A few “clarifications” may simplify coding in 2008

Fecal blood testing

If you bill 82272 [blood, occult, by peroxidase activity (e.g., guaiac), qualitative, feces, single specimen (e.g., from digital rectal exam)] for the annual fecal occult blood screening test, CPT has revised the code to make it clear that this code is not to be reported for a screening test.

The only two CPT codes that can be reported for the screening fecal occult blood test are 82270 [blood, occult, by peroxidase activity (e.g., guaiac), qualitative, feces, consecutive collected specimens with single determination, for colorectal neoplasm screening] (that is, the patient was provided three cards or a single triple card for consecutive collection) or 82274 [blood, occult, by fecal hemoglobin determination by immunoassay, qualitative, feces, 1–3 simultaneous determinations].

Note: The physician may collect the specimen for an immunoassay (except on a Medicare patient), but a guaiac test specimen must be collected by the patient.

Cervical biopsy

The descriptor for 57500 will now specifically refer to the cervix as the location for biopsy or excision of a lesion. Before this change, only the subheading title gave any indication of anatomic location.

Hysterectomy

If you perform a laparoscopic-assisted (58550–58554), total (58570–58573), or supracervical (58541–58544) hysterectomy, CPT has added a list of codes that you may not report as well. These include:

  • 49320 [diagnostic laparoscopy]
  • 57000 [colpotomy]
  • 57180 [hemostatic vaginal packing]
  • 57410 [EUA]
  • 58140–58146, 58545–58546, 58561 [myomectomy]
  • 58661 [removal of tubes and/or ovaries]
  • 58670, 58671 [tubal ligations]

Vascular ultrasound

Last, CPT has clarified that, to bill 93975 or 93976 [duplex scan of arterial inflow and venous outflow of abdominal, pelvic, scrotal contents and/or retroperitoneal organs], the purpose of the exam must be to evaluate vascular structures. If color Doppler ultrasound is used to identify anatomic structures at the time of US scan, neither of those two codes may be billed additionally.

In 2008, long-awaited surgical codes are being added to Current Procedural Terminology (CPT) for total laparoscopic hysterectomy and repair of a paravaginal defect. Pay attention to code renumbering and revisions in the New Year, too: Bladder aspiration codes have new numbers, and removal of an intra-abdominal tumor will require more careful documentation, to cite two changes.

There’s more: If you’ve been spending time on telephone or on-line counseling, codes that may get you paid for that service are about to make their debut.

Key additions and revisions to CPT for the new year are detailed in this article and in next issue’s Reimbursement Adviser.

Specify repair of paravaginal defect

57284  Paravaginal defect repair (including repair of cystocele, if performed); open abdominal approach

57285   Paravaginal defect repair (including repair of cystocele, if performed); vaginal approach

57423  Paravaginal defect repair (including repair of cystocele, if performed); laparoscopic approach

You’ll now have to carefully document your surgical approach to repairing a paravaginal defect, thanks to creation of two new codes and revision of the existing 57284.

Several bundles are still attached to the new codes, however. CPT did remove references to “stress urinary incontinence, and/or incomplete vaginal prolapse” from the revised and new codes, but repair of a cystocele, by any method, is still included.

CPT 2008 is, therefore, listing codes that cannot be reported additionally. In general, urethropexy codes 51840, 51841, 51990, 58152, and 58267 and cystocele repair codes 57240, 57260, and 57265 should not be reported when a paravaginal defect repair is performed.

Also, be alert for any National Correct Coding Initiatives (NCCI) bundles assigned by Medicare to these new codes if they are different from the ones that will be listed by CPT. In particular, 57288 [sling operation for stress incontinence (e.g., fascia or synthetic)] was permanently bundled into 57284. (If that bundle isn’t removed in 2008, I encourage you to contact ACOG and urge the College to discuss this inappropriate bundle with Medicare administrators.)

Total lap hysterectomy

58570  Laparoscopy, surgical, with total hysterectomy, for uterus 250 g or less

58571  Laparoscopy, surgical, with total hysterectomy, for uterus 250 g or less; with removal of tube(s) and/or ovary(ies)

58572  Laparoscopy, surgical, with total hysterectomy, for uterus greater than 250 g

58573  Laparoscopy, surgical, with total hysterectomy, for uterus greater than 250 g; with removal of tube(s) and/or ovary(ies)

For some time, surgeons have been able to perform a hysterectomy by completely detaching both the uterine cervix and the body of the uterus from their surrounding support structures laparoscopically, then closing the vaginal cuff via this approach as well. Before 2008, the only coding choices were laparoscopic-assisted hysterectomy codes (58550–58554) or the unlisted laparoscopic code 58578. The new codes—as with codes for any vaginal or laparoscopic approach—are selected based on 1) the documented weight of the uterus and 2) whether the fallopian tubes or ovaries have been removed.

Intraperitoneal tumors, coded by size

49203 Excision or destruction, open, intra-abdominal tumors, cysts or endometriomas, 1 or more peritoneal, mesenteric, or retroperitoneal primary or secondary tumors; largest tumor 5 cm diameter or less

49204 …largest tumor 5.1–10.0 cm diameter

49205 …largest tumor greater than 10.0 cm diameter

In 2007, documenting the removal of intraperitoneal or retroperitoneal tumors, cysts, and endometriomas via abdominal incision was fairly simple: There were two codes and you had only to decide if removal was extensive or not.

In 2008, codes 49200 and 49201 are deleted and replaced by three new codes—each of which requires you to document the size of the largest tumor or lesion removed.

The new codes will come in handy during surgery in which the originating organ has been removed but the patient is found to have additional tumors. For example: A patient had ovarian cancer and now there are additional tumors in the abdominal cavity, but an omentectomy is not being performed. Of course, the new codes can still be used for excision or destruction of cysts or endometriomas, as well. But CPT has also listed codes that cannot be billed with the new codes: Among them are 38770 [pelvic lymphadenectomy] and 58900–58960 [surgeries performed on the ovaries]. If the new codes don’t fit the surgery, the other option for tumor debulking after the organ has been removed is to report 58957 or 58958; note, however, that these codes include omentectomy and optional pelvic lymph node sampling.

Bladder aspiration is renumbered

51100 Aspiration of bladder; by needle

 

 

51101 …by trocar or intracatheter

51102 …with insertion of suprapubic catheter

If you have the old codes for bladder aspiration memorized, relearn them. Once again, CPT tinkered with placement of codes and decided that bladder aspiration codes are placed more appropriately under “Bladder, Removal” than “Bladder, Incision.” The uses of those codes are unchanged.

Giving flu, HPV vaccines

90661 Influenza virus vaccine, derived from cell cultures, subunit, preservative and antibiotic free, for intramuscular use

90662 Influenza virus vaccine, split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use

90663 Influenza virus vaccine, pandemic formulation

90650 Human papillomavirus (HPV) vaccine, types 16 and 18, bivalent, 3-dose schedule, for intramuscular use

Four new codes for vaccines can be reported beginning January 1, but only those for the influenza vaccine appear in the CPT 2008 book. The code for the new bivalent HPV vaccine is a valid code for 2008 but will not appear in print until CPT 2009.

Changes made to “modifier -51” exemptions

CPT 2008 also reassessed codes that have been designated as “modifier - 51 exempt.” Typically, these are codes that do not involve significant preoperative or postoperative work. 36660 [catheterization, umbilical artery, newborn, for diagnosis or therapy] now requires a modifier when performed with other procedures, whereas 51797 [voiding pressure studies (VP); intra-abdominal voiding pressure (AP) (rectal, gastric, intraperitoneal)] becomes an add-on code that does not take a modifier -51. Beginning January 1, 51797 can be billed only if 51795 [voiding pressure studies (VP); bladder voiding pressure, any technique] has also been reported.

A few “clarifications” may simplify coding in 2008

Fecal blood testing

If you bill 82272 [blood, occult, by peroxidase activity (e.g., guaiac), qualitative, feces, single specimen (e.g., from digital rectal exam)] for the annual fecal occult blood screening test, CPT has revised the code to make it clear that this code is not to be reported for a screening test.

The only two CPT codes that can be reported for the screening fecal occult blood test are 82270 [blood, occult, by peroxidase activity (e.g., guaiac), qualitative, feces, consecutive collected specimens with single determination, for colorectal neoplasm screening] (that is, the patient was provided three cards or a single triple card for consecutive collection) or 82274 [blood, occult, by fecal hemoglobin determination by immunoassay, qualitative, feces, 1–3 simultaneous determinations].

Note: The physician may collect the specimen for an immunoassay (except on a Medicare patient), but a guaiac test specimen must be collected by the patient.

Cervical biopsy

The descriptor for 57500 will now specifically refer to the cervix as the location for biopsy or excision of a lesion. Before this change, only the subheading title gave any indication of anatomic location.

Hysterectomy

If you perform a laparoscopic-assisted (58550–58554), total (58570–58573), or supracervical (58541–58544) hysterectomy, CPT has added a list of codes that you may not report as well. These include:

  • 49320 [diagnostic laparoscopy]
  • 57000 [colpotomy]
  • 57180 [hemostatic vaginal packing]
  • 57410 [EUA]
  • 58140–58146, 58545–58546, 58561 [myomectomy]
  • 58661 [removal of tubes and/or ovaries]
  • 58670, 58671 [tubal ligations]

Vascular ultrasound

Last, CPT has clarified that, to bill 93975 or 93976 [duplex scan of arterial inflow and venous outflow of abdominal, pelvic, scrotal contents and/or retroperitoneal organs], the purpose of the exam must be to evaluate vascular structures. If color Doppler ultrasound is used to identify anatomic structures at the time of US scan, neither of those two codes may be billed additionally.

Issue
OBG Management - 19(12)
Issue
OBG Management - 19(12)
Page Number
59-64
Page Number
59-64
Publications
Publications
Topics
Article Type
Display Headline
CPT codes diversify for hysterectomy and repair of paravaginal defects
Display Headline
CPT codes diversify for hysterectomy and repair of paravaginal defects
Legacy Keywords
Melanie Witt RN CPC-OGS MA; reimbursement; coding; CPT codes; Current Procedural Terminology; total laparoscopic hysterectomy; paravaginal defect; bladder aspiration; intra-abdominal tumor; online counseling; fascial sling; synthetic sling; stress incontinence; National Correct Coding Initiatives; NCCI; hysterectomy; laparoscopy; intraperitoneal tumors; influenza virus vaccine; HPV vaccine; fecal blood testing; cervical biopsy; modifier -51
Legacy Keywords
Melanie Witt RN CPC-OGS MA; reimbursement; coding; CPT codes; Current Procedural Terminology; total laparoscopic hysterectomy; paravaginal defect; bladder aspiration; intra-abdominal tumor; online counseling; fascial sling; synthetic sling; stress incontinence; National Correct Coding Initiatives; NCCI; hysterectomy; laparoscopy; intraperitoneal tumors; influenza virus vaccine; HPV vaccine; fecal blood testing; cervical biopsy; modifier -51
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Should You Do This Deal?

Article Type
Changed
Display Headline
Should You Do This Deal?

DR. NEEDHAM is a family physician in Santa Monica, Calif. He teaches a course on net present value at the annual meeting of the American Academy of Family Physicians.

If you've ever wondered whether you should buy a DXA machine or start offering botox in your practice, read on: Learning how to calculate the net present value of that venture would go a long way toward helping you figure out if it's truly a good move.

For all their training and experience in clinical decision making, physicians are no better than anyone else at making business decisions if they lack the necessary quantitative tools.

And yet, I've seen plenty of my colleagues invest their time and money in significant practice-changing ventures without first rigorously evaluating them, only to wonder a year later why they aren't making any money.

The most common mistake is making decisions, not blindly, but partially blindly. I'm referring to the physician who decides to buy a dual-energy x-ray absorptiometry machine because the age and demographic profile of his or her patient population would seem to make the purchase a no-brainer. But there are a lot more factors to consider besides the ideal patient population.

Why do I recommend using a net present value (NPV) equation in particular? Because it's a fairly straightforward way to take into account the risk and opportunity costs of any venture.

The first step is figuring out cash flow. For example, say the DXA machine you're eyeing costs $100,000 and is good for 10 years of use before it needs to be replaced. Let's say that payers will reimburse you $100 for each scan. And based on your patient population, you may estimate that you will be performing x number of scans per year.

Next, figure out what the cost of each of those scans will be. If you have to hire a technician, factor in his or her salary and benefits, the cost of that person's training, and the cost of any supplies. In addition, consider what the marketing costs will be.

The second step is figuring out opportunity costs. Will be you be giving up time or space, or both? Reading DXA scans doesn't take much time, but space may be an issue. If you place the machine in an exam room, what is the opportunity cost of giving up that space? Will it reduce the number of patients who can be seen each hour?

Sometimes the opportunity costs may not be as obvious as you think. Take the example of a colleague of mine who is considering adding colonoscopy to his practice.

Let's assume that, on average, Medicare reimbursement is $225, and that he can perform two colonoscopies per hour. Factor in the time that it takes to travel to and from the colonoscopy center—as well as the inevitable no-shows—and it may appear that the opportunity costs of providing colonoscopy are too great.

That would certainly be the case if his time could instead be spent seeing four patients per hour at $110 each, without the travel time. On the other hand, when he is away at the colonoscopy center, perhaps an exam room is freed up for a colleague to see more patients, a factor that may shore up the deal, at least in a large practice.

The third step is to evaluate what that cash flow is worth to you over time. Let's say you expect $20,000 in income from the DXA scanner each year for the next 10 years. Ask yourself: Is $20,000 a year worth $100,000 to me now? Calculating the discount rate—which is your estimate of the risk of your project—can help answer that question. So let's say much of your practice's patient population comprises postmenopausal women. But there are 10 other physicians in your area, as well as a few hospitals, that offer DXA scanning, so there is no shortage of competition. In this case, the discount rate is quite high.

The fourth step is doing a sensitivity analysis, which is a way of testing your estimates.

After you've made estimates in good faith, you may then discover that your discount rate is 12%. In other words, you're not super confident, but the venture isn't a flier either. Based on that estimate, you find that your NPV is $200,000, which is more than what you expect to pay for the machine, a favorable finding. The higher the NPV is over the initial cash investment, the more confident you can be that you will make money. The beauty of this NPV number is that it can then be used to compare projects, say one that may last 3 years versus another that will last 10 years.

 

 

You can also go back and change your assumptions and see how the changes alter the NPV. If Medicare reimbursement for DXA scans is reduced by 10%, for example, or if the number of scans you expected to perform each year is cut by 10%, what does that do to the NPV? If it veers into the red, don't do the deal.

A low NPV may give you bargaining power. In negotiations with the DXA machine vendor, a low NPV will substantiate why you're will to pay only $70,000 for the machine, or you may more clearly see the wisdom of purchasing a lightly used, refurbished machine instead.

Physicians don't tend to calculate NPV because it's time consuming, and it's not as challenging or as exciting as a clinical problem. But a lot of money may ride on it and it will help you know if your financial intuition is correct.

My advice: Go online, learn about net present value.

Crunch the numbers yourself, or hire someone to do it for you. But be aware of all the tools at your disposal before you cut that check.

Article PDF
Author and Disclosure Information

Publications
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

DR. NEEDHAM is a family physician in Santa Monica, Calif. He teaches a course on net present value at the annual meeting of the American Academy of Family Physicians.

If you've ever wondered whether you should buy a DXA machine or start offering botox in your practice, read on: Learning how to calculate the net present value of that venture would go a long way toward helping you figure out if it's truly a good move.

For all their training and experience in clinical decision making, physicians are no better than anyone else at making business decisions if they lack the necessary quantitative tools.

And yet, I've seen plenty of my colleagues invest their time and money in significant practice-changing ventures without first rigorously evaluating them, only to wonder a year later why they aren't making any money.

The most common mistake is making decisions, not blindly, but partially blindly. I'm referring to the physician who decides to buy a dual-energy x-ray absorptiometry machine because the age and demographic profile of his or her patient population would seem to make the purchase a no-brainer. But there are a lot more factors to consider besides the ideal patient population.

Why do I recommend using a net present value (NPV) equation in particular? Because it's a fairly straightforward way to take into account the risk and opportunity costs of any venture.

The first step is figuring out cash flow. For example, say the DXA machine you're eyeing costs $100,000 and is good for 10 years of use before it needs to be replaced. Let's say that payers will reimburse you $100 for each scan. And based on your patient population, you may estimate that you will be performing x number of scans per year.

Next, figure out what the cost of each of those scans will be. If you have to hire a technician, factor in his or her salary and benefits, the cost of that person's training, and the cost of any supplies. In addition, consider what the marketing costs will be.

The second step is figuring out opportunity costs. Will be you be giving up time or space, or both? Reading DXA scans doesn't take much time, but space may be an issue. If you place the machine in an exam room, what is the opportunity cost of giving up that space? Will it reduce the number of patients who can be seen each hour?

Sometimes the opportunity costs may not be as obvious as you think. Take the example of a colleague of mine who is considering adding colonoscopy to his practice.

Let's assume that, on average, Medicare reimbursement is $225, and that he can perform two colonoscopies per hour. Factor in the time that it takes to travel to and from the colonoscopy center—as well as the inevitable no-shows—and it may appear that the opportunity costs of providing colonoscopy are too great.

That would certainly be the case if his time could instead be spent seeing four patients per hour at $110 each, without the travel time. On the other hand, when he is away at the colonoscopy center, perhaps an exam room is freed up for a colleague to see more patients, a factor that may shore up the deal, at least in a large practice.

The third step is to evaluate what that cash flow is worth to you over time. Let's say you expect $20,000 in income from the DXA scanner each year for the next 10 years. Ask yourself: Is $20,000 a year worth $100,000 to me now? Calculating the discount rate—which is your estimate of the risk of your project—can help answer that question. So let's say much of your practice's patient population comprises postmenopausal women. But there are 10 other physicians in your area, as well as a few hospitals, that offer DXA scanning, so there is no shortage of competition. In this case, the discount rate is quite high.

The fourth step is doing a sensitivity analysis, which is a way of testing your estimates.

After you've made estimates in good faith, you may then discover that your discount rate is 12%. In other words, you're not super confident, but the venture isn't a flier either. Based on that estimate, you find that your NPV is $200,000, which is more than what you expect to pay for the machine, a favorable finding. The higher the NPV is over the initial cash investment, the more confident you can be that you will make money. The beauty of this NPV number is that it can then be used to compare projects, say one that may last 3 years versus another that will last 10 years.

 

 

You can also go back and change your assumptions and see how the changes alter the NPV. If Medicare reimbursement for DXA scans is reduced by 10%, for example, or if the number of scans you expected to perform each year is cut by 10%, what does that do to the NPV? If it veers into the red, don't do the deal.

A low NPV may give you bargaining power. In negotiations with the DXA machine vendor, a low NPV will substantiate why you're will to pay only $70,000 for the machine, or you may more clearly see the wisdom of purchasing a lightly used, refurbished machine instead.

Physicians don't tend to calculate NPV because it's time consuming, and it's not as challenging or as exciting as a clinical problem. But a lot of money may ride on it and it will help you know if your financial intuition is correct.

My advice: Go online, learn about net present value.

Crunch the numbers yourself, or hire someone to do it for you. But be aware of all the tools at your disposal before you cut that check.

DR. NEEDHAM is a family physician in Santa Monica, Calif. He teaches a course on net present value at the annual meeting of the American Academy of Family Physicians.

If you've ever wondered whether you should buy a DXA machine or start offering botox in your practice, read on: Learning how to calculate the net present value of that venture would go a long way toward helping you figure out if it's truly a good move.

For all their training and experience in clinical decision making, physicians are no better than anyone else at making business decisions if they lack the necessary quantitative tools.

And yet, I've seen plenty of my colleagues invest their time and money in significant practice-changing ventures without first rigorously evaluating them, only to wonder a year later why they aren't making any money.

The most common mistake is making decisions, not blindly, but partially blindly. I'm referring to the physician who decides to buy a dual-energy x-ray absorptiometry machine because the age and demographic profile of his or her patient population would seem to make the purchase a no-brainer. But there are a lot more factors to consider besides the ideal patient population.

Why do I recommend using a net present value (NPV) equation in particular? Because it's a fairly straightforward way to take into account the risk and opportunity costs of any venture.

The first step is figuring out cash flow. For example, say the DXA machine you're eyeing costs $100,000 and is good for 10 years of use before it needs to be replaced. Let's say that payers will reimburse you $100 for each scan. And based on your patient population, you may estimate that you will be performing x number of scans per year.

Next, figure out what the cost of each of those scans will be. If you have to hire a technician, factor in his or her salary and benefits, the cost of that person's training, and the cost of any supplies. In addition, consider what the marketing costs will be.

The second step is figuring out opportunity costs. Will be you be giving up time or space, or both? Reading DXA scans doesn't take much time, but space may be an issue. If you place the machine in an exam room, what is the opportunity cost of giving up that space? Will it reduce the number of patients who can be seen each hour?

Sometimes the opportunity costs may not be as obvious as you think. Take the example of a colleague of mine who is considering adding colonoscopy to his practice.

Let's assume that, on average, Medicare reimbursement is $225, and that he can perform two colonoscopies per hour. Factor in the time that it takes to travel to and from the colonoscopy center—as well as the inevitable no-shows—and it may appear that the opportunity costs of providing colonoscopy are too great.

That would certainly be the case if his time could instead be spent seeing four patients per hour at $110 each, without the travel time. On the other hand, when he is away at the colonoscopy center, perhaps an exam room is freed up for a colleague to see more patients, a factor that may shore up the deal, at least in a large practice.

The third step is to evaluate what that cash flow is worth to you over time. Let's say you expect $20,000 in income from the DXA scanner each year for the next 10 years. Ask yourself: Is $20,000 a year worth $100,000 to me now? Calculating the discount rate—which is your estimate of the risk of your project—can help answer that question. So let's say much of your practice's patient population comprises postmenopausal women. But there are 10 other physicians in your area, as well as a few hospitals, that offer DXA scanning, so there is no shortage of competition. In this case, the discount rate is quite high.

The fourth step is doing a sensitivity analysis, which is a way of testing your estimates.

After you've made estimates in good faith, you may then discover that your discount rate is 12%. In other words, you're not super confident, but the venture isn't a flier either. Based on that estimate, you find that your NPV is $200,000, which is more than what you expect to pay for the machine, a favorable finding. The higher the NPV is over the initial cash investment, the more confident you can be that you will make money. The beauty of this NPV number is that it can then be used to compare projects, say one that may last 3 years versus another that will last 10 years.

 

 

You can also go back and change your assumptions and see how the changes alter the NPV. If Medicare reimbursement for DXA scans is reduced by 10%, for example, or if the number of scans you expected to perform each year is cut by 10%, what does that do to the NPV? If it veers into the red, don't do the deal.

A low NPV may give you bargaining power. In negotiations with the DXA machine vendor, a low NPV will substantiate why you're will to pay only $70,000 for the machine, or you may more clearly see the wisdom of purchasing a lightly used, refurbished machine instead.

Physicians don't tend to calculate NPV because it's time consuming, and it's not as challenging or as exciting as a clinical problem. But a lot of money may ride on it and it will help you know if your financial intuition is correct.

My advice: Go online, learn about net present value.

Crunch the numbers yourself, or hire someone to do it for you. But be aware of all the tools at your disposal before you cut that check.

Publications
Publications
Article Type
Display Headline
Should You Do This Deal?
Display Headline
Should You Do This Deal?
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Sprucing Up the Office

Article Type
Changed
Display Headline
Sprucing Up the Office

One day last month, I noticed that the plastic carpet protector under my desk chair was disintegrating. When I pulled it up to replace it with a new one I got quite a surprise: The patch of carpet it had been protecting was considerably brighter and cleaner than the rest of the carpeting in my office.

Sometimes it takes a jolt like that to remind us to take a good look at our office furnishings. I discovered that a lot more than a carpet protector needed replacing. We tend not to notice gradual deterioration. Carpets fade and dull with constant traffic and cleaning. Wallpaper and paint accumulate dirt, stains, and damage. Furniture gets dirty and dented.

In particular, you might be surprised by the condition of your waiting room if you haven't been out there for awhile. I certainly was. The wallpaper was smudged behind chairs, where patients had rested their heads. There were stains and pen marks on the chairs' upholstery, and the frames were scratched and worn. The well-trafficked carpet was stained, faded, and pulled.

Even if you don't find anything obvious, it is wise to check periodically for subtle evidence of age. Find some patches of carpeting and flooring under desks and compare them with the exposed areas.

You also might want to look at the décor itself. Is it dated and just plain old looking? Any interior designer can determine when a space was last decorated, simply by the color and style of the materials used. If your office is stuck in the 1980s, it's probably time for a change.

Your next vacation would be a great time to make those changes. You'll come back to a new, fresh environment.

Start by reviewing your color scheme, and consider changing it if you're tired of it, or if, as mentioned, it's hopelessly out of date. Wallpaper and carpeting should be long-wearing industrial quality. The paint should have a high-quality “eggshell” finish to facilitate cleaning, and it should be professionally applied.

If you've grown tired of your wall decorations, now would be a good time to replace at least some of them. This need not be an expensive proposition. If you or a family member is an artist or photographer, consider framing some of the best work. Or invite local artists to display some of their work on your walls.

Furniture is another important consideration. You may be able to resurface and reupholster what you have now, but if not, shop carefully. Beware of products that are promoted specifically to physicians, as they tend to be overpriced.

Get recommendations from colleagues and others, and never shop solely on price. If you shop online, factor in shipping costs, which can be considerable for furniture. Don't be afraid to ask for discounts. You won't get them if you don't ask.

Plants, in my opinion, are important in any indoor environment. They help you, your employees, and your patients feel less cut off from the outside world. If you are hesitant to take on the extra work of plant upkeep, a corporate plant service will rent you the plants, keep them healthy, and replace any that begin to wither.

As I've mentioned in previous columns, consider joining a state or community business/industry association. They maintain lists of merchants willing to give discounts, and they enable you to find other members looking for similar furniture, which could land all of you a big quantity discount.

This is also a good time to clear out old textbooks, magazines, and files you haven't opened in years. And get your building's maintenance crew in to fix any nagging plumbing, electrical, or heating/air conditioning problems that may have developed.

Finally, spruce-up time is an excellent opportunity to take a look at your medical equipment. We've all seen vintage offices containing gadgets that were new when the office opened decades ago, with no modernization in the interim. Would you want to be treated by those physicians? Neither would your patients, for the most part. Patients want cutting-edge technology. Consider replacing your obsolete equipment, even if it “still works okay.”

Article PDF
Author and Disclosure Information

Publications
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

One day last month, I noticed that the plastic carpet protector under my desk chair was disintegrating. When I pulled it up to replace it with a new one I got quite a surprise: The patch of carpet it had been protecting was considerably brighter and cleaner than the rest of the carpeting in my office.

Sometimes it takes a jolt like that to remind us to take a good look at our office furnishings. I discovered that a lot more than a carpet protector needed replacing. We tend not to notice gradual deterioration. Carpets fade and dull with constant traffic and cleaning. Wallpaper and paint accumulate dirt, stains, and damage. Furniture gets dirty and dented.

In particular, you might be surprised by the condition of your waiting room if you haven't been out there for awhile. I certainly was. The wallpaper was smudged behind chairs, where patients had rested their heads. There were stains and pen marks on the chairs' upholstery, and the frames were scratched and worn. The well-trafficked carpet was stained, faded, and pulled.

Even if you don't find anything obvious, it is wise to check periodically for subtle evidence of age. Find some patches of carpeting and flooring under desks and compare them with the exposed areas.

You also might want to look at the décor itself. Is it dated and just plain old looking? Any interior designer can determine when a space was last decorated, simply by the color and style of the materials used. If your office is stuck in the 1980s, it's probably time for a change.

Your next vacation would be a great time to make those changes. You'll come back to a new, fresh environment.

Start by reviewing your color scheme, and consider changing it if you're tired of it, or if, as mentioned, it's hopelessly out of date. Wallpaper and carpeting should be long-wearing industrial quality. The paint should have a high-quality “eggshell” finish to facilitate cleaning, and it should be professionally applied.

If you've grown tired of your wall decorations, now would be a good time to replace at least some of them. This need not be an expensive proposition. If you or a family member is an artist or photographer, consider framing some of the best work. Or invite local artists to display some of their work on your walls.

Furniture is another important consideration. You may be able to resurface and reupholster what you have now, but if not, shop carefully. Beware of products that are promoted specifically to physicians, as they tend to be overpriced.

Get recommendations from colleagues and others, and never shop solely on price. If you shop online, factor in shipping costs, which can be considerable for furniture. Don't be afraid to ask for discounts. You won't get them if you don't ask.

Plants, in my opinion, are important in any indoor environment. They help you, your employees, and your patients feel less cut off from the outside world. If you are hesitant to take on the extra work of plant upkeep, a corporate plant service will rent you the plants, keep them healthy, and replace any that begin to wither.

As I've mentioned in previous columns, consider joining a state or community business/industry association. They maintain lists of merchants willing to give discounts, and they enable you to find other members looking for similar furniture, which could land all of you a big quantity discount.

This is also a good time to clear out old textbooks, magazines, and files you haven't opened in years. And get your building's maintenance crew in to fix any nagging plumbing, electrical, or heating/air conditioning problems that may have developed.

Finally, spruce-up time is an excellent opportunity to take a look at your medical equipment. We've all seen vintage offices containing gadgets that were new when the office opened decades ago, with no modernization in the interim. Would you want to be treated by those physicians? Neither would your patients, for the most part. Patients want cutting-edge technology. Consider replacing your obsolete equipment, even if it “still works okay.”

One day last month, I noticed that the plastic carpet protector under my desk chair was disintegrating. When I pulled it up to replace it with a new one I got quite a surprise: The patch of carpet it had been protecting was considerably brighter and cleaner than the rest of the carpeting in my office.

Sometimes it takes a jolt like that to remind us to take a good look at our office furnishings. I discovered that a lot more than a carpet protector needed replacing. We tend not to notice gradual deterioration. Carpets fade and dull with constant traffic and cleaning. Wallpaper and paint accumulate dirt, stains, and damage. Furniture gets dirty and dented.

In particular, you might be surprised by the condition of your waiting room if you haven't been out there for awhile. I certainly was. The wallpaper was smudged behind chairs, where patients had rested their heads. There were stains and pen marks on the chairs' upholstery, and the frames were scratched and worn. The well-trafficked carpet was stained, faded, and pulled.

Even if you don't find anything obvious, it is wise to check periodically for subtle evidence of age. Find some patches of carpeting and flooring under desks and compare them with the exposed areas.

You also might want to look at the décor itself. Is it dated and just plain old looking? Any interior designer can determine when a space was last decorated, simply by the color and style of the materials used. If your office is stuck in the 1980s, it's probably time for a change.

Your next vacation would be a great time to make those changes. You'll come back to a new, fresh environment.

Start by reviewing your color scheme, and consider changing it if you're tired of it, or if, as mentioned, it's hopelessly out of date. Wallpaper and carpeting should be long-wearing industrial quality. The paint should have a high-quality “eggshell” finish to facilitate cleaning, and it should be professionally applied.

If you've grown tired of your wall decorations, now would be a good time to replace at least some of them. This need not be an expensive proposition. If you or a family member is an artist or photographer, consider framing some of the best work. Or invite local artists to display some of their work on your walls.

Furniture is another important consideration. You may be able to resurface and reupholster what you have now, but if not, shop carefully. Beware of products that are promoted specifically to physicians, as they tend to be overpriced.

Get recommendations from colleagues and others, and never shop solely on price. If you shop online, factor in shipping costs, which can be considerable for furniture. Don't be afraid to ask for discounts. You won't get them if you don't ask.

Plants, in my opinion, are important in any indoor environment. They help you, your employees, and your patients feel less cut off from the outside world. If you are hesitant to take on the extra work of plant upkeep, a corporate plant service will rent you the plants, keep them healthy, and replace any that begin to wither.

As I've mentioned in previous columns, consider joining a state or community business/industry association. They maintain lists of merchants willing to give discounts, and they enable you to find other members looking for similar furniture, which could land all of you a big quantity discount.

This is also a good time to clear out old textbooks, magazines, and files you haven't opened in years. And get your building's maintenance crew in to fix any nagging plumbing, electrical, or heating/air conditioning problems that may have developed.

Finally, spruce-up time is an excellent opportunity to take a look at your medical equipment. We've all seen vintage offices containing gadgets that were new when the office opened decades ago, with no modernization in the interim. Would you want to be treated by those physicians? Neither would your patients, for the most part. Patients want cutting-edge technology. Consider replacing your obsolete equipment, even if it “still works okay.”

Publications
Publications
Article Type
Display Headline
Sprucing Up the Office
Display Headline
Sprucing Up the Office
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Demystify Admissions

Article Type
Changed
Display Headline
Demystify Admissions

Physicians may encounter patients in various ways during the first few days of a hospitalization: admission services, consultations, and medical-surgical co-management.

Submitting claims for these services is often inconsistent and inaccurate because billing education is not a standard part of medical education.

In an attempt to clarify the rules and reduce frustration, I will address billing, coding, and reimbursement guidelines for each type of initial hospital encounter over the next several issues.

Code of the Month Initial Hospital Care

99221: Initial hospital care, per day, for evaluation and management of a patient that requires:

  • A detailed or comprehensive history;
  • A detailed or comprehensive examination; and
  • Straightforward or low complexity medical decision making.

Counseling and/or coordination of care with other providers or agencies are offered consistent with the nature of the problem(s) and the patient’s and/or family’s needs. Usually, the problem(s) requiring admission are of low severity. Physicians typically spend 30 minutes at the bedside and on the patient’s hospital floor or unit.

99222: Initial hospital care, per day, for the evaluation and management of a patient, which requires these three key components:

  • A comprehensive history;
  • A comprehensive examination; and
  • Moderately complex medical decision making.

Counseling and/or coordination of care with other providers or agencies are offered consistent with the nature of the problem(s) and the patient’s and/or family’s needs. Usually, the problem(s) requiring admission are of moderate severity. Physicians typically spend 50 minutes at the bedside and on the patient’s hospital floor or unit.

99223: Initial hospital care, per day, for the evaluation and management of a patient, which requires these three key components:

  • A comprehensive history;
  • A comprehensive exam; and
  • Highly complex medical decision making.

Counseling and/or coordination of care with other providers or agencies are offered consistent with the nature of the problem(s) and the patient’s and/or family’s needs. Usually, the problem(s) requiring admission are of high severity. Physicians typically spend 70 minutes at the bedside and on the patient’s hospital floor or unit.

Note: These codes are used for new or patients. The physician does not have to spend the associated “typical” visit time with the patient to report an initial hospital care code. Time is only considered when more than half the visit is spent counseling/coordinating patient care. See Section 30.6.1C (www.cms.hhs.gov/manuals/downloads/clm104c12.pdf) for more information about reporting visit level based on time.

Definition

Initial Hospital Care (IHC) comprises all services related to the patient’s admission to an acute care facility. An acute care facility is any that registers inpatients but does not have a corresponding Current Procedural Terminology (CPT) code category for claim reporting. Acute care facilities also include “partial hospitals.”

For example, admissions to inpatient rehabilitation are reported with IHC codes 99221-99223, while nursing facility admissions have a designated category and are best reported with CPT codes 99304-99306 for Initial Nursing Facility Care.

Code Use

IHC codes are reported once per hospitalization and reserved for the physician/group assuming primary responsibility for the patient’s care during that time.

If reported more frequently, all claims within the same hospitalization subsequently reported with codes 99221-99223 are denied or rejected pending review of documentation to ascertain the correct service date and responsible party. This is common because physicians confuse code description IHC with its true intent. They mistakenly report these codes for their first inpatient encounter, regardless of the encounter date or the admitting physician/group.

Specialists assisting in the patient’s management and not primarily responsible for the entire hospitalization report the code category that best reflects the performed service and documentation—as long as the selected category requirements are met. The physician selects from either Inpatient Consultation codes 99251-99255 or Subsequent Hospital Care (SHC) codes 99231-99233. Any physician who provides patient services after the initial encounter, including those by the responsible attending physician/group or a specialist concurrently involved in the patient’s care, reports SHC codes for each date in which a face-to-face encounter occurs.

 

 

When services begin in one location (e.g., physician’s office, emergency department, or observation) and end with an inpatient admission on the same calendar day, the physician reports only the most appropriate initial hospital care code. It is not necessary for the physician to duplicate the information from the earlier encounter for the admission service. Instead, the physician can forward a copy of the progress note from the earlier encounter to the inpatient chart, along with the documented decision for admission and pertinent information obtained throughout the day. Auditors consider the culmination of all chart entries in a given date when reviewed. When services begin in one location but end with an admission on different calendar day, the physician separately reports each service provided on each date: 99220 on Day 1 and 99223 on Day 2.

Intrafacility Transfers

Patients may receive different components of inpatient services within the same (uninterrupted) episode of care, all within the same building but treated as separate facility admissions (e.g., rehabilitation or long-term acute care).

It is unlikely the attending physician of record during the acute care phase will also be the attending physician during the second phase of care. Should this occur, Medicare contractors and those payers who follow Medicare guidelines permit the attending physician to separately report the acute care discharge (99238-99239) and the secondary admission (99221-99223), but only in the absence of a shared medical record (see Section 30.6.9.1D,www.cms.hhs.gov/manuals/downloads/clm104c12.pdf). If a common chart is used, the physician reports the secondary admission services as ongoing care, using SHC codes 99231-99233 instead.

Similarly, transfers occur within a single phase of care, such as transfers to and from a medical intensive care unit and a standard medical-surgical unit. Such transfers are not treated as separate admissions, and the receiving physician reports only the SHC codes because the IHC service was previously reported by the admitting physician/group. TH

Carol Pohlig is a billing and coding expert with the University of Pennsylvania Medical Center, Philadelphia.

Code This Case

A hospitalist admits a patient to observation for chest pain to rule out myocardial infarction at 11 p.m. on Day 1.

Early on Day 2, test results, including serial electrocardiograms, cardiac enzyme and troponin levels, and echocardiography, confirm suspicions, and the physician admits the patient for treatment.

The inpatient admission documentation includes a detailed history and exam (because a complete history and exam, along with high complexity decision making, was previously recorded upon admission to observation) and high complexity medical decision-making. What service(s) can the hospitalist report?

The Solution

The hospitalist can potentially report two services because each occurred on a different calendar day; this assumes that the documentation and billing requirements for each service are met. The hospitalist must document the inpatient admission service separately from the observation admission, and only portions of the documentation from the observation admission can be counted toward the inpatient admission information.

The Centers for Medicare and Medicaid Services Documentation Guidelines for Evaluation and Management Services (E/M) is considered the gold standard of E/M resources. It indicates the physician must redocument the history of present illness (HPI), physical exam and medical decision-making (MDM) when referencing encounters from a previous date of service. In other words, the hospitalist can reference, by date, the review of systems and past, family, and social histories without having to redocument these elements. However, the hospitalist must reconfirm the HPI, reperform the physical exam, reconsider the plan of care, and redocument each of these items in a currently dated progress note.

Assuming separate notes were appropriately documented with the levels of history, exam and MDM indicated in the scenario above, the hospitalist reports 99220 for chest pain (ICD-9-CM 786.50) on Day 1 and 99221 for anterolateral myocardial infarction (ICD-9-CM 410.01) on Day 2.

Although the documentation for the inpatient admission service included high-complexity MDM, the hospitalist selects the visit level supported by each of the key components (i.e., history exam, and decision making). The lowest component determines the visit level; a detailed history and exam with high complexity MDM only supports 99221.

In contrast, if the hospitalist documented a single, yet cumulative, note with a comprehensive history and physical exam, and high complexity MDM on Day 2, he/she may report only the inpatient admission service (99223) unless the note identified each date and their corresponding components of documentation.

More information regarding the key components and guidelines for E/M documentation is available at www.cms.hhs.gov/MLNEdWebGuide/25_EMDOC.asp.—CP

Issue
The Hospitalist - 2007(11)
Publications
Sections

Physicians may encounter patients in various ways during the first few days of a hospitalization: admission services, consultations, and medical-surgical co-management.

Submitting claims for these services is often inconsistent and inaccurate because billing education is not a standard part of medical education.

In an attempt to clarify the rules and reduce frustration, I will address billing, coding, and reimbursement guidelines for each type of initial hospital encounter over the next several issues.

Code of the Month Initial Hospital Care

99221: Initial hospital care, per day, for evaluation and management of a patient that requires:

  • A detailed or comprehensive history;
  • A detailed or comprehensive examination; and
  • Straightforward or low complexity medical decision making.

Counseling and/or coordination of care with other providers or agencies are offered consistent with the nature of the problem(s) and the patient’s and/or family’s needs. Usually, the problem(s) requiring admission are of low severity. Physicians typically spend 30 minutes at the bedside and on the patient’s hospital floor or unit.

99222: Initial hospital care, per day, for the evaluation and management of a patient, which requires these three key components:

  • A comprehensive history;
  • A comprehensive examination; and
  • Moderately complex medical decision making.

Counseling and/or coordination of care with other providers or agencies are offered consistent with the nature of the problem(s) and the patient’s and/or family’s needs. Usually, the problem(s) requiring admission are of moderate severity. Physicians typically spend 50 minutes at the bedside and on the patient’s hospital floor or unit.

99223: Initial hospital care, per day, for the evaluation and management of a patient, which requires these three key components:

  • A comprehensive history;
  • A comprehensive exam; and
  • Highly complex medical decision making.

Counseling and/or coordination of care with other providers or agencies are offered consistent with the nature of the problem(s) and the patient’s and/or family’s needs. Usually, the problem(s) requiring admission are of high severity. Physicians typically spend 70 minutes at the bedside and on the patient’s hospital floor or unit.

Note: These codes are used for new or patients. The physician does not have to spend the associated “typical” visit time with the patient to report an initial hospital care code. Time is only considered when more than half the visit is spent counseling/coordinating patient care. See Section 30.6.1C (www.cms.hhs.gov/manuals/downloads/clm104c12.pdf) for more information about reporting visit level based on time.

Definition

Initial Hospital Care (IHC) comprises all services related to the patient’s admission to an acute care facility. An acute care facility is any that registers inpatients but does not have a corresponding Current Procedural Terminology (CPT) code category for claim reporting. Acute care facilities also include “partial hospitals.”

For example, admissions to inpatient rehabilitation are reported with IHC codes 99221-99223, while nursing facility admissions have a designated category and are best reported with CPT codes 99304-99306 for Initial Nursing Facility Care.

Code Use

IHC codes are reported once per hospitalization and reserved for the physician/group assuming primary responsibility for the patient’s care during that time.

If reported more frequently, all claims within the same hospitalization subsequently reported with codes 99221-99223 are denied or rejected pending review of documentation to ascertain the correct service date and responsible party. This is common because physicians confuse code description IHC with its true intent. They mistakenly report these codes for their first inpatient encounter, regardless of the encounter date or the admitting physician/group.

Specialists assisting in the patient’s management and not primarily responsible for the entire hospitalization report the code category that best reflects the performed service and documentation—as long as the selected category requirements are met. The physician selects from either Inpatient Consultation codes 99251-99255 or Subsequent Hospital Care (SHC) codes 99231-99233. Any physician who provides patient services after the initial encounter, including those by the responsible attending physician/group or a specialist concurrently involved in the patient’s care, reports SHC codes for each date in which a face-to-face encounter occurs.

 

 

When services begin in one location (e.g., physician’s office, emergency department, or observation) and end with an inpatient admission on the same calendar day, the physician reports only the most appropriate initial hospital care code. It is not necessary for the physician to duplicate the information from the earlier encounter for the admission service. Instead, the physician can forward a copy of the progress note from the earlier encounter to the inpatient chart, along with the documented decision for admission and pertinent information obtained throughout the day. Auditors consider the culmination of all chart entries in a given date when reviewed. When services begin in one location but end with an admission on different calendar day, the physician separately reports each service provided on each date: 99220 on Day 1 and 99223 on Day 2.

Intrafacility Transfers

Patients may receive different components of inpatient services within the same (uninterrupted) episode of care, all within the same building but treated as separate facility admissions (e.g., rehabilitation or long-term acute care).

It is unlikely the attending physician of record during the acute care phase will also be the attending physician during the second phase of care. Should this occur, Medicare contractors and those payers who follow Medicare guidelines permit the attending physician to separately report the acute care discharge (99238-99239) and the secondary admission (99221-99223), but only in the absence of a shared medical record (see Section 30.6.9.1D,www.cms.hhs.gov/manuals/downloads/clm104c12.pdf). If a common chart is used, the physician reports the secondary admission services as ongoing care, using SHC codes 99231-99233 instead.

Similarly, transfers occur within a single phase of care, such as transfers to and from a medical intensive care unit and a standard medical-surgical unit. Such transfers are not treated as separate admissions, and the receiving physician reports only the SHC codes because the IHC service was previously reported by the admitting physician/group. TH

Carol Pohlig is a billing and coding expert with the University of Pennsylvania Medical Center, Philadelphia.

Code This Case

A hospitalist admits a patient to observation for chest pain to rule out myocardial infarction at 11 p.m. on Day 1.

Early on Day 2, test results, including serial electrocardiograms, cardiac enzyme and troponin levels, and echocardiography, confirm suspicions, and the physician admits the patient for treatment.

The inpatient admission documentation includes a detailed history and exam (because a complete history and exam, along with high complexity decision making, was previously recorded upon admission to observation) and high complexity medical decision-making. What service(s) can the hospitalist report?

The Solution

The hospitalist can potentially report two services because each occurred on a different calendar day; this assumes that the documentation and billing requirements for each service are met. The hospitalist must document the inpatient admission service separately from the observation admission, and only portions of the documentation from the observation admission can be counted toward the inpatient admission information.

The Centers for Medicare and Medicaid Services Documentation Guidelines for Evaluation and Management Services (E/M) is considered the gold standard of E/M resources. It indicates the physician must redocument the history of present illness (HPI), physical exam and medical decision-making (MDM) when referencing encounters from a previous date of service. In other words, the hospitalist can reference, by date, the review of systems and past, family, and social histories without having to redocument these elements. However, the hospitalist must reconfirm the HPI, reperform the physical exam, reconsider the plan of care, and redocument each of these items in a currently dated progress note.

Assuming separate notes were appropriately documented with the levels of history, exam and MDM indicated in the scenario above, the hospitalist reports 99220 for chest pain (ICD-9-CM 786.50) on Day 1 and 99221 for anterolateral myocardial infarction (ICD-9-CM 410.01) on Day 2.

Although the documentation for the inpatient admission service included high-complexity MDM, the hospitalist selects the visit level supported by each of the key components (i.e., history exam, and decision making). The lowest component determines the visit level; a detailed history and exam with high complexity MDM only supports 99221.

In contrast, if the hospitalist documented a single, yet cumulative, note with a comprehensive history and physical exam, and high complexity MDM on Day 2, he/she may report only the inpatient admission service (99223) unless the note identified each date and their corresponding components of documentation.

More information regarding the key components and guidelines for E/M documentation is available at www.cms.hhs.gov/MLNEdWebGuide/25_EMDOC.asp.—CP

Physicians may encounter patients in various ways during the first few days of a hospitalization: admission services, consultations, and medical-surgical co-management.

Submitting claims for these services is often inconsistent and inaccurate because billing education is not a standard part of medical education.

In an attempt to clarify the rules and reduce frustration, I will address billing, coding, and reimbursement guidelines for each type of initial hospital encounter over the next several issues.

Code of the Month Initial Hospital Care

99221: Initial hospital care, per day, for evaluation and management of a patient that requires:

  • A detailed or comprehensive history;
  • A detailed or comprehensive examination; and
  • Straightforward or low complexity medical decision making.

Counseling and/or coordination of care with other providers or agencies are offered consistent with the nature of the problem(s) and the patient’s and/or family’s needs. Usually, the problem(s) requiring admission are of low severity. Physicians typically spend 30 minutes at the bedside and on the patient’s hospital floor or unit.

99222: Initial hospital care, per day, for the evaluation and management of a patient, which requires these three key components:

  • A comprehensive history;
  • A comprehensive examination; and
  • Moderately complex medical decision making.

Counseling and/or coordination of care with other providers or agencies are offered consistent with the nature of the problem(s) and the patient’s and/or family’s needs. Usually, the problem(s) requiring admission are of moderate severity. Physicians typically spend 50 minutes at the bedside and on the patient’s hospital floor or unit.

99223: Initial hospital care, per day, for the evaluation and management of a patient, which requires these three key components:

  • A comprehensive history;
  • A comprehensive exam; and
  • Highly complex medical decision making.

Counseling and/or coordination of care with other providers or agencies are offered consistent with the nature of the problem(s) and the patient’s and/or family’s needs. Usually, the problem(s) requiring admission are of high severity. Physicians typically spend 70 minutes at the bedside and on the patient’s hospital floor or unit.

Note: These codes are used for new or patients. The physician does not have to spend the associated “typical” visit time with the patient to report an initial hospital care code. Time is only considered when more than half the visit is spent counseling/coordinating patient care. See Section 30.6.1C (www.cms.hhs.gov/manuals/downloads/clm104c12.pdf) for more information about reporting visit level based on time.

Definition

Initial Hospital Care (IHC) comprises all services related to the patient’s admission to an acute care facility. An acute care facility is any that registers inpatients but does not have a corresponding Current Procedural Terminology (CPT) code category for claim reporting. Acute care facilities also include “partial hospitals.”

For example, admissions to inpatient rehabilitation are reported with IHC codes 99221-99223, while nursing facility admissions have a designated category and are best reported with CPT codes 99304-99306 for Initial Nursing Facility Care.

Code Use

IHC codes are reported once per hospitalization and reserved for the physician/group assuming primary responsibility for the patient’s care during that time.

If reported more frequently, all claims within the same hospitalization subsequently reported with codes 99221-99223 are denied or rejected pending review of documentation to ascertain the correct service date and responsible party. This is common because physicians confuse code description IHC with its true intent. They mistakenly report these codes for their first inpatient encounter, regardless of the encounter date or the admitting physician/group.

Specialists assisting in the patient’s management and not primarily responsible for the entire hospitalization report the code category that best reflects the performed service and documentation—as long as the selected category requirements are met. The physician selects from either Inpatient Consultation codes 99251-99255 or Subsequent Hospital Care (SHC) codes 99231-99233. Any physician who provides patient services after the initial encounter, including those by the responsible attending physician/group or a specialist concurrently involved in the patient’s care, reports SHC codes for each date in which a face-to-face encounter occurs.

 

 

When services begin in one location (e.g., physician’s office, emergency department, or observation) and end with an inpatient admission on the same calendar day, the physician reports only the most appropriate initial hospital care code. It is not necessary for the physician to duplicate the information from the earlier encounter for the admission service. Instead, the physician can forward a copy of the progress note from the earlier encounter to the inpatient chart, along with the documented decision for admission and pertinent information obtained throughout the day. Auditors consider the culmination of all chart entries in a given date when reviewed. When services begin in one location but end with an admission on different calendar day, the physician separately reports each service provided on each date: 99220 on Day 1 and 99223 on Day 2.

Intrafacility Transfers

Patients may receive different components of inpatient services within the same (uninterrupted) episode of care, all within the same building but treated as separate facility admissions (e.g., rehabilitation or long-term acute care).

It is unlikely the attending physician of record during the acute care phase will also be the attending physician during the second phase of care. Should this occur, Medicare contractors and those payers who follow Medicare guidelines permit the attending physician to separately report the acute care discharge (99238-99239) and the secondary admission (99221-99223), but only in the absence of a shared medical record (see Section 30.6.9.1D,www.cms.hhs.gov/manuals/downloads/clm104c12.pdf). If a common chart is used, the physician reports the secondary admission services as ongoing care, using SHC codes 99231-99233 instead.

Similarly, transfers occur within a single phase of care, such as transfers to and from a medical intensive care unit and a standard medical-surgical unit. Such transfers are not treated as separate admissions, and the receiving physician reports only the SHC codes because the IHC service was previously reported by the admitting physician/group. TH

Carol Pohlig is a billing and coding expert with the University of Pennsylvania Medical Center, Philadelphia.

Code This Case

A hospitalist admits a patient to observation for chest pain to rule out myocardial infarction at 11 p.m. on Day 1.

Early on Day 2, test results, including serial electrocardiograms, cardiac enzyme and troponin levels, and echocardiography, confirm suspicions, and the physician admits the patient for treatment.

The inpatient admission documentation includes a detailed history and exam (because a complete history and exam, along with high complexity decision making, was previously recorded upon admission to observation) and high complexity medical decision-making. What service(s) can the hospitalist report?

The Solution

The hospitalist can potentially report two services because each occurred on a different calendar day; this assumes that the documentation and billing requirements for each service are met. The hospitalist must document the inpatient admission service separately from the observation admission, and only portions of the documentation from the observation admission can be counted toward the inpatient admission information.

The Centers for Medicare and Medicaid Services Documentation Guidelines for Evaluation and Management Services (E/M) is considered the gold standard of E/M resources. It indicates the physician must redocument the history of present illness (HPI), physical exam and medical decision-making (MDM) when referencing encounters from a previous date of service. In other words, the hospitalist can reference, by date, the review of systems and past, family, and social histories without having to redocument these elements. However, the hospitalist must reconfirm the HPI, reperform the physical exam, reconsider the plan of care, and redocument each of these items in a currently dated progress note.

Assuming separate notes were appropriately documented with the levels of history, exam and MDM indicated in the scenario above, the hospitalist reports 99220 for chest pain (ICD-9-CM 786.50) on Day 1 and 99221 for anterolateral myocardial infarction (ICD-9-CM 410.01) on Day 2.

Although the documentation for the inpatient admission service included high-complexity MDM, the hospitalist selects the visit level supported by each of the key components (i.e., history exam, and decision making). The lowest component determines the visit level; a detailed history and exam with high complexity MDM only supports 99221.

In contrast, if the hospitalist documented a single, yet cumulative, note with a comprehensive history and physical exam, and high complexity MDM on Day 2, he/she may report only the inpatient admission service (99223) unless the note identified each date and their corresponding components of documentation.

More information regarding the key components and guidelines for E/M documentation is available at www.cms.hhs.gov/MLNEdWebGuide/25_EMDOC.asp.—CP

Issue
The Hospitalist - 2007(11)
Issue
The Hospitalist - 2007(11)
Publications
Publications
Article Type
Display Headline
Demystify Admissions
Display Headline
Demystify Admissions
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)

Medical Verdicts

Article Type
Changed
Display Headline
Medical Verdicts

Pain, brain injury due to ruptured uterus

A woman now pregnant with her third child—who had delivered her other two children by cesarean section—presented at the hospital with painful contractions 1 week before a scheduled cesarean section. Because her cervix was dilated only 1 cm, it was decided to monitor her cervical dilation until it indicated active labor and then perform a cesarean section.

Her contractions continued. Despite pain medication, she complained of pain at the “10+” level. Fetal monitoring became difficult and an emergency cesarean section was performed. The baby was found floating freely in the abdominal cavity because the uterus had ruptured. He suffered catastrophic injuries caused by a hypoxic–ischemic brain injury and will require assistance in all activities of daily living.

Patient’s claim The cesarean section should have been performed sooner. Also, the complaints of pain should have been investigated further.

Doctor’s defense Waiting for cervical dilation before proceeding to cesarean section was proper.

Verdict $5 million Minnesota settlement; part was used to purchase an annuity, and part was placed in a supplemental needs trust.

Wrong ovary removed? Judge dismisses case

A 42-year-old woman complaining of abdominal pain underwent a cholecystectomy and oophorectomy. During the surgery, the surgeon discovered that the right ovary, which was supposed to be removed, was densely adherent to the pelvic side wall. In order to leave the patient with some ovarian function, he decided to just “loosen” the right ovary and remove the left ovary, which was also diseased. The right ovary was removed in a later surgery.

Patient’s claim She alleged medical battery for removal of the left ovary, to which she had not consented. Also, failure to remove the right ovary required her to undergo additional surgery.

Doctor’s defense Consent for the surgery included authorization to perform medically indicated procedures. By removing the left ovary instead of the right one, the surgeon hoped the patient could maintain some ovarian function.

Verdict $175,000 Tennessee verdict on the battery issue. The trial judge granted the defendant’s motion for JNOV (judgment notwithstanding the verdict) and ruled there could be no medical battery. He found that (1) all experts stated that both ovaries were diseased and needed to be removed, (2) it was medically necessary to remove the left ovary, and (3) the patient had authorized any medically indicated procedure. The court dismissed the case. An appeal was pending.

Baby is entrapped by cervix; no OB to help

A 25-year-old woman presented at the hospital in preterm labor. Her ObGyn was contacted at home and prescribed medications. There was no obstetrician at the hospital when the patient’s water broke and the baby was found to be in a footling breech position. Delivery of the baby—at 23 5/7 weeks and 2 lb—began 5 minutes later, but the head became entrapped by the cervix, leading to asphyxiation. The ObGyn arrived nearly 1 hour later and completed the delivery.

Patient’s claim The mother claimed wrongful death and conscious pain and suffering of the infant, as well as negligent infliction of emotional distress for herself. Also, the ObGyn should have left immediately for the hospital when he was first contacted.

Doctor’s defense The initial information given to him did not indicate that a rapid delivery was about to occur. The second contact came after the infant had died, and the defendant left immediately for the hospital. Also, it was unlikely the infant would have been born alive because of the early gestational age.

Verdict Initially, a $175,000 verdict against the hospital for intentional infliction of emotional distress and a defense verdict for the ObGyn were returned in Illinois. The latter was overturned on appeal, and a second trial returned a $700,000 verdict for emotional distress.

Did infection cause child’s brain damage?

A woman in her 24th week of pregnancy presented with protracted vomiting and other symptoms of hyperemesis gravidarum. Her treating ObGyns ordered a peripherally inserted central line for the infusion of fluid, after which the patient was cared for at home by a home health nurse. Neither the physicians nor the nurse noticed that the central catheter had caused an infection. The patient went into septic shock but recovered. The child, however, was born with severe brain damage and requires 24-hour care, which he receives at home.

Patient’s claim The undiagnosed infection caused the fetal injury in utero.

Doctor’s defense The child’s condition was genetic and unrelated to the infection.

Verdict Michigan defense verdict.

Death following endometrial ablation

A 51-year-old woman weighing between 270 and 290 lb was to undergo endometrial ablation to control heavy menstrual bleeding. To increase her hematocrit for the surgery, her internist treated her with iron infusions. The patient told the anesthesiologist who reviewed her medical history and current physical health that, despite her weight, she could climb stairs and walk several blocks without shortness of breath. She rejected spinal anesthesia, and the anesthesiologist decided surgery could proceed safely.

 

 

About 40 minutes into the surgery, the gynecologist noticed the patent’s leg moving slightly. He then used a nerve stimulator to produce additional movement. Vital signs remained stable. The anesthesiologist administered a paralyzing agent, and the patient’s heart rate decreased 5 minutes later. The patient then died, apparently due to an embolism.

Plaintiff’s claim (1) Inappropriate hormone therapy from the gynecologist caused the need for endometrial ablation. (2) A significant fibroid made her a poor candidate for endometrial ablation. (3) A more thorough workup, including chest radiograph, echocardiogram, pulmonary function test, and arterial blood gas analysis, should have been performed by the anesthesiologist before surgery.

Doctor’s defense (1) There was no negligence involved. (2) Additional tests would not have provided helpful information. (3) Additional tests would not have changed the clinical plan.

Verdict California defense verdict.

References

The cases in this column are selected by the editors of OBG MANAGEMENT from Medical Malpractice Verdicts, Settlements & Experts, with permission of the editor, Lewis Laska, of Nashville, Tenn (www.verdictslaska.com). The available information about the cases presented here is sometimes incomplete; thus, pertinent details of a given situation may be unavailable. Moreover, the cases may or may not have merit. Nevertheless, these cases represent the types of clinical situations that typically result in litigation and are meant to illustrate nationwide variation in jury verdicts and awards.

Article PDF
Author and Disclosure Information

Issue
OBG Management - 19(11)
Publications
Topics
Page Number
84-88
Legacy Keywords
liability; malpractice; lawsuit; ruptured uterus; uterus; brain injury; hypoxic–ischemic brain injury; oophorectomy; cholecystectomy; abdominal pain; entrapped by cervix; hyperemesis gravidarum; peripherally inserted central line; endometrial ablation
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Pain, brain injury due to ruptured uterus

A woman now pregnant with her third child—who had delivered her other two children by cesarean section—presented at the hospital with painful contractions 1 week before a scheduled cesarean section. Because her cervix was dilated only 1 cm, it was decided to monitor her cervical dilation until it indicated active labor and then perform a cesarean section.

Her contractions continued. Despite pain medication, she complained of pain at the “10+” level. Fetal monitoring became difficult and an emergency cesarean section was performed. The baby was found floating freely in the abdominal cavity because the uterus had ruptured. He suffered catastrophic injuries caused by a hypoxic–ischemic brain injury and will require assistance in all activities of daily living.

Patient’s claim The cesarean section should have been performed sooner. Also, the complaints of pain should have been investigated further.

Doctor’s defense Waiting for cervical dilation before proceeding to cesarean section was proper.

Verdict $5 million Minnesota settlement; part was used to purchase an annuity, and part was placed in a supplemental needs trust.

Wrong ovary removed? Judge dismisses case

A 42-year-old woman complaining of abdominal pain underwent a cholecystectomy and oophorectomy. During the surgery, the surgeon discovered that the right ovary, which was supposed to be removed, was densely adherent to the pelvic side wall. In order to leave the patient with some ovarian function, he decided to just “loosen” the right ovary and remove the left ovary, which was also diseased. The right ovary was removed in a later surgery.

Patient’s claim She alleged medical battery for removal of the left ovary, to which she had not consented. Also, failure to remove the right ovary required her to undergo additional surgery.

Doctor’s defense Consent for the surgery included authorization to perform medically indicated procedures. By removing the left ovary instead of the right one, the surgeon hoped the patient could maintain some ovarian function.

Verdict $175,000 Tennessee verdict on the battery issue. The trial judge granted the defendant’s motion for JNOV (judgment notwithstanding the verdict) and ruled there could be no medical battery. He found that (1) all experts stated that both ovaries were diseased and needed to be removed, (2) it was medically necessary to remove the left ovary, and (3) the patient had authorized any medically indicated procedure. The court dismissed the case. An appeal was pending.

Baby is entrapped by cervix; no OB to help

A 25-year-old woman presented at the hospital in preterm labor. Her ObGyn was contacted at home and prescribed medications. There was no obstetrician at the hospital when the patient’s water broke and the baby was found to be in a footling breech position. Delivery of the baby—at 23 5/7 weeks and 2 lb—began 5 minutes later, but the head became entrapped by the cervix, leading to asphyxiation. The ObGyn arrived nearly 1 hour later and completed the delivery.

Patient’s claim The mother claimed wrongful death and conscious pain and suffering of the infant, as well as negligent infliction of emotional distress for herself. Also, the ObGyn should have left immediately for the hospital when he was first contacted.

Doctor’s defense The initial information given to him did not indicate that a rapid delivery was about to occur. The second contact came after the infant had died, and the defendant left immediately for the hospital. Also, it was unlikely the infant would have been born alive because of the early gestational age.

Verdict Initially, a $175,000 verdict against the hospital for intentional infliction of emotional distress and a defense verdict for the ObGyn were returned in Illinois. The latter was overturned on appeal, and a second trial returned a $700,000 verdict for emotional distress.

Did infection cause child’s brain damage?

A woman in her 24th week of pregnancy presented with protracted vomiting and other symptoms of hyperemesis gravidarum. Her treating ObGyns ordered a peripherally inserted central line for the infusion of fluid, after which the patient was cared for at home by a home health nurse. Neither the physicians nor the nurse noticed that the central catheter had caused an infection. The patient went into septic shock but recovered. The child, however, was born with severe brain damage and requires 24-hour care, which he receives at home.

Patient’s claim The undiagnosed infection caused the fetal injury in utero.

Doctor’s defense The child’s condition was genetic and unrelated to the infection.

Verdict Michigan defense verdict.

Death following endometrial ablation

A 51-year-old woman weighing between 270 and 290 lb was to undergo endometrial ablation to control heavy menstrual bleeding. To increase her hematocrit for the surgery, her internist treated her with iron infusions. The patient told the anesthesiologist who reviewed her medical history and current physical health that, despite her weight, she could climb stairs and walk several blocks without shortness of breath. She rejected spinal anesthesia, and the anesthesiologist decided surgery could proceed safely.

 

 

About 40 minutes into the surgery, the gynecologist noticed the patent’s leg moving slightly. He then used a nerve stimulator to produce additional movement. Vital signs remained stable. The anesthesiologist administered a paralyzing agent, and the patient’s heart rate decreased 5 minutes later. The patient then died, apparently due to an embolism.

Plaintiff’s claim (1) Inappropriate hormone therapy from the gynecologist caused the need for endometrial ablation. (2) A significant fibroid made her a poor candidate for endometrial ablation. (3) A more thorough workup, including chest radiograph, echocardiogram, pulmonary function test, and arterial blood gas analysis, should have been performed by the anesthesiologist before surgery.

Doctor’s defense (1) There was no negligence involved. (2) Additional tests would not have provided helpful information. (3) Additional tests would not have changed the clinical plan.

Verdict California defense verdict.

Pain, brain injury due to ruptured uterus

A woman now pregnant with her third child—who had delivered her other two children by cesarean section—presented at the hospital with painful contractions 1 week before a scheduled cesarean section. Because her cervix was dilated only 1 cm, it was decided to monitor her cervical dilation until it indicated active labor and then perform a cesarean section.

Her contractions continued. Despite pain medication, she complained of pain at the “10+” level. Fetal monitoring became difficult and an emergency cesarean section was performed. The baby was found floating freely in the abdominal cavity because the uterus had ruptured. He suffered catastrophic injuries caused by a hypoxic–ischemic brain injury and will require assistance in all activities of daily living.

Patient’s claim The cesarean section should have been performed sooner. Also, the complaints of pain should have been investigated further.

Doctor’s defense Waiting for cervical dilation before proceeding to cesarean section was proper.

Verdict $5 million Minnesota settlement; part was used to purchase an annuity, and part was placed in a supplemental needs trust.

Wrong ovary removed? Judge dismisses case

A 42-year-old woman complaining of abdominal pain underwent a cholecystectomy and oophorectomy. During the surgery, the surgeon discovered that the right ovary, which was supposed to be removed, was densely adherent to the pelvic side wall. In order to leave the patient with some ovarian function, he decided to just “loosen” the right ovary and remove the left ovary, which was also diseased. The right ovary was removed in a later surgery.

Patient’s claim She alleged medical battery for removal of the left ovary, to which she had not consented. Also, failure to remove the right ovary required her to undergo additional surgery.

Doctor’s defense Consent for the surgery included authorization to perform medically indicated procedures. By removing the left ovary instead of the right one, the surgeon hoped the patient could maintain some ovarian function.

Verdict $175,000 Tennessee verdict on the battery issue. The trial judge granted the defendant’s motion for JNOV (judgment notwithstanding the verdict) and ruled there could be no medical battery. He found that (1) all experts stated that both ovaries were diseased and needed to be removed, (2) it was medically necessary to remove the left ovary, and (3) the patient had authorized any medically indicated procedure. The court dismissed the case. An appeal was pending.

Baby is entrapped by cervix; no OB to help

A 25-year-old woman presented at the hospital in preterm labor. Her ObGyn was contacted at home and prescribed medications. There was no obstetrician at the hospital when the patient’s water broke and the baby was found to be in a footling breech position. Delivery of the baby—at 23 5/7 weeks and 2 lb—began 5 minutes later, but the head became entrapped by the cervix, leading to asphyxiation. The ObGyn arrived nearly 1 hour later and completed the delivery.

Patient’s claim The mother claimed wrongful death and conscious pain and suffering of the infant, as well as negligent infliction of emotional distress for herself. Also, the ObGyn should have left immediately for the hospital when he was first contacted.

Doctor’s defense The initial information given to him did not indicate that a rapid delivery was about to occur. The second contact came after the infant had died, and the defendant left immediately for the hospital. Also, it was unlikely the infant would have been born alive because of the early gestational age.

Verdict Initially, a $175,000 verdict against the hospital for intentional infliction of emotional distress and a defense verdict for the ObGyn were returned in Illinois. The latter was overturned on appeal, and a second trial returned a $700,000 verdict for emotional distress.

Did infection cause child’s brain damage?

A woman in her 24th week of pregnancy presented with protracted vomiting and other symptoms of hyperemesis gravidarum. Her treating ObGyns ordered a peripherally inserted central line for the infusion of fluid, after which the patient was cared for at home by a home health nurse. Neither the physicians nor the nurse noticed that the central catheter had caused an infection. The patient went into septic shock but recovered. The child, however, was born with severe brain damage and requires 24-hour care, which he receives at home.

Patient’s claim The undiagnosed infection caused the fetal injury in utero.

Doctor’s defense The child’s condition was genetic and unrelated to the infection.

Verdict Michigan defense verdict.

Death following endometrial ablation

A 51-year-old woman weighing between 270 and 290 lb was to undergo endometrial ablation to control heavy menstrual bleeding. To increase her hematocrit for the surgery, her internist treated her with iron infusions. The patient told the anesthesiologist who reviewed her medical history and current physical health that, despite her weight, she could climb stairs and walk several blocks without shortness of breath. She rejected spinal anesthesia, and the anesthesiologist decided surgery could proceed safely.

 

 

About 40 minutes into the surgery, the gynecologist noticed the patent’s leg moving slightly. He then used a nerve stimulator to produce additional movement. Vital signs remained stable. The anesthesiologist administered a paralyzing agent, and the patient’s heart rate decreased 5 minutes later. The patient then died, apparently due to an embolism.

Plaintiff’s claim (1) Inappropriate hormone therapy from the gynecologist caused the need for endometrial ablation. (2) A significant fibroid made her a poor candidate for endometrial ablation. (3) A more thorough workup, including chest radiograph, echocardiogram, pulmonary function test, and arterial blood gas analysis, should have been performed by the anesthesiologist before surgery.

Doctor’s defense (1) There was no negligence involved. (2) Additional tests would not have provided helpful information. (3) Additional tests would not have changed the clinical plan.

Verdict California defense verdict.

References

The cases in this column are selected by the editors of OBG MANAGEMENT from Medical Malpractice Verdicts, Settlements & Experts, with permission of the editor, Lewis Laska, of Nashville, Tenn (www.verdictslaska.com). The available information about the cases presented here is sometimes incomplete; thus, pertinent details of a given situation may be unavailable. Moreover, the cases may or may not have merit. Nevertheless, these cases represent the types of clinical situations that typically result in litigation and are meant to illustrate nationwide variation in jury verdicts and awards.

References

The cases in this column are selected by the editors of OBG MANAGEMENT from Medical Malpractice Verdicts, Settlements & Experts, with permission of the editor, Lewis Laska, of Nashville, Tenn (www.verdictslaska.com). The available information about the cases presented here is sometimes incomplete; thus, pertinent details of a given situation may be unavailable. Moreover, the cases may or may not have merit. Nevertheless, these cases represent the types of clinical situations that typically result in litigation and are meant to illustrate nationwide variation in jury verdicts and awards.

Issue
OBG Management - 19(11)
Issue
OBG Management - 19(11)
Page Number
84-88
Page Number
84-88
Publications
Publications
Topics
Article Type
Display Headline
Medical Verdicts
Display Headline
Medical Verdicts
Legacy Keywords
liability; malpractice; lawsuit; ruptured uterus; uterus; brain injury; hypoxic–ischemic brain injury; oophorectomy; cholecystectomy; abdominal pain; entrapped by cervix; hyperemesis gravidarum; peripherally inserted central line; endometrial ablation
Legacy Keywords
liability; malpractice; lawsuit; ruptured uterus; uterus; brain injury; hypoxic–ischemic brain injury; oophorectomy; cholecystectomy; abdominal pain; entrapped by cervix; hyperemesis gravidarum; peripherally inserted central line; endometrial ablation
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

An idea takes root: Hold those expert witnesses accountable

Article Type
Changed
Display Headline
An idea takes root: Hold those expert witnesses accountable

The author reports no financial relationships relevant to this article.

CASE #1 Suit filed after trauma during home delivery

The facts of the matter. Two parents, whose child was injured during a home delivery, sued the supervising nurse and their obstetrician. An expert witness for the plaintiffs testified that the defendant OB departed from the standard of care under the circumstances. The OB settled the case.

Later, the OB filed a complaint with ACOG’s grievance committee, in which he detailed factual misrepresentations that he claimed were made by the physician–expert witness during that expert’s testimony. (The defendant OB and the expert witness were both members of ACOG.)

The expert witness then sued the OB….

Physician–expert witnesses in medical malpractice litigation have come under increasing scrutiny in recent years. Specifically, many observers worry about “hired guns” who support the testimony of a plaintiff or a defendant in the face (and at the expense) of prevailing medical evidence. That concern is particularly salient in obstetrics, where the cause of a bad outcome that can lead to litigation—such as neurologic birth injury—is, in many cases, still unknown and where malpractice insurance coverage comes at high cost. Many lawsuits often attribute such injury to inappropriate intrapartum management, especially in times of fetal distress, even though leading pediatric neuroepidemiologists have long argued that many of these injuries may be the result of unavoidable antepartum events.1 On the other hand, improper testimony from expert witnesses for the defense may prevent legitimate cases from proceeding.

Medical societies build a place for complaints

Commentators have encouraged medical societies to create venues in which members can bring complaints about the appropriateness of expert witness testimony by other physicians.2 ACOG has established guidelines in its Code of Professional Ethics for members who serve as an expert witness:

…before offering testimony, the obstetrician–gynecologist must thoroughly review the medical facts of the case and all available relevant information…

and, then, during trial:

…the obstetrician–gynecologist testifying as an expert witness must have knowledge and experience about the range of the standard of care and the available scientific evidence for the condition in question during the relevant time and must respond accurately to questions about the range of the standard of care and the available scientific evidence.3

If a member of ACOG considers a fellow member to have violated one of these, or any other, provision of the code, and any litigation has ended, a complaint can be initiated before its grievance committee.

A federal court of appeals recently supported the ability of a professional society to discipline members who violate the society’s code of conduct,4 but such processes can still be subject to judicial review.

Here are three cases that describe professional societies’ role in the oversight of physician–expert witnesses. The cases also reveal how physicians use those review systems and how expert witnesses attempt to rebuff complaints made against them.

Who are the “expert” witnesses in OB malpractice cases?

A recent study revealed that a small cadre of physicians testified in nearly 90% of a national sample of neurologic birth injury cases. These witnesses tended to act consistently for one side. Frequent witnesses for the plaintiff had fewer markers of expertise than frequent witnesses for the defendant did.1

Reference

1. Kesselheim AS, Studdert DM. Characteristics of physicians who frequently act as expert witnesses in neurological birth injury litigation. Obstet Gynecol. 2006;108:273-279.

CASE #1 continued Birth trauma

The controversy. As described, the physician–expert witness sued the defendant OB after he filed a complaint with ACOG against that expert witness. The suit alleged:

  • interference with business contractshe claimed that ACOG’s grievance committee procedure impaired his ability to obtain more expert witness-related work
  • defamationthe complaint damaged his reputation before his peers in ACOG.
The expert witness suggested that it would have been more proper for the defendant OB to forward the complaint to the trial court in which the malpractice action took place or to his employer.

What was the outcome? A federal district court ruled for the defendant OB. It found that the OB’s statement to the ACOG grievance committee was not, for a number of reasons, defamatory:

  • The complaint constituted a long statement of the obstetrician’s opinions that was supported by a number of underlying facts
  • The complaint was submitted to the grievance committee as part of ACOG’s established procedure and was not communicated to other third parties; no apparent effort to intentionally harm the reputation of the expert witness could be inferred.
 

 

The court also dismissed the charge of interference with business contracts because, in its jurisdiction, such a claim required an intentionally malicious motive.

To the contrary, according to the court, the defendant OB “limited himself to advancing a confidential complaint to a peer group in which both parties were members, which might have remained confidential but for” the present litigation.5

What should the parties to a suit expect of an expert witness?

Ideally, physician–expert witnesses should strive to follow the standards for testimony proposed by any state licensing board or professional society to which they are responsible or belong. Most such standards include being sure to review the entire case history before providing an opinion in court and basing opinions on peer-reviewed evidence when such evidence exists.

The goal of the physician–expert witness should be threefold: to put forth the best medical expertise in litigation, to help secure compensation for deserving plaintiffs in true cases of malpractice, and to reduce the impact of frivolous lawsuits on the medical profession.

CASE #2 Revision of a ventricular shunt

The facts of the matter. A lawsuit charged two neurosurgeons with malpractice in managing a ventricular shunt in a patient who had hydrocephalus. The plaintiff’s expert witness, a neurosurgeon, testified in a deposition that:

  • the standard of care for managing a patient after a surgical shunt revision wasn’t met
  • communication between the two neurosurgeons was faulty
  • he “had difficulty believing” statements made by one of the defendants in the medical chart after the patient’s health declined.
After the case, a complaint was brought by one defendant to the North Carolina Medical Board (the licensing authority in the state where the expert witness was licensed) that charged the expert witness with unprofessional conduct for misrepresenting the applicable standard of care and testifying, without corroborating evidence, that a physician had falsified a medical record.

The controversy. At a hearing, the medical board agreed that the expert witness engaged in unprofessional conduct on all counts. It revoked his medical license.

The expert witness appealed the decision to the local state court.

That court found no basis for disciplining the expert for his testimony about the applicable standard of care or the communication between the neurosurgeons. It did uphold the charge of testifying improperly that the defendant had falsified medical records.

The medical board altered its punishment, suspending the expert witness’s medical license for 1 year. The expert witness then appealed this suspension to the North Carolina Court of Appeals.

What was the outcome? The appeals court concluded, after “careful review of the record,” that “the substantial record of evidence does not permit an inference that [the expert witness] made an entirely unfounded statement” about the medical record.

The court held that the expert witness’s opinions were based on a review of multiple aspects of the case, including imaging results and reports of the patient’s behavior. According to the court, “these observations provided a good faith evidentiary basis” for the expert’s opinion. The court reversed the medical board’s suspension of the expert witness’s license.6

CASE #3 Poor care after CVA

The facts of the matter. In a medical malpractice action, a group of physicians were charged with negligence in their care of an elderly diabetic patient who suffered a cerebrovascular accident. During the trial, the plaintiff’s expert witness testified that the defendant physicians’ actions did not meet the standard of care. Ultimately, the case was decided in favor of the defendants.

Afterward, the defendant physicians forwarded a complaint to their state physicians’ association (of which the expert witness was not a member), claiming that the expert witness’s testimony was inappropriate and recommending disciplinary action to prevent the profession “from being terrorized by similar experts.”

The controversy. The expert witness sued the defendants and the state physicians’ association to stop the grievance process, claiming defamation, interference with contract, conspiracy, and other counts. The defendant physicians and the physicians’ association countered that the lawsuit should be dismissed because state and federal laws grant immunity to members of medical peer review committees when there is no evidence of intentional fraud.

The trial court agreed with the defendant physicians. The expert witness appealed.

What was the outcome? The court of appeals overturned the trial court’s opinion. It found that state and federal laws do not clearly provide immunity to the defendants.

The court held that the statutes protecting peer review committees were constructed to help evaluate and improve “the quality of health care rendered by providers of health services”—protection that does not necessarily extend to testimony in a malpractice case. The appeals court also found that the state medical association is not afforded immunity “in its role as an examiner of the quality of a non-member physician’s judicial testimony.”

 

 

Ultimately, the court determined that the case could go forward to assess whether there was any validity to the charges made by the expert witness.7

Tips on filing a complaint

Oversight of physician–expert witnesses is becoming more prevalent among professional specialty societies, state medical societies, and state medical licensing boards. Depending on the region, state, or locale, a physician who notes inappropriate testimony by an expert witness—on behalf of a plaintiff or defendant—may have a better opportunity now to file a complaint with a professional grievance committee established in a pertinent venue.

The cases here teach important lessons for physicians considering bringing a complaint to a grievance committee:

  • A physician who files a complaint should be certain not to make unsupported claims or inflammatory statements, or breach any confidentiality provisions in the grievance process
  • Complainants’ actions should be well documented because they may be subject to judicial review later
  • Physicians should refrain from bringing a complaint against an expert witness to any organization with which that witness is not affiliated because a court might view the role of the organization in that situation differently
  • An expert witness who believes that he (or she) has been improperly accused of wrongdoing might not be able to appeal the decision of a professional society to an external court, but he can seek judicial review of actions that affect his medical license and may be able to bring a personal lawsuit in extreme cases of illegal accusation.
For groups managing such a review process:

  • The grievance process should be organized to avoid favoring either party; it should allow both sides to present their opinions and supporting evidence before a set of impartial observers
  • An appropriate opportunity should be available for internal appeal
  • Although a professional conduct committee can regulate expert witness-related work of its members, that authority may not extend to non-members.
References

1. Nelson KB, Ellenberg JH. Antecedents of cerebral palsy. Multivariate analysis of risk. N Engl J Med. 1986;315:81-86.

2. Freeman JM, Nelson KB. Expert medical testimony: responsibilities of medical societies. Neurology. 2004;63:1557-1558.

3. Code of professional ethics of the American College of Obstetricians and Gynecologists. Washington, DC: American College of Obstetricians and Gynecologists; 2004. Available at http://www.acog.org/from_home/acogcode.pdf.

4. Austin v. American Association of Neurological Surgeons, 253 F3d 967 (7th Cir 2001).

5. Bundren v. Parriott, 2006 US Dist LEXIS 44591 (D Kansas 2006).

6. In Re: Gary James Lustgarten 629 SE2d 886 (NC Ct App 2006)

7. Fullerton v. Florida Medical Association, 938 So2d 587 (Fla Ct App 2006).

Article PDF
Author and Disclosure Information

Aaron S. Kesselheim, MD, JD
Dr. Kesselheim is on the faculty of the Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women’s Hospital, Boston, where he is also an Associate Physician. He is a Clinical Fellow in the Department of Medicine, Harvard School of Public Health, Boston, Mass.

Issue
OBG Management - 19(11)
Publications
Topics
Page Number
30-36
Legacy Keywords
Aaron S. Kesselheim MD JD; professional liability; expert witness; physician–expert witness; medical malpractice litigation; medical malpractice; malpractice; medical evidence; obstetrician–gynecologist; ACOG; testimony; lawsuit
Sections
Author and Disclosure Information

Aaron S. Kesselheim, MD, JD
Dr. Kesselheim is on the faculty of the Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women’s Hospital, Boston, where he is also an Associate Physician. He is a Clinical Fellow in the Department of Medicine, Harvard School of Public Health, Boston, Mass.

Author and Disclosure Information

Aaron S. Kesselheim, MD, JD
Dr. Kesselheim is on the faculty of the Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women’s Hospital, Boston, where he is also an Associate Physician. He is a Clinical Fellow in the Department of Medicine, Harvard School of Public Health, Boston, Mass.

Article PDF
Article PDF

The author reports no financial relationships relevant to this article.

CASE #1 Suit filed after trauma during home delivery

The facts of the matter. Two parents, whose child was injured during a home delivery, sued the supervising nurse and their obstetrician. An expert witness for the plaintiffs testified that the defendant OB departed from the standard of care under the circumstances. The OB settled the case.

Later, the OB filed a complaint with ACOG’s grievance committee, in which he detailed factual misrepresentations that he claimed were made by the physician–expert witness during that expert’s testimony. (The defendant OB and the expert witness were both members of ACOG.)

The expert witness then sued the OB….

Physician–expert witnesses in medical malpractice litigation have come under increasing scrutiny in recent years. Specifically, many observers worry about “hired guns” who support the testimony of a plaintiff or a defendant in the face (and at the expense) of prevailing medical evidence. That concern is particularly salient in obstetrics, where the cause of a bad outcome that can lead to litigation—such as neurologic birth injury—is, in many cases, still unknown and where malpractice insurance coverage comes at high cost. Many lawsuits often attribute such injury to inappropriate intrapartum management, especially in times of fetal distress, even though leading pediatric neuroepidemiologists have long argued that many of these injuries may be the result of unavoidable antepartum events.1 On the other hand, improper testimony from expert witnesses for the defense may prevent legitimate cases from proceeding.

Medical societies build a place for complaints

Commentators have encouraged medical societies to create venues in which members can bring complaints about the appropriateness of expert witness testimony by other physicians.2 ACOG has established guidelines in its Code of Professional Ethics for members who serve as an expert witness:

…before offering testimony, the obstetrician–gynecologist must thoroughly review the medical facts of the case and all available relevant information…

and, then, during trial:

…the obstetrician–gynecologist testifying as an expert witness must have knowledge and experience about the range of the standard of care and the available scientific evidence for the condition in question during the relevant time and must respond accurately to questions about the range of the standard of care and the available scientific evidence.3

If a member of ACOG considers a fellow member to have violated one of these, or any other, provision of the code, and any litigation has ended, a complaint can be initiated before its grievance committee.

A federal court of appeals recently supported the ability of a professional society to discipline members who violate the society’s code of conduct,4 but such processes can still be subject to judicial review.

Here are three cases that describe professional societies’ role in the oversight of physician–expert witnesses. The cases also reveal how physicians use those review systems and how expert witnesses attempt to rebuff complaints made against them.

Who are the “expert” witnesses in OB malpractice cases?

A recent study revealed that a small cadre of physicians testified in nearly 90% of a national sample of neurologic birth injury cases. These witnesses tended to act consistently for one side. Frequent witnesses for the plaintiff had fewer markers of expertise than frequent witnesses for the defendant did.1

Reference

1. Kesselheim AS, Studdert DM. Characteristics of physicians who frequently act as expert witnesses in neurological birth injury litigation. Obstet Gynecol. 2006;108:273-279.

CASE #1 continued Birth trauma

The controversy. As described, the physician–expert witness sued the defendant OB after he filed a complaint with ACOG against that expert witness. The suit alleged:

  • interference with business contractshe claimed that ACOG’s grievance committee procedure impaired his ability to obtain more expert witness-related work
  • defamationthe complaint damaged his reputation before his peers in ACOG.
The expert witness suggested that it would have been more proper for the defendant OB to forward the complaint to the trial court in which the malpractice action took place or to his employer.

What was the outcome? A federal district court ruled for the defendant OB. It found that the OB’s statement to the ACOG grievance committee was not, for a number of reasons, defamatory:

  • The complaint constituted a long statement of the obstetrician’s opinions that was supported by a number of underlying facts
  • The complaint was submitted to the grievance committee as part of ACOG’s established procedure and was not communicated to other third parties; no apparent effort to intentionally harm the reputation of the expert witness could be inferred.
 

 

The court also dismissed the charge of interference with business contracts because, in its jurisdiction, such a claim required an intentionally malicious motive.

To the contrary, according to the court, the defendant OB “limited himself to advancing a confidential complaint to a peer group in which both parties were members, which might have remained confidential but for” the present litigation.5

What should the parties to a suit expect of an expert witness?

Ideally, physician–expert witnesses should strive to follow the standards for testimony proposed by any state licensing board or professional society to which they are responsible or belong. Most such standards include being sure to review the entire case history before providing an opinion in court and basing opinions on peer-reviewed evidence when such evidence exists.

The goal of the physician–expert witness should be threefold: to put forth the best medical expertise in litigation, to help secure compensation for deserving plaintiffs in true cases of malpractice, and to reduce the impact of frivolous lawsuits on the medical profession.

CASE #2 Revision of a ventricular shunt

The facts of the matter. A lawsuit charged two neurosurgeons with malpractice in managing a ventricular shunt in a patient who had hydrocephalus. The plaintiff’s expert witness, a neurosurgeon, testified in a deposition that:

  • the standard of care for managing a patient after a surgical shunt revision wasn’t met
  • communication between the two neurosurgeons was faulty
  • he “had difficulty believing” statements made by one of the defendants in the medical chart after the patient’s health declined.
After the case, a complaint was brought by one defendant to the North Carolina Medical Board (the licensing authority in the state where the expert witness was licensed) that charged the expert witness with unprofessional conduct for misrepresenting the applicable standard of care and testifying, without corroborating evidence, that a physician had falsified a medical record.

The controversy. At a hearing, the medical board agreed that the expert witness engaged in unprofessional conduct on all counts. It revoked his medical license.

The expert witness appealed the decision to the local state court.

That court found no basis for disciplining the expert for his testimony about the applicable standard of care or the communication between the neurosurgeons. It did uphold the charge of testifying improperly that the defendant had falsified medical records.

The medical board altered its punishment, suspending the expert witness’s medical license for 1 year. The expert witness then appealed this suspension to the North Carolina Court of Appeals.

What was the outcome? The appeals court concluded, after “careful review of the record,” that “the substantial record of evidence does not permit an inference that [the expert witness] made an entirely unfounded statement” about the medical record.

The court held that the expert witness’s opinions were based on a review of multiple aspects of the case, including imaging results and reports of the patient’s behavior. According to the court, “these observations provided a good faith evidentiary basis” for the expert’s opinion. The court reversed the medical board’s suspension of the expert witness’s license.6

CASE #3 Poor care after CVA

The facts of the matter. In a medical malpractice action, a group of physicians were charged with negligence in their care of an elderly diabetic patient who suffered a cerebrovascular accident. During the trial, the plaintiff’s expert witness testified that the defendant physicians’ actions did not meet the standard of care. Ultimately, the case was decided in favor of the defendants.

Afterward, the defendant physicians forwarded a complaint to their state physicians’ association (of which the expert witness was not a member), claiming that the expert witness’s testimony was inappropriate and recommending disciplinary action to prevent the profession “from being terrorized by similar experts.”

The controversy. The expert witness sued the defendants and the state physicians’ association to stop the grievance process, claiming defamation, interference with contract, conspiracy, and other counts. The defendant physicians and the physicians’ association countered that the lawsuit should be dismissed because state and federal laws grant immunity to members of medical peer review committees when there is no evidence of intentional fraud.

The trial court agreed with the defendant physicians. The expert witness appealed.

What was the outcome? The court of appeals overturned the trial court’s opinion. It found that state and federal laws do not clearly provide immunity to the defendants.

The court held that the statutes protecting peer review committees were constructed to help evaluate and improve “the quality of health care rendered by providers of health services”—protection that does not necessarily extend to testimony in a malpractice case. The appeals court also found that the state medical association is not afforded immunity “in its role as an examiner of the quality of a non-member physician’s judicial testimony.”

 

 

Ultimately, the court determined that the case could go forward to assess whether there was any validity to the charges made by the expert witness.7

Tips on filing a complaint

Oversight of physician–expert witnesses is becoming more prevalent among professional specialty societies, state medical societies, and state medical licensing boards. Depending on the region, state, or locale, a physician who notes inappropriate testimony by an expert witness—on behalf of a plaintiff or defendant—may have a better opportunity now to file a complaint with a professional grievance committee established in a pertinent venue.

The cases here teach important lessons for physicians considering bringing a complaint to a grievance committee:

  • A physician who files a complaint should be certain not to make unsupported claims or inflammatory statements, or breach any confidentiality provisions in the grievance process
  • Complainants’ actions should be well documented because they may be subject to judicial review later
  • Physicians should refrain from bringing a complaint against an expert witness to any organization with which that witness is not affiliated because a court might view the role of the organization in that situation differently
  • An expert witness who believes that he (or she) has been improperly accused of wrongdoing might not be able to appeal the decision of a professional society to an external court, but he can seek judicial review of actions that affect his medical license and may be able to bring a personal lawsuit in extreme cases of illegal accusation.
For groups managing such a review process:

  • The grievance process should be organized to avoid favoring either party; it should allow both sides to present their opinions and supporting evidence before a set of impartial observers
  • An appropriate opportunity should be available for internal appeal
  • Although a professional conduct committee can regulate expert witness-related work of its members, that authority may not extend to non-members.

The author reports no financial relationships relevant to this article.

CASE #1 Suit filed after trauma during home delivery

The facts of the matter. Two parents, whose child was injured during a home delivery, sued the supervising nurse and their obstetrician. An expert witness for the plaintiffs testified that the defendant OB departed from the standard of care under the circumstances. The OB settled the case.

Later, the OB filed a complaint with ACOG’s grievance committee, in which he detailed factual misrepresentations that he claimed were made by the physician–expert witness during that expert’s testimony. (The defendant OB and the expert witness were both members of ACOG.)

The expert witness then sued the OB….

Physician–expert witnesses in medical malpractice litigation have come under increasing scrutiny in recent years. Specifically, many observers worry about “hired guns” who support the testimony of a plaintiff or a defendant in the face (and at the expense) of prevailing medical evidence. That concern is particularly salient in obstetrics, where the cause of a bad outcome that can lead to litigation—such as neurologic birth injury—is, in many cases, still unknown and where malpractice insurance coverage comes at high cost. Many lawsuits often attribute such injury to inappropriate intrapartum management, especially in times of fetal distress, even though leading pediatric neuroepidemiologists have long argued that many of these injuries may be the result of unavoidable antepartum events.1 On the other hand, improper testimony from expert witnesses for the defense may prevent legitimate cases from proceeding.

Medical societies build a place for complaints

Commentators have encouraged medical societies to create venues in which members can bring complaints about the appropriateness of expert witness testimony by other physicians.2 ACOG has established guidelines in its Code of Professional Ethics for members who serve as an expert witness:

…before offering testimony, the obstetrician–gynecologist must thoroughly review the medical facts of the case and all available relevant information…

and, then, during trial:

…the obstetrician–gynecologist testifying as an expert witness must have knowledge and experience about the range of the standard of care and the available scientific evidence for the condition in question during the relevant time and must respond accurately to questions about the range of the standard of care and the available scientific evidence.3

If a member of ACOG considers a fellow member to have violated one of these, or any other, provision of the code, and any litigation has ended, a complaint can be initiated before its grievance committee.

A federal court of appeals recently supported the ability of a professional society to discipline members who violate the society’s code of conduct,4 but such processes can still be subject to judicial review.

Here are three cases that describe professional societies’ role in the oversight of physician–expert witnesses. The cases also reveal how physicians use those review systems and how expert witnesses attempt to rebuff complaints made against them.

Who are the “expert” witnesses in OB malpractice cases?

A recent study revealed that a small cadre of physicians testified in nearly 90% of a national sample of neurologic birth injury cases. These witnesses tended to act consistently for one side. Frequent witnesses for the plaintiff had fewer markers of expertise than frequent witnesses for the defendant did.1

Reference

1. Kesselheim AS, Studdert DM. Characteristics of physicians who frequently act as expert witnesses in neurological birth injury litigation. Obstet Gynecol. 2006;108:273-279.

CASE #1 continued Birth trauma

The controversy. As described, the physician–expert witness sued the defendant OB after he filed a complaint with ACOG against that expert witness. The suit alleged:

  • interference with business contractshe claimed that ACOG’s grievance committee procedure impaired his ability to obtain more expert witness-related work
  • defamationthe complaint damaged his reputation before his peers in ACOG.
The expert witness suggested that it would have been more proper for the defendant OB to forward the complaint to the trial court in which the malpractice action took place or to his employer.

What was the outcome? A federal district court ruled for the defendant OB. It found that the OB’s statement to the ACOG grievance committee was not, for a number of reasons, defamatory:

  • The complaint constituted a long statement of the obstetrician’s opinions that was supported by a number of underlying facts
  • The complaint was submitted to the grievance committee as part of ACOG’s established procedure and was not communicated to other third parties; no apparent effort to intentionally harm the reputation of the expert witness could be inferred.
 

 

The court also dismissed the charge of interference with business contracts because, in its jurisdiction, such a claim required an intentionally malicious motive.

To the contrary, according to the court, the defendant OB “limited himself to advancing a confidential complaint to a peer group in which both parties were members, which might have remained confidential but for” the present litigation.5

What should the parties to a suit expect of an expert witness?

Ideally, physician–expert witnesses should strive to follow the standards for testimony proposed by any state licensing board or professional society to which they are responsible or belong. Most such standards include being sure to review the entire case history before providing an opinion in court and basing opinions on peer-reviewed evidence when such evidence exists.

The goal of the physician–expert witness should be threefold: to put forth the best medical expertise in litigation, to help secure compensation for deserving plaintiffs in true cases of malpractice, and to reduce the impact of frivolous lawsuits on the medical profession.

CASE #2 Revision of a ventricular shunt

The facts of the matter. A lawsuit charged two neurosurgeons with malpractice in managing a ventricular shunt in a patient who had hydrocephalus. The plaintiff’s expert witness, a neurosurgeon, testified in a deposition that:

  • the standard of care for managing a patient after a surgical shunt revision wasn’t met
  • communication between the two neurosurgeons was faulty
  • he “had difficulty believing” statements made by one of the defendants in the medical chart after the patient’s health declined.
After the case, a complaint was brought by one defendant to the North Carolina Medical Board (the licensing authority in the state where the expert witness was licensed) that charged the expert witness with unprofessional conduct for misrepresenting the applicable standard of care and testifying, without corroborating evidence, that a physician had falsified a medical record.

The controversy. At a hearing, the medical board agreed that the expert witness engaged in unprofessional conduct on all counts. It revoked his medical license.

The expert witness appealed the decision to the local state court.

That court found no basis for disciplining the expert for his testimony about the applicable standard of care or the communication between the neurosurgeons. It did uphold the charge of testifying improperly that the defendant had falsified medical records.

The medical board altered its punishment, suspending the expert witness’s medical license for 1 year. The expert witness then appealed this suspension to the North Carolina Court of Appeals.

What was the outcome? The appeals court concluded, after “careful review of the record,” that “the substantial record of evidence does not permit an inference that [the expert witness] made an entirely unfounded statement” about the medical record.

The court held that the expert witness’s opinions were based on a review of multiple aspects of the case, including imaging results and reports of the patient’s behavior. According to the court, “these observations provided a good faith evidentiary basis” for the expert’s opinion. The court reversed the medical board’s suspension of the expert witness’s license.6

CASE #3 Poor care after CVA

The facts of the matter. In a medical malpractice action, a group of physicians were charged with negligence in their care of an elderly diabetic patient who suffered a cerebrovascular accident. During the trial, the plaintiff’s expert witness testified that the defendant physicians’ actions did not meet the standard of care. Ultimately, the case was decided in favor of the defendants.

Afterward, the defendant physicians forwarded a complaint to their state physicians’ association (of which the expert witness was not a member), claiming that the expert witness’s testimony was inappropriate and recommending disciplinary action to prevent the profession “from being terrorized by similar experts.”

The controversy. The expert witness sued the defendants and the state physicians’ association to stop the grievance process, claiming defamation, interference with contract, conspiracy, and other counts. The defendant physicians and the physicians’ association countered that the lawsuit should be dismissed because state and federal laws grant immunity to members of medical peer review committees when there is no evidence of intentional fraud.

The trial court agreed with the defendant physicians. The expert witness appealed.

What was the outcome? The court of appeals overturned the trial court’s opinion. It found that state and federal laws do not clearly provide immunity to the defendants.

The court held that the statutes protecting peer review committees were constructed to help evaluate and improve “the quality of health care rendered by providers of health services”—protection that does not necessarily extend to testimony in a malpractice case. The appeals court also found that the state medical association is not afforded immunity “in its role as an examiner of the quality of a non-member physician’s judicial testimony.”

 

 

Ultimately, the court determined that the case could go forward to assess whether there was any validity to the charges made by the expert witness.7

Tips on filing a complaint

Oversight of physician–expert witnesses is becoming more prevalent among professional specialty societies, state medical societies, and state medical licensing boards. Depending on the region, state, or locale, a physician who notes inappropriate testimony by an expert witness—on behalf of a plaintiff or defendant—may have a better opportunity now to file a complaint with a professional grievance committee established in a pertinent venue.

The cases here teach important lessons for physicians considering bringing a complaint to a grievance committee:

  • A physician who files a complaint should be certain not to make unsupported claims or inflammatory statements, or breach any confidentiality provisions in the grievance process
  • Complainants’ actions should be well documented because they may be subject to judicial review later
  • Physicians should refrain from bringing a complaint against an expert witness to any organization with which that witness is not affiliated because a court might view the role of the organization in that situation differently
  • An expert witness who believes that he (or she) has been improperly accused of wrongdoing might not be able to appeal the decision of a professional society to an external court, but he can seek judicial review of actions that affect his medical license and may be able to bring a personal lawsuit in extreme cases of illegal accusation.
For groups managing such a review process:

  • The grievance process should be organized to avoid favoring either party; it should allow both sides to present their opinions and supporting evidence before a set of impartial observers
  • An appropriate opportunity should be available for internal appeal
  • Although a professional conduct committee can regulate expert witness-related work of its members, that authority may not extend to non-members.
References

1. Nelson KB, Ellenberg JH. Antecedents of cerebral palsy. Multivariate analysis of risk. N Engl J Med. 1986;315:81-86.

2. Freeman JM, Nelson KB. Expert medical testimony: responsibilities of medical societies. Neurology. 2004;63:1557-1558.

3. Code of professional ethics of the American College of Obstetricians and Gynecologists. Washington, DC: American College of Obstetricians and Gynecologists; 2004. Available at http://www.acog.org/from_home/acogcode.pdf.

4. Austin v. American Association of Neurological Surgeons, 253 F3d 967 (7th Cir 2001).

5. Bundren v. Parriott, 2006 US Dist LEXIS 44591 (D Kansas 2006).

6. In Re: Gary James Lustgarten 629 SE2d 886 (NC Ct App 2006)

7. Fullerton v. Florida Medical Association, 938 So2d 587 (Fla Ct App 2006).

References

1. Nelson KB, Ellenberg JH. Antecedents of cerebral palsy. Multivariate analysis of risk. N Engl J Med. 1986;315:81-86.

2. Freeman JM, Nelson KB. Expert medical testimony: responsibilities of medical societies. Neurology. 2004;63:1557-1558.

3. Code of professional ethics of the American College of Obstetricians and Gynecologists. Washington, DC: American College of Obstetricians and Gynecologists; 2004. Available at http://www.acog.org/from_home/acogcode.pdf.

4. Austin v. American Association of Neurological Surgeons, 253 F3d 967 (7th Cir 2001).

5. Bundren v. Parriott, 2006 US Dist LEXIS 44591 (D Kansas 2006).

6. In Re: Gary James Lustgarten 629 SE2d 886 (NC Ct App 2006)

7. Fullerton v. Florida Medical Association, 938 So2d 587 (Fla Ct App 2006).

Issue
OBG Management - 19(11)
Issue
OBG Management - 19(11)
Page Number
30-36
Page Number
30-36
Publications
Publications
Topics
Article Type
Display Headline
An idea takes root: Hold those expert witnesses accountable
Display Headline
An idea takes root: Hold those expert witnesses accountable
Legacy Keywords
Aaron S. Kesselheim MD JD; professional liability; expert witness; physician–expert witness; medical malpractice litigation; medical malpractice; malpractice; medical evidence; obstetrician–gynecologist; ACOG; testimony; lawsuit
Legacy Keywords
Aaron S. Kesselheim MD JD; professional liability; expert witness; physician–expert witness; medical malpractice litigation; medical malpractice; malpractice; medical evidence; obstetrician–gynecologist; ACOG; testimony; lawsuit
Sections
Article Source

PURLs Copyright

Inside the Article
Article PDF Media

Choosing a Credit Card Company

Article Type
Changed
Display Headline
Choosing a Credit Card Company

[email protected]

Accepting credit cards in your office—both for capturing charges immediately at the time of service and for billing residual balances—has huge advantages. But how do you arrange for credit card processing at your office at the best possible price?

Several processing services are available. Which one you choose will depend not only on cost, but on what specific services you need.

It will also depend on what cards you wish to take. MasterCard and Visa require you to establish a merchant account through an intermediary, but American Express and Discover give you the option of applying directly to them.

Your current bank is probably the easiest intermediary to turn to, but many offer credit card services as part of a package that will include other merchant services you may or may not need.

Another option is an independent sales organization (ISO), which is essentially a broker who represents one or more card processors. An ISO will set up and serve your office but, like a bank, will not do the actual processing itself: It outsources that job to a third-party credit card processor.

If your state or city has a small business and trade association, ask if it offers credit card processing at discount prices.

Consider only processors that provide excellent customer service. Call colleagues and ask which banks or processing companies they use, and ask each candidate company for a list of the medical offices they already serve. Call some of those offices and ask questions: How difficult is it to reach customer support? Are problems handled quickly? How does the provider deal with “chargebacks” (charges later disputed by the cardholder)?

Question the processors about their level of support: Are their phones staffed 24 hours a day? Do they charge for support, either monthly or per call?

Compare prices carefully. Some providers charge application fees of up to $200, and these may be nonrefundable even if you change your mind. You may also be asked to pay setup or account activation fees, Internet processing fees, customer support fees, etc. As always, be sure you have a complete understanding of all the charges you will incur before making your decision and signing a contract.

The principal equipment cost will be for the terminal, which is the machine used to swipe cards. Basic terminals typically cost between $150 and $300; terminals with printers are $200 to $600; and wireless terminals can run from $600 to $1,000. Leases start at $35 a month and rise from there, depending on the sophistication of the terminal and the length of the lease.

The primary ongoing fee is the “discount rate” or “swipe rate,” a percentage the provider takes off the top of each transaction. Ask about reduced rates for high volume, or for total receipts higher than a specified amount per month.

Watch out for extra charges, such as “per transaction” fees and monthly transaction summary preparation fees. Such fees may be negotiable or even waivable, although the company may not volunteer that information.

Beware of long-term leases with early-termination fees. If you are unhappy with your service, you don't want to have to pay a hefty charge for the privilege of changing companies. Also watch out for a trick borrowed from the consumer credit card industry: low introductory rates that increase significantly after a few months or a year.

Find out how long it takes for receipts to be deposited to your account, as this can vary widely. A marginally lower swipe rate won't be worth it if you don't have the use of your money for months.

Finally, if you're not using a bank or financial company you know well, make sure the company is legitimate. Contact the Better Business Bureau to check its status. And if the company is based primarily on the Internet, make sure that you get a physical address and phone number, plus recommendations from existing clients.

Article PDF
Author and Disclosure Information

Publications
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

[email protected]

Accepting credit cards in your office—both for capturing charges immediately at the time of service and for billing residual balances—has huge advantages. But how do you arrange for credit card processing at your office at the best possible price?

Several processing services are available. Which one you choose will depend not only on cost, but on what specific services you need.

It will also depend on what cards you wish to take. MasterCard and Visa require you to establish a merchant account through an intermediary, but American Express and Discover give you the option of applying directly to them.

Your current bank is probably the easiest intermediary to turn to, but many offer credit card services as part of a package that will include other merchant services you may or may not need.

Another option is an independent sales organization (ISO), which is essentially a broker who represents one or more card processors. An ISO will set up and serve your office but, like a bank, will not do the actual processing itself: It outsources that job to a third-party credit card processor.

If your state or city has a small business and trade association, ask if it offers credit card processing at discount prices.

Consider only processors that provide excellent customer service. Call colleagues and ask which banks or processing companies they use, and ask each candidate company for a list of the medical offices they already serve. Call some of those offices and ask questions: How difficult is it to reach customer support? Are problems handled quickly? How does the provider deal with “chargebacks” (charges later disputed by the cardholder)?

Question the processors about their level of support: Are their phones staffed 24 hours a day? Do they charge for support, either monthly or per call?

Compare prices carefully. Some providers charge application fees of up to $200, and these may be nonrefundable even if you change your mind. You may also be asked to pay setup or account activation fees, Internet processing fees, customer support fees, etc. As always, be sure you have a complete understanding of all the charges you will incur before making your decision and signing a contract.

The principal equipment cost will be for the terminal, which is the machine used to swipe cards. Basic terminals typically cost between $150 and $300; terminals with printers are $200 to $600; and wireless terminals can run from $600 to $1,000. Leases start at $35 a month and rise from there, depending on the sophistication of the terminal and the length of the lease.

The primary ongoing fee is the “discount rate” or “swipe rate,” a percentage the provider takes off the top of each transaction. Ask about reduced rates for high volume, or for total receipts higher than a specified amount per month.

Watch out for extra charges, such as “per transaction” fees and monthly transaction summary preparation fees. Such fees may be negotiable or even waivable, although the company may not volunteer that information.

Beware of long-term leases with early-termination fees. If you are unhappy with your service, you don't want to have to pay a hefty charge for the privilege of changing companies. Also watch out for a trick borrowed from the consumer credit card industry: low introductory rates that increase significantly after a few months or a year.

Find out how long it takes for receipts to be deposited to your account, as this can vary widely. A marginally lower swipe rate won't be worth it if you don't have the use of your money for months.

Finally, if you're not using a bank or financial company you know well, make sure the company is legitimate. Contact the Better Business Bureau to check its status. And if the company is based primarily on the Internet, make sure that you get a physical address and phone number, plus recommendations from existing clients.

[email protected]

Accepting credit cards in your office—both for capturing charges immediately at the time of service and for billing residual balances—has huge advantages. But how do you arrange for credit card processing at your office at the best possible price?

Several processing services are available. Which one you choose will depend not only on cost, but on what specific services you need.

It will also depend on what cards you wish to take. MasterCard and Visa require you to establish a merchant account through an intermediary, but American Express and Discover give you the option of applying directly to them.

Your current bank is probably the easiest intermediary to turn to, but many offer credit card services as part of a package that will include other merchant services you may or may not need.

Another option is an independent sales organization (ISO), which is essentially a broker who represents one or more card processors. An ISO will set up and serve your office but, like a bank, will not do the actual processing itself: It outsources that job to a third-party credit card processor.

If your state or city has a small business and trade association, ask if it offers credit card processing at discount prices.

Consider only processors that provide excellent customer service. Call colleagues and ask which banks or processing companies they use, and ask each candidate company for a list of the medical offices they already serve. Call some of those offices and ask questions: How difficult is it to reach customer support? Are problems handled quickly? How does the provider deal with “chargebacks” (charges later disputed by the cardholder)?

Question the processors about their level of support: Are their phones staffed 24 hours a day? Do they charge for support, either monthly or per call?

Compare prices carefully. Some providers charge application fees of up to $200, and these may be nonrefundable even if you change your mind. You may also be asked to pay setup or account activation fees, Internet processing fees, customer support fees, etc. As always, be sure you have a complete understanding of all the charges you will incur before making your decision and signing a contract.

The principal equipment cost will be for the terminal, which is the machine used to swipe cards. Basic terminals typically cost between $150 and $300; terminals with printers are $200 to $600; and wireless terminals can run from $600 to $1,000. Leases start at $35 a month and rise from there, depending on the sophistication of the terminal and the length of the lease.

The primary ongoing fee is the “discount rate” or “swipe rate,” a percentage the provider takes off the top of each transaction. Ask about reduced rates for high volume, or for total receipts higher than a specified amount per month.

Watch out for extra charges, such as “per transaction” fees and monthly transaction summary preparation fees. Such fees may be negotiable or even waivable, although the company may not volunteer that information.

Beware of long-term leases with early-termination fees. If you are unhappy with your service, you don't want to have to pay a hefty charge for the privilege of changing companies. Also watch out for a trick borrowed from the consumer credit card industry: low introductory rates that increase significantly after a few months or a year.

Find out how long it takes for receipts to be deposited to your account, as this can vary widely. A marginally lower swipe rate won't be worth it if you don't have the use of your money for months.

Finally, if you're not using a bank or financial company you know well, make sure the company is legitimate. Contact the Better Business Bureau to check its status. And if the company is based primarily on the Internet, make sure that you get a physical address and phone number, plus recommendations from existing clients.

Publications
Publications
Article Type
Display Headline
Choosing a Credit Card Company
Display Headline
Choosing a Credit Card Company
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Credit Card Processing

Article Type
Changed
Display Headline
Credit Card Processing

Last month, I outlined the advantages of accepting credit cards in your office, both for capturing charges immediately at the time of service and for billing residual balances which come in later. (If you missed that column, you can find it at www.skinandallergynews.com

This month, I'll discuss the nuts and bolts of acquiring credit card processing for your office at the best possible price.

Several sources of processing services are available. Which you choose will depend not only on cost, but on which specific services you need.

It will also depend on which cards you wish to take. MasterCard and Visa require you to establish a merchant account through an intermediary, but American Express and Discover give you the option of applying directly to them.

Your current bank is probably the easiest intermediary to turn to, but many offer credit card services as part of a package that will include other merchant services you may or may not need.

Another option is an independent sales organization (ISO), which is essentially a broker who represents one or more card processors. An ISO will set up and service your office but, like a bank, will not do the actual processing itself: It outsources that job to a third-party credit card processor.

If your state or city has a small business and trade association, ask if it offers credit card processing at discount prices. This is a particularly good option in many areas.

Consider only processors that provide excellent customer service. Call colleagues and ask which banks or processing companies they use, and ask each candidate company for a list of the medical offices they already service. Call some of those offices and ask hard questions: How difficult is it to reach customer support? Are problems handled quickly? How does the provider deal with “chargebacks” (charges later disputed by the cardholder)?

Also question the processors closely about their level of support: Do they have phones staffed 24 hours a day? Do they charge for support, either monthly or per call?

Compare prices carefully. Some providers charge application fees of up to $200, and they may be nonrefundable, even if you change your mind. You may also be asked to pay setup or account activation fees, Internet processing fees, customer support fees, etc. As always, be sure you have a complete understanding of all the charges you will incur before making your decision and signing a contract.

The principal equipment cost will be for the terminal, the machine used to swipe cards. Basic terminals typically cost between $150 and $300, terminals with printers are $200 to $600, and wireless terminals can run from $600 to $1,000. Leases start at $35 a month and rise depending on the sophistication of the terminal and the length of the lease.

The primary ongoing fee is the “discount rate” or “swipe rate,” a percentage the provider takes off the top of each transaction. Some processors charge different rates for in-person transactions and for mail/telephone/Internet transactions. If you plan to sell products via mail order on your Web site, you'll want to ask about that. Ask about reduced rates for high volume or for total receipts higher than a specified amount per month.

Watch out for extra charges, such as “per transaction” fees and monthly transaction summary preparation fees. Such fees may be negotiable or even waivable, although the company may not volunteer that information.

Beware of long-term leases with early termination fees. If you are unhappy with your service, you don't want to have to pay a hefty charge for the privilege of changing companies. Also watch out for a trick borrowed from the consumer credit card industry: low introductory rates that increase significantly after a few months or a year.

Find out how long it takes for receipts to be deposited to your account, since this can vary widely. A marginally lower swipe rate won't be worth it if you don't have the use of your money for months after the transaction.

If your office will be selling merchandise over the Internet, you will need either a secure server that can encrypt credit card information or a processing company that provides secure ordering, or (preferably) both.

Finally, if you are not using a bank or financial company you know well, make sure it is legitimate. Contact the Better Business Bureau to check the company's status. And if the company is based primarily on the Internet, as happens more and more frequently, make sure you get a physical address and phone number, plus recommendations from existing clients.

Article PDF
Author and Disclosure Information

Publications
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Last month, I outlined the advantages of accepting credit cards in your office, both for capturing charges immediately at the time of service and for billing residual balances which come in later. (If you missed that column, you can find it at www.skinandallergynews.com

This month, I'll discuss the nuts and bolts of acquiring credit card processing for your office at the best possible price.

Several sources of processing services are available. Which you choose will depend not only on cost, but on which specific services you need.

It will also depend on which cards you wish to take. MasterCard and Visa require you to establish a merchant account through an intermediary, but American Express and Discover give you the option of applying directly to them.

Your current bank is probably the easiest intermediary to turn to, but many offer credit card services as part of a package that will include other merchant services you may or may not need.

Another option is an independent sales organization (ISO), which is essentially a broker who represents one or more card processors. An ISO will set up and service your office but, like a bank, will not do the actual processing itself: It outsources that job to a third-party credit card processor.

If your state or city has a small business and trade association, ask if it offers credit card processing at discount prices. This is a particularly good option in many areas.

Consider only processors that provide excellent customer service. Call colleagues and ask which banks or processing companies they use, and ask each candidate company for a list of the medical offices they already service. Call some of those offices and ask hard questions: How difficult is it to reach customer support? Are problems handled quickly? How does the provider deal with “chargebacks” (charges later disputed by the cardholder)?

Also question the processors closely about their level of support: Do they have phones staffed 24 hours a day? Do they charge for support, either monthly or per call?

Compare prices carefully. Some providers charge application fees of up to $200, and they may be nonrefundable, even if you change your mind. You may also be asked to pay setup or account activation fees, Internet processing fees, customer support fees, etc. As always, be sure you have a complete understanding of all the charges you will incur before making your decision and signing a contract.

The principal equipment cost will be for the terminal, the machine used to swipe cards. Basic terminals typically cost between $150 and $300, terminals with printers are $200 to $600, and wireless terminals can run from $600 to $1,000. Leases start at $35 a month and rise depending on the sophistication of the terminal and the length of the lease.

The primary ongoing fee is the “discount rate” or “swipe rate,” a percentage the provider takes off the top of each transaction. Some processors charge different rates for in-person transactions and for mail/telephone/Internet transactions. If you plan to sell products via mail order on your Web site, you'll want to ask about that. Ask about reduced rates for high volume or for total receipts higher than a specified amount per month.

Watch out for extra charges, such as “per transaction” fees and monthly transaction summary preparation fees. Such fees may be negotiable or even waivable, although the company may not volunteer that information.

Beware of long-term leases with early termination fees. If you are unhappy with your service, you don't want to have to pay a hefty charge for the privilege of changing companies. Also watch out for a trick borrowed from the consumer credit card industry: low introductory rates that increase significantly after a few months or a year.

Find out how long it takes for receipts to be deposited to your account, since this can vary widely. A marginally lower swipe rate won't be worth it if you don't have the use of your money for months after the transaction.

If your office will be selling merchandise over the Internet, you will need either a secure server that can encrypt credit card information or a processing company that provides secure ordering, or (preferably) both.

Finally, if you are not using a bank or financial company you know well, make sure it is legitimate. Contact the Better Business Bureau to check the company's status. And if the company is based primarily on the Internet, as happens more and more frequently, make sure you get a physical address and phone number, plus recommendations from existing clients.

Last month, I outlined the advantages of accepting credit cards in your office, both for capturing charges immediately at the time of service and for billing residual balances which come in later. (If you missed that column, you can find it at www.skinandallergynews.com

This month, I'll discuss the nuts and bolts of acquiring credit card processing for your office at the best possible price.

Several sources of processing services are available. Which you choose will depend not only on cost, but on which specific services you need.

It will also depend on which cards you wish to take. MasterCard and Visa require you to establish a merchant account through an intermediary, but American Express and Discover give you the option of applying directly to them.

Your current bank is probably the easiest intermediary to turn to, but many offer credit card services as part of a package that will include other merchant services you may or may not need.

Another option is an independent sales organization (ISO), which is essentially a broker who represents one or more card processors. An ISO will set up and service your office but, like a bank, will not do the actual processing itself: It outsources that job to a third-party credit card processor.

If your state or city has a small business and trade association, ask if it offers credit card processing at discount prices. This is a particularly good option in many areas.

Consider only processors that provide excellent customer service. Call colleagues and ask which banks or processing companies they use, and ask each candidate company for a list of the medical offices they already service. Call some of those offices and ask hard questions: How difficult is it to reach customer support? Are problems handled quickly? How does the provider deal with “chargebacks” (charges later disputed by the cardholder)?

Also question the processors closely about their level of support: Do they have phones staffed 24 hours a day? Do they charge for support, either monthly or per call?

Compare prices carefully. Some providers charge application fees of up to $200, and they may be nonrefundable, even if you change your mind. You may also be asked to pay setup or account activation fees, Internet processing fees, customer support fees, etc. As always, be sure you have a complete understanding of all the charges you will incur before making your decision and signing a contract.

The principal equipment cost will be for the terminal, the machine used to swipe cards. Basic terminals typically cost between $150 and $300, terminals with printers are $200 to $600, and wireless terminals can run from $600 to $1,000. Leases start at $35 a month and rise depending on the sophistication of the terminal and the length of the lease.

The primary ongoing fee is the “discount rate” or “swipe rate,” a percentage the provider takes off the top of each transaction. Some processors charge different rates for in-person transactions and for mail/telephone/Internet transactions. If you plan to sell products via mail order on your Web site, you'll want to ask about that. Ask about reduced rates for high volume or for total receipts higher than a specified amount per month.

Watch out for extra charges, such as “per transaction” fees and monthly transaction summary preparation fees. Such fees may be negotiable or even waivable, although the company may not volunteer that information.

Beware of long-term leases with early termination fees. If you are unhappy with your service, you don't want to have to pay a hefty charge for the privilege of changing companies. Also watch out for a trick borrowed from the consumer credit card industry: low introductory rates that increase significantly after a few months or a year.

Find out how long it takes for receipts to be deposited to your account, since this can vary widely. A marginally lower swipe rate won't be worth it if you don't have the use of your money for months after the transaction.

If your office will be selling merchandise over the Internet, you will need either a secure server that can encrypt credit card information or a processing company that provides secure ordering, or (preferably) both.

Finally, if you are not using a bank or financial company you know well, make sure it is legitimate. Contact the Better Business Bureau to check the company's status. And if the company is based primarily on the Internet, as happens more and more frequently, make sure you get a physical address and phone number, plus recommendations from existing clients.

Publications
Publications
Article Type
Display Headline
Credit Card Processing
Display Headline
Credit Card Processing
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Medical Verdicts

Article Type
Changed
Display Headline
Medical Verdicts

Baby’s death in infancy blamed on difficult birth

A woman who was receiving prenatal care from a family medicine practice had a positive 1-hour glucose test, but never took the 3-hour glucose test. She later went into preterm labor and delivered a child vaginally at 34 to 36 weeks’ gestation. Shoulder dystocia occurred during delivery and a nuchal cord was present. An attempt to reduce the cord failed, and it was clamped and divided. Although the child was born depressed, he was resuscitated successfully. He later was diagnosed with hypoxic–ischemic encephalopathy. His neurological status degenerated, and he died at 3 months.

Patient’s claim Negligence occurred in several areas: failure to order a 3-hour glucose test; failure to refer the patient to an OB; failure to order a tocolytic to stop premature labor; and use of too much force to reduce the nuchal cord.

Doctor’s defense An OB consult was not required as this pregnancy was not high-risk; tocolytic treatment was not indicated; and a problem with the cord integrity caused its rupture, not excessive force. Also, a sonogram on the first day of life showed periventricular leukomalacia, indicating that a hypoxic event had occurred in utero and caused the hypoxic–ischemic encephalopathy.

Verdict Illinois defense verdict.

Shoulder dystocia

Shoulder dystocia is part of the complexity of birth problems in the first two cases in this installment of Medical Verdicts. Learn how an expert clinician sheds light on this condition in "Shoulder dystocia: Clarifying the care of an old problem"

Did the forces of labor cause Erb’s palsy?

During a delivery marked by shoulder dystocia, the McRoberts maneuver and suprapubic pressure were used. The infant suffered injury to her brachial plexus, resulting in paralysis of the brachial plexus, shoulder, and upper arm on the right side. The child now receives physical therapy for her injury, which has caused her to be left-side dominant.

Patient’s claim The delivering physician used excessive pressure. Shoulder dystocia should have been expected because of the large fetal size.

Doctor’s defense The physician claimed that he had handled the dystocia properly and avoided possible brain damage. He also argued that the shoulder dystocia could not have been predicted. The brachial plexus injury was caused by the natural forces of labor, which were especially pronounced because the mother weighed 350 pounds.

Verdict Pennsylvania defense verdict.

Severe retardation after troubled delivery

A woman pregnant with her third child presented at a hospital in the early stages of labor. Her second child had been delivered by cesarean section. The morning after her admission, a physician noted that the pregnancy was at term and characterized by a failed trial of labor and cephalopelvic disproportion. He recommended that the woman undergo cesarean section due to failure to progress. Fetal heart tracings were within normal limits.

The woman was given general anesthesia and underwent a nonemergency cesarean section, during which uterine dehiscence was found. The child was pale, floppy, and bradycardic, lacked respiration, and had an initial Apgar score of 1.

Patient’s claim A first-year resident not fully trained in obstetrics observed repetitive decelerations on the fetal heart tracings. An emergency cesarean section should have been performed more than 2 hours before the actual delivery because of nonreassuring fetal monitor strips and evidence of uterine rupture. The child suffered hypoxic–ischemic encephalopathy, resulting in brain damage and severe mental retardation.

Doctor’s defense The doctor maintained that he had seen the child’s head during delivery, with no myometrial membranes covering it, and had used a catheter to suction the infant to prevent aspiration of meconium. The child was depressed at birth due to the anesthesia administered to the mother, but recovered and had a normal Apgar of 7 at 5 minutes after meconium was suctioned from the airway.

The physician also argued that the infant had a normal neonatal course and was moved to a regular nursery, where he thrived. He did not suffer hypoxia, multiple organ failure, or seizures during the neonatal period. Febrile seizures at 21 months resulted from a seizure disorder not related to an injury at birth.

Verdict $300,000 Illinois verdict against the physician; $4 million settlement with the hospital.

Did delay in diagnosis alter cancer outcome?

After finding a lump in her breast, a 28-year-old woman went to her ObGyn, who ordered a biopsy but did not obtain the biopsy results or follow up. Four months later, the woman consulted a second physician and was diagnosed with breast cancer. She underwent lumpectomy, chemotherapy, and radiation.

Patient’s claim Her cancer diagnosis was delayed because of the inaction of the first ObGyn, decreasing her chances of survival from 80% to 40%.

 

 

Doctor’s defense He was not negligent. Also, the delay did not significantly alter the outcome.

Verdict $750,000 Georgia verdict.

Hysterectomy results in vesicovaginal fistula

After a total abdominal hysterectomy and bilateral salpingo-oophorectomy, a woman in her late 30s experienced 3 weeks of “nonstop” urination and leakage. She was diagnosed with a vesicovaginal fistula and referred to a urologist, who confirmed the fistula by cystography. Her incontinence continued.

During open surgical repair 3 months after the hysterectomy, a suprapubic catheter was placed in the patient’s bladder and a Foley catheter in her urethra. The catheters were removed a few weeks later.

Following surgery, the patient experienced urinary tract infections, bladder infections, and incontinence. A cystogram revealed a vesicovaginal fistula from the middle area of the bladder into the vagina. A second Foley catheter was inserted. Four months later, surgery to repair the fistula and lysis of adhesions was mostly successful.

Patient’s claim A laceration that occurred during the hysterectomy led to a vesicovaginal fistula. Also, despite the apparent success of the final surgery, she continues to suffer urinary urgency, frequency, and pain.

Doctor’s defense Not reported.

Verdict $525,000 settlement, paid by the physician’s insurer and his practice.

References

The cases in this column are selected by the editors of OBG MANAGEMENT from Medical Malpractice Verdicts, Settlements & Experts, with permission of the editor, Lewis Laska, of Nashville, Tenn (www.verdictslaska.com). The available information about the cases presented here is sometimes incomplete; thus, pertinent details of a given situation may be unavailable. Moreover, the cases may or may not have merit. Nevertheless, these cases represent the types of clinical situations that typically result in litigation and are meant to illustrate nationwide variation in jury verdicts and awards.

Article PDF
Author and Disclosure Information

Issue
OBG Management - 19(10)
Publications
Topics
Page Number
78-81
Legacy Keywords
liability; malpractice; lawsuit; Lewis Laska; Medical Verdicts
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Baby’s death in infancy blamed on difficult birth

A woman who was receiving prenatal care from a family medicine practice had a positive 1-hour glucose test, but never took the 3-hour glucose test. She later went into preterm labor and delivered a child vaginally at 34 to 36 weeks’ gestation. Shoulder dystocia occurred during delivery and a nuchal cord was present. An attempt to reduce the cord failed, and it was clamped and divided. Although the child was born depressed, he was resuscitated successfully. He later was diagnosed with hypoxic–ischemic encephalopathy. His neurological status degenerated, and he died at 3 months.

Patient’s claim Negligence occurred in several areas: failure to order a 3-hour glucose test; failure to refer the patient to an OB; failure to order a tocolytic to stop premature labor; and use of too much force to reduce the nuchal cord.

Doctor’s defense An OB consult was not required as this pregnancy was not high-risk; tocolytic treatment was not indicated; and a problem with the cord integrity caused its rupture, not excessive force. Also, a sonogram on the first day of life showed periventricular leukomalacia, indicating that a hypoxic event had occurred in utero and caused the hypoxic–ischemic encephalopathy.

Verdict Illinois defense verdict.

Shoulder dystocia

Shoulder dystocia is part of the complexity of birth problems in the first two cases in this installment of Medical Verdicts. Learn how an expert clinician sheds light on this condition in "Shoulder dystocia: Clarifying the care of an old problem"

Did the forces of labor cause Erb’s palsy?

During a delivery marked by shoulder dystocia, the McRoberts maneuver and suprapubic pressure were used. The infant suffered injury to her brachial plexus, resulting in paralysis of the brachial plexus, shoulder, and upper arm on the right side. The child now receives physical therapy for her injury, which has caused her to be left-side dominant.

Patient’s claim The delivering physician used excessive pressure. Shoulder dystocia should have been expected because of the large fetal size.

Doctor’s defense The physician claimed that he had handled the dystocia properly and avoided possible brain damage. He also argued that the shoulder dystocia could not have been predicted. The brachial plexus injury was caused by the natural forces of labor, which were especially pronounced because the mother weighed 350 pounds.

Verdict Pennsylvania defense verdict.

Severe retardation after troubled delivery

A woman pregnant with her third child presented at a hospital in the early stages of labor. Her second child had been delivered by cesarean section. The morning after her admission, a physician noted that the pregnancy was at term and characterized by a failed trial of labor and cephalopelvic disproportion. He recommended that the woman undergo cesarean section due to failure to progress. Fetal heart tracings were within normal limits.

The woman was given general anesthesia and underwent a nonemergency cesarean section, during which uterine dehiscence was found. The child was pale, floppy, and bradycardic, lacked respiration, and had an initial Apgar score of 1.

Patient’s claim A first-year resident not fully trained in obstetrics observed repetitive decelerations on the fetal heart tracings. An emergency cesarean section should have been performed more than 2 hours before the actual delivery because of nonreassuring fetal monitor strips and evidence of uterine rupture. The child suffered hypoxic–ischemic encephalopathy, resulting in brain damage and severe mental retardation.

Doctor’s defense The doctor maintained that he had seen the child’s head during delivery, with no myometrial membranes covering it, and had used a catheter to suction the infant to prevent aspiration of meconium. The child was depressed at birth due to the anesthesia administered to the mother, but recovered and had a normal Apgar of 7 at 5 minutes after meconium was suctioned from the airway.

The physician also argued that the infant had a normal neonatal course and was moved to a regular nursery, where he thrived. He did not suffer hypoxia, multiple organ failure, or seizures during the neonatal period. Febrile seizures at 21 months resulted from a seizure disorder not related to an injury at birth.

Verdict $300,000 Illinois verdict against the physician; $4 million settlement with the hospital.

Did delay in diagnosis alter cancer outcome?

After finding a lump in her breast, a 28-year-old woman went to her ObGyn, who ordered a biopsy but did not obtain the biopsy results or follow up. Four months later, the woman consulted a second physician and was diagnosed with breast cancer. She underwent lumpectomy, chemotherapy, and radiation.

Patient’s claim Her cancer diagnosis was delayed because of the inaction of the first ObGyn, decreasing her chances of survival from 80% to 40%.

 

 

Doctor’s defense He was not negligent. Also, the delay did not significantly alter the outcome.

Verdict $750,000 Georgia verdict.

Hysterectomy results in vesicovaginal fistula

After a total abdominal hysterectomy and bilateral salpingo-oophorectomy, a woman in her late 30s experienced 3 weeks of “nonstop” urination and leakage. She was diagnosed with a vesicovaginal fistula and referred to a urologist, who confirmed the fistula by cystography. Her incontinence continued.

During open surgical repair 3 months after the hysterectomy, a suprapubic catheter was placed in the patient’s bladder and a Foley catheter in her urethra. The catheters were removed a few weeks later.

Following surgery, the patient experienced urinary tract infections, bladder infections, and incontinence. A cystogram revealed a vesicovaginal fistula from the middle area of the bladder into the vagina. A second Foley catheter was inserted. Four months later, surgery to repair the fistula and lysis of adhesions was mostly successful.

Patient’s claim A laceration that occurred during the hysterectomy led to a vesicovaginal fistula. Also, despite the apparent success of the final surgery, she continues to suffer urinary urgency, frequency, and pain.

Doctor’s defense Not reported.

Verdict $525,000 settlement, paid by the physician’s insurer and his practice.

Baby’s death in infancy blamed on difficult birth

A woman who was receiving prenatal care from a family medicine practice had a positive 1-hour glucose test, but never took the 3-hour glucose test. She later went into preterm labor and delivered a child vaginally at 34 to 36 weeks’ gestation. Shoulder dystocia occurred during delivery and a nuchal cord was present. An attempt to reduce the cord failed, and it was clamped and divided. Although the child was born depressed, he was resuscitated successfully. He later was diagnosed with hypoxic–ischemic encephalopathy. His neurological status degenerated, and he died at 3 months.

Patient’s claim Negligence occurred in several areas: failure to order a 3-hour glucose test; failure to refer the patient to an OB; failure to order a tocolytic to stop premature labor; and use of too much force to reduce the nuchal cord.

Doctor’s defense An OB consult was not required as this pregnancy was not high-risk; tocolytic treatment was not indicated; and a problem with the cord integrity caused its rupture, not excessive force. Also, a sonogram on the first day of life showed periventricular leukomalacia, indicating that a hypoxic event had occurred in utero and caused the hypoxic–ischemic encephalopathy.

Verdict Illinois defense verdict.

Shoulder dystocia

Shoulder dystocia is part of the complexity of birth problems in the first two cases in this installment of Medical Verdicts. Learn how an expert clinician sheds light on this condition in "Shoulder dystocia: Clarifying the care of an old problem"

Did the forces of labor cause Erb’s palsy?

During a delivery marked by shoulder dystocia, the McRoberts maneuver and suprapubic pressure were used. The infant suffered injury to her brachial plexus, resulting in paralysis of the brachial plexus, shoulder, and upper arm on the right side. The child now receives physical therapy for her injury, which has caused her to be left-side dominant.

Patient’s claim The delivering physician used excessive pressure. Shoulder dystocia should have been expected because of the large fetal size.

Doctor’s defense The physician claimed that he had handled the dystocia properly and avoided possible brain damage. He also argued that the shoulder dystocia could not have been predicted. The brachial plexus injury was caused by the natural forces of labor, which were especially pronounced because the mother weighed 350 pounds.

Verdict Pennsylvania defense verdict.

Severe retardation after troubled delivery

A woman pregnant with her third child presented at a hospital in the early stages of labor. Her second child had been delivered by cesarean section. The morning after her admission, a physician noted that the pregnancy was at term and characterized by a failed trial of labor and cephalopelvic disproportion. He recommended that the woman undergo cesarean section due to failure to progress. Fetal heart tracings were within normal limits.

The woman was given general anesthesia and underwent a nonemergency cesarean section, during which uterine dehiscence was found. The child was pale, floppy, and bradycardic, lacked respiration, and had an initial Apgar score of 1.

Patient’s claim A first-year resident not fully trained in obstetrics observed repetitive decelerations on the fetal heart tracings. An emergency cesarean section should have been performed more than 2 hours before the actual delivery because of nonreassuring fetal monitor strips and evidence of uterine rupture. The child suffered hypoxic–ischemic encephalopathy, resulting in brain damage and severe mental retardation.

Doctor’s defense The doctor maintained that he had seen the child’s head during delivery, with no myometrial membranes covering it, and had used a catheter to suction the infant to prevent aspiration of meconium. The child was depressed at birth due to the anesthesia administered to the mother, but recovered and had a normal Apgar of 7 at 5 minutes after meconium was suctioned from the airway.

The physician also argued that the infant had a normal neonatal course and was moved to a regular nursery, where he thrived. He did not suffer hypoxia, multiple organ failure, or seizures during the neonatal period. Febrile seizures at 21 months resulted from a seizure disorder not related to an injury at birth.

Verdict $300,000 Illinois verdict against the physician; $4 million settlement with the hospital.

Did delay in diagnosis alter cancer outcome?

After finding a lump in her breast, a 28-year-old woman went to her ObGyn, who ordered a biopsy but did not obtain the biopsy results or follow up. Four months later, the woman consulted a second physician and was diagnosed with breast cancer. She underwent lumpectomy, chemotherapy, and radiation.

Patient’s claim Her cancer diagnosis was delayed because of the inaction of the first ObGyn, decreasing her chances of survival from 80% to 40%.

 

 

Doctor’s defense He was not negligent. Also, the delay did not significantly alter the outcome.

Verdict $750,000 Georgia verdict.

Hysterectomy results in vesicovaginal fistula

After a total abdominal hysterectomy and bilateral salpingo-oophorectomy, a woman in her late 30s experienced 3 weeks of “nonstop” urination and leakage. She was diagnosed with a vesicovaginal fistula and referred to a urologist, who confirmed the fistula by cystography. Her incontinence continued.

During open surgical repair 3 months after the hysterectomy, a suprapubic catheter was placed in the patient’s bladder and a Foley catheter in her urethra. The catheters were removed a few weeks later.

Following surgery, the patient experienced urinary tract infections, bladder infections, and incontinence. A cystogram revealed a vesicovaginal fistula from the middle area of the bladder into the vagina. A second Foley catheter was inserted. Four months later, surgery to repair the fistula and lysis of adhesions was mostly successful.

Patient’s claim A laceration that occurred during the hysterectomy led to a vesicovaginal fistula. Also, despite the apparent success of the final surgery, she continues to suffer urinary urgency, frequency, and pain.

Doctor’s defense Not reported.

Verdict $525,000 settlement, paid by the physician’s insurer and his practice.

References

The cases in this column are selected by the editors of OBG MANAGEMENT from Medical Malpractice Verdicts, Settlements & Experts, with permission of the editor, Lewis Laska, of Nashville, Tenn (www.verdictslaska.com). The available information about the cases presented here is sometimes incomplete; thus, pertinent details of a given situation may be unavailable. Moreover, the cases may or may not have merit. Nevertheless, these cases represent the types of clinical situations that typically result in litigation and are meant to illustrate nationwide variation in jury verdicts and awards.

References

The cases in this column are selected by the editors of OBG MANAGEMENT from Medical Malpractice Verdicts, Settlements & Experts, with permission of the editor, Lewis Laska, of Nashville, Tenn (www.verdictslaska.com). The available information about the cases presented here is sometimes incomplete; thus, pertinent details of a given situation may be unavailable. Moreover, the cases may or may not have merit. Nevertheless, these cases represent the types of clinical situations that typically result in litigation and are meant to illustrate nationwide variation in jury verdicts and awards.

Issue
OBG Management - 19(10)
Issue
OBG Management - 19(10)
Page Number
78-81
Page Number
78-81
Publications
Publications
Topics
Article Type
Display Headline
Medical Verdicts
Display Headline
Medical Verdicts
Legacy Keywords
liability; malpractice; lawsuit; Lewis Laska; Medical Verdicts
Legacy Keywords
liability; malpractice; lawsuit; Lewis Laska; Medical Verdicts
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media